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Design, Development and Biomechanical Analysis of Scaffolds for Augmentation of 
Rotator Cuff Repairs  
 
ABSTRACT  
AMIT AURORA 
Rotator cuff tears are a source of debilitating pain that commonly affects more 
than 40% of our aging population. Despite advances in surgical treatment, the failure rate 
of rotator cuff repairs is as high as 20-90%. Extracellular matrix (ECM) derived scaffolds 
have recently been investigated as augmentation devices for rotator cuff repairs, but none 
has yet demonstrated both the appropriate biological and mechanical properties for 
mitigating re-tears and enhancing healing.  
This dissertation proposes to engineer the mechanical properties of allograft fascia 
lata in a manner that will allow its use as an augmentation device for rotator cuff repairs. 
This dissertation also aims to develop a simple quasi-linear spring-network model for 
rotator cuff repairs to elucidate the basic biomechanics of these repairs. The central 
hypothesis is that engineered fascia lata will have suture retention strength similar to that 
of human rotator cuff tendon (~250N), even after in vivo implantation. The specific aims 
are to engineer the mechanical properties of allograft fascia lata ECM and to 
subsequently evaluate the host response and concomitant mechanical properties of the 
engineered (reinforced) fascia in a rat model. Further, this dissertation will also develop 
and validate a spring-network model for simplified rotator cuff repairs.  
Studies presented in this dissertation demonstrate stitching as a technology to 
engineer the suture retention and stiffness of allograft (human derived) fascia lata ECM. 
Stitching fascia ECM with braided, resorbable, polymer fibers in a unique, controlled 
 viii 
manner increased the suture retention load of reinforced fascia scaffolds by six fold over 
non-reinforced fascia. Additionally, the suture retention properties of reinforced fascia 
scaffolds were comparable to that of human rotator cuff tendon (~250N) at time zero and 
even after in vivo implantation for twelve weeks. Except for the increased presence of 
foreign body giant cells in areas concentrated around the polymer fibers, the host 
response of the reinforced fascia scaffolds were comparable to the non-reinforced fascia 
at the time points investigated. The spring-network model predicted that the scaffold 
component carries ~20-30% of the total load on the repair. Parametric sensitivity analysis 
predicted that greatest improvements in the force carrying capacity of the repair may be 
achieved by improving the properties of the tendon-to-bone repair. Parametric simulation 
studies suggested that in the clinical setting of a weak tendon-to-bone repair, scaffold 
augmentation could significantly off-load the repair and largely mitigate the poor 
construct properties. However, engineering a scaffold with supra-physiologic stiffness 
would not translate into stiffer or stronger repairs.  
The results of this dissertation show that reinforced fascia scaffolds may have and 
possibly maintain mechanical properties comparable to the suture retention properties of 
human rotator cuff tendon. This suggests that reinforced fascia scaffolds may be able to 
provide mechanical augmentation to rotator cuff repairs and also modulate tendon 
retraction in a manner that reduces the incidence of tendon re-tear. The spring-network 
model provides a starting point to develop more clinically relevant models for rotator cuff 
repairs.  
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Chapter I 
BACKGROUND AND SIGNIFICANCE 
 
I have yet to see any problem, however complicated, which, when you looked at it the right way, 
did not become still more complicated…Paul Anderson, New Scientist  
 
 
 
1.1 Rotator Cuff Tears 
Rotator cuff tears are a common source of debilitating pain, weakness and 
reduced shoulder function, which can lead to degenerative changes in the glenohumeral 
joint over time 67. An estimated thirty to seventy five thousand rotator cuff surgeries are 
performed annually in the United States, the treatment, evaluation and management of 
which puts an annual financial burden of 7 billion US Dollars on the United States 
economy 76. 
 The complex anatomy of the shoulder, contact of the torn rotator cuff with 
the synovial fluid milieu and the relative hypovascularity of tendons contribute to the 
impaired healing of these tears and impose significant challenges in the treatment of the 
disorder. Currently, open and arthroscopic surgical repair is accepted as the “gold” 
standard for the treatment of tears that fail to improve even after conservative treatment. 
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Despite improvements in the surgical treatment and our understanding of the etiology of 
these tears, rotator cuff re-tear rates ranging from 20-90% 3, 18, 19, 54, 56, 59, 72 have been 
reported due to factors not restricted to biological, anatomic and mechanical factors, 
which include inferior tissue quality, tendon retraction, muscle atrophy and fatty 
infiltration, undue tension at the repair site in the early post-operative period and the 
synovial fluid environment 15, 24, 49, 54, 60, 83, 86, 96, 97. Furthermore, recurrent and chronic 
rotator cuff tears may not be repairable. Treatment of symptomatic irreparable tears is 
extremely challenging and limited to partial cuff repair 20, surgical debridement with no 
repair57, 77, 84 and physical therapy with no surgery 56 or major reconstructive procedures 
such as muscle transfers 37. Hence, there is a need for repair strategies that can augment 
the repair by mechanically reinforcing it, while at the same time biologically enhancing 
the intrinsic healing potential of the patient 2, 85. Tissue engineering offers a viable 
alternative for the treatment of rotator cuff tears with the aim of restoring tissue and joint 
function.  
 
 
Figure 1. 1: Tissue engineering paradigm 
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1.2 Tissue Engineering  
Tissue engineering seeks to merge engineering and biology towards the 
development of biological substitutes that will repair, or replace tissues and/or organs by 
delivering implanted cells, scaffolds, growth factors or any combination thereof at the 
time of surgery 22, 50 (Figure 1.1). Currently, synthetic and extracellular matrix (ECM) 
derived scaffolds are extensively being investigated as a tissue engineered strategy for the 
treatment of rotator cuff tears.  
 
1.3 Scaffolds for Rotator Cuff Repair  
    The rationale for using a scaffold for rotator cuff repair may include 
reinforcement of the repair and improvement in the rate and quality of biologic healing 33. 
Thus far, scaffolds derived from synthetic biomaterials, human (allografts) and animal 
sources (xenografts) have been investigated and developed for clinical use. Table 1.1 and 
1.2 gives a list of commercially available scaffolds derived from various natural and 
synthetic biomaterials that are being marketed as augmentation devices for rotator cuff 
repairs at the time of surgery, i.e., the scaffold is applied over the primary tendon repair. 
The US Food and Drug Administration (FDA) has cleared these devices “to support soft 
tissues where weakness exists” but not “to provide the full mechanical strength for the 
tendon repair” 
1.3.1 Synthetic Scaffolds  
Rotator cuff repair with scaffolds derived from poly(urethane urea), polylactic 
acid 5, 36, 65, 72, polytetrafluoroethylene 63, chitin 41, chitosan-hyaluronan 40 and 
polycarbonate polyurethane polymer 26 have been studied in animal models over the past 
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decade. Of these scaffolds, only biodegradable poly (urethane urea) and polylactic acid 
scaffolds have been presently cleared by the FDA for the clinical use (Table 1.1). A 
detailed description of several of these products can be found in recent publications 6, 28, 
35, 36, 75, 98. 
 Synthetic scaffolds can be fabricated into three-dimensional scaffolds of variable 
structure and porosity with a wide range of mechanical and degradation                      
properties 36, 48, 75. Ideally host neo-matrix tissue deposition would occur at the same rate 
as the degradation of the synthetic scaffold material thereby maintaining mechanical 
integrity while functional remodeling occurs. However, the success of these synthetically 
derived constructs has been limited due to rapid scaffold degradation kinetics as 
compared to neo-tissue formation/deposition 48. Additionally, synthetic scaffolds are 
associated with limited tissue formation and incorporation into native tissue as well as a 
persistent low-level inflammatory response. Thus, while synthetic scaffolds have a 
distinct advantage of mass production with control over initial strength, rates of 
degradation and microstructure (e.g. three dimensionality, specified porosity, and shape) 
one definite drawback is the lack of biological recognition by the host leading to inferior 
tissue regeneration.  
Product Name Material Marketed By 
SportMesh™ Soft 
Tissue Reinforcement Poly(urethaneurea) Biomet Sports Medicine 
X-Repair® Poly-L-Lactide (PLLA) Synthasome 
Table 1 1: Synthetic scaffold devices with FDA clearance for rotator cuff repair (Adapted from 
Table I in Derwin et al., 33) 
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1.3.2 Extracellular Matrix (ECM) Derived Scaffolds   
Extracellular matrix derived scaffolds are natural occurring biomaterials that have 
a three dimensional architecture with inherent structural and functional proteins, which 
include but are not restricted to collagen, elastin, proteoglycans and glycosaminoglycans 
(GAGs). ECM derived biomaterials also contain macromolecules like vascular 
endothelial growth factor, basic fibroblast growth factor and transforming growth factor 
β1, which may mediate inflammation as well as direct host functions, such as cell 
migration and proliferation, collagen deposition and angiogenesis. Further, the 
degradation products of the molecules that constitute the ECM appear to mediate 
subsequent remodeling events 9, 10, 82. In other words, ECM derived scaffolds may possess 
many of the characteristics desired in an ideal tissue engineered scaffold for regenerative 
medicine. These features of ECMs have garnered the interest of the orthopedic 
community, making ECM technology the most commonly utilized tissue engineering 
strategy to improve the functional outcomes of rotator cuff tears. Presently, ECM 
scaffolds derived and processed from different origins of human and non-human sources 
have been cleared by the FDA to reinforce rotator cuff repairs at the time of surgery 
(Table 1.2). A detailed description of these materials can been found in recent 
publications 28, 35, 98. 
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Product Name ECM Type ECM Source Marketed By 
Restore® SIS Porcine Depuy Orthopaedics 
CuffPatch™ SIS (crosslinked) Porcine Organogenesis 
GraftJacket® Dermis Human Wright Medical 
Conexa™ Dermis Porcine Tornier 
TissueMend® Dermis (fetal) Bovine Stryker Orthopaedics 
Zimmer® Collagen 
Repair  
Dermis 
(crosslinked) Porcine Zimmer 
Bio-Blanket® Dermis (crosslinked) Bovine Kensey Nash 
OrthADAPT™ 
Bioimplant 
Pericardium 
(crosslinked) Equine Pegasus Biologics 
Table 1.2: Extracellular Matrix (ECM) derived scaffold devices with FDA clearance for rotator 
cuff repair. Small Intestinal Submucosa (SIS) (Adapted from Table I in Derwin et al., 33) 
 
 
Hence, the aim of this chapter is to review the current state of knowledge 
regarding the use of extracellular matrix derived (ECM) scaffolds for rotator cuff repair 
including the results of in-vitro biomechanical and biochemical properties, results of pre-
clinical models used to evaluate the efficacy of ECM scaffolds as augmentation devices 
and outcomes of clinical trials using ECM scaffolds for the treatment of rotator cuff tears. 
The indications for clinical use of these scaffolds will then be presented. The review will 
conclude with concluding remarks that will provide suggestions for future investigations. 
Finally, two potential areas of research will be identified and the chapter will conclude 
with the specific aims of the proposed research.  
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1.4  In-vitro Properties of ECMs  
1.4.1 Biomechanical Properties  
Both, the mechanical and suture retention properties of a scaffold will influence 
the extent to which a scaffold can augment the mechanical properties of a tendon repair at 
the time of implantation (time zero). To serve as an augmentation device, scaffolds must 
have the necessary mechanical and suture retention properties to withstand the high in 
vivo tensile loads on the repair and resist suture failure at the scaffold-bone and/or 
scaffold-tendon-suture interface.  
The stiffness (approximately 200 N/mm) and ultimate load (approximately 800 N) 
of human rotator cuff tendon strips have been reported previously 52, 53, 62. The suture 
retention properties of human rotator cuff tendon were shown to be approximately 230 N 
for two mattress sutures subjected to a graduated cyclic load protocol 91  and 224 ± 77 N 
for one mattress stitch pulled to failure (n = 8, unpublished data from Derwin laboratory). 
These properties have been suggested to be used as targets that might guide our choice of 
scaffolds for rotator cuff repair, when mechanical augmentation at time zero is desired 33.  
Previously, Derwin et al., performed uniaxial tension tests (unconstrained) on thin 
strips of commercially available ECM scaffold materials 35. These tests demonstrate that 
small intestinal submucosa (SIS) and dermis derived scaffolds stretch considerably 
(Figure 1.2) and have material properties (modulus of elasticity) an order of magnitude 
lower than tendon (Table 1.3). In contrast, fascia lata has material properties comparable 
to canine infraspinatus tendon and the human supraspinatus tendon 62 (Figure 1.2, Table 
1.3). The structural properties (stiffness) of SIS and dermis derived scaffolds are also 
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more compliant that tendon. In comparison, fascia lata has stiffness similar to that of 
human infraspinatus tendon (97 - 171 N/mm) 53. 
  
 
Figure 1.2: Representative stress versus grip-to-grip strain curves for 4 mm wide ECM strips as 
compared to normal canine infraspinatus tendon. The dotted lines were added to demonstrate that 
the failure point is underrepresented in all curves because all failures occurred at the grip. 
(Adapted from Figure 1 in Derwin et al., 35) 
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Graft 
Material 
Linear 
Region 
Strain* 
(%) 
Linear  
Linear 
Stiffness*** 
(N/mm) 
Suture 
Failure 
Load (N) 
Modulus** 
(MPa) 
Infraspinatus 
tendon 
(canine) 
5-12 405±86 ---- ---- 
Allograft 
Fascia Lata  3-11 304±52 98.2±16.2 10 ± 3 
Restore 22-25 35.5±9.1 7.0±1.5 38.2 ± 2.8 
CuffPatch 20-22 40.1±15 6.8±2.3 32 ± 4.1 
GraftJacket  53-93 22.5±5.3 16.4±5.9 229 ± 72#   
TissueMend 37-53 15.2±3.5 7.4±1.4 76  ± 21.5#   
Zimmer 
Collagen Patch ---- ---- ---- 128 ± 26.3 
Table 1. 3: Biomechanical properties of commercially available ECMs (mean ± SD). The table is 
compiled from Barber et al 14, Derwin et al 34 and Derwin et al 35. The statistical comparisons 
among groups are given in the respective publications. * Grip- to-grip strain ** Linear modulus 
was determined from 4 x 30 mm test strips using grip-to-grip strains.*** Linear stiffness was 
determined from 12 x 30 mm test strips using grip-to-grip strains. # Suture retention loads using 
GraftJacket Extreme and TissueMend 1.2, respectively. Suture retention load of allograft fascia 
lata (unpublished data from Derwin laboratory). (Adapted from Table II in Aurora et al., 6) 
 
However, modulus and stiffness alone are insufficient to predict the 
biomechanical utility of an ECM scaffold. The suture retention properties of a scaffold 
also influence the extent to which a scaffold can augment the mechanical properties of a 
tendon repair at the time of implantation (time zero). Barber et al., have shown that 
dermis derived scaffolds have superior suture retention strength (~200 N) compared to 
SIS scaffolds (~40 N) 14. Our laboratory has shown that fascia lata has poor suture 
retention properties (~10 N) compared to other commercially available ECM scaffolds 
(unpublished data).  
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Together, these mechanical studies help evaluate the extent to which ECM 
scaffolds have the ability to “off-load” the repair at the time of implantation. These 
studies suggest that in their present configuration SIS and dermis derived scaffolds may 
not be capable of providing appreciable mechanical augmentation to rotator cuff repairs 
at time zero. Further, even though, fascia lata has material properties comparable to 
tendon, its poor suture retention properties limit its use as an augmentation device for 
rotator cuff repairs. It is important to note that the in-vitro mechanical properties are only 
applicable at the time of implantation. A loss of mechanical and suture retention 
properties is expected when scaffolds are subjected to the in vivo biological milieu. 
However, the rate and extent of mechanical changes will in part depend on the nature of 
tear, scaffold material, its remodeling characteristics, rehabilitation protocol (mechanical 
loading) and in vivo environment.  
1.4.2 Biochemical Properties 
ECM derived scaffolds are subjected to an acellularization treatment, which is 
intended to remove water-soluble cellular proteins in order to reduce antigenicity 35, 45, 
disrupt cells and reduce the DNA content. However, recent reports 34, 35 have shown that 
show that except for fascia lata that has small, but measurable amounts of DNA, dermis 
derived (GraftJacket and TissueMend) and SIS derived ECM scaffold (Restore, 
CuffPatch) contain appreciable amounts of DNA. Based on hydroxyproline content, the 
collagen content (Type I) of the ECM scaffolds is estimated at 60 to 95% of their dry 
weight 35, demonstrating that like tendon, the primary matrix constituent of these ECMs 
is also collagen. Additionally, processed ECMs have similar chondroitin/dermatan sulfate 
(CSDS) glycosaminoglycan (GAG) content as fresh tendon. Table 1.4 lists the 
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biochemical properties of commercially available ECM scaffolds. The influence of 
glycosaminoglycan (GAG) on tissue regeneration has not been studied directly; however, 
GAGs are known to modulate the healing of soft tissues is several different ways 
including organizing the deposition of collagen fibers 64, 70, stimulating angiogenesis 68, 
inhibiting coagulation 17, 68 and initiating cell and tissue proliferation 39and differentiation 
71. Hence, the presence of relative amounts of GAG in ECM scaffolds will most likely 
favorably impact the host response to the scaffold in vivo. 
 
Graft 
Material 
DNA  CSDS 
GAG 
(µg/mg 
dry wt) 
Hyaluronan 
(µg/mg dry 
wt) 
Hydroxyproline 
(mg/mg dry wt) (ng/mg dry wt) 
Infraspinatus 
Tendon 
(Canine) 
----- 0.84 ± 0.24 ---- 0.110 ± 0.004 
Allograft 
Fascia Lata 66 ± 43 0.61 ± 0.30 0.31 ± 0.19 0.114 ± 0.014 
Restore 526.8 ± 125.6 0.96 ± 0.22 0.78 ± 0.22 0.102 ± 0.008 
CuffPatch 0.6 ± 0.6 0.05 ± 0.01 0.05 ± 0.01 0.112 ± 0.015 
GraftJacket 134.3 ± 44.0 0.27 ± 0.15 0.40 ± 0.08 0.078 ± 0.013 
TissueMend 794.6 ± 97.8 0.08 ± 0.02 0.06 ± 0.02 0.122 ± 0.009 
Zimmer 
Collagen 
Repair Patch 
---- ---- ---- ---- 
Table 1.4: Biochemical properties of commercially available ECMs (mean ± SD). The table 
is compiled from Derwin et al 34 and Derwin et al 35.  The statistical comparisons among groups 
are given in the respective publications. (Adapted from Table III in Aurora et al., 6) 
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In summary, these studies demonstrate that processing does not completely 
acellularize the ECM scaffolds. The clinical implications of incomplete acellularization 
of these ECM scaffolds are not known, but it is believed that the cellular remnants may 
increase antigenicity to the scaffolds in vivo. Amongst the available ECM scaffolds, only 
allograft fascia lata seems to have a low DNA content and a biochemical make-up that is 
similar to that found in canine flexor tendon.  
 
1.5 Pre-clinical Studies of ECMs  
1.5.1 Host Response (Biocompatibility) 
The in vivo remodeling characteristics of dermis and SIS derived ECM scaffolds 
were compared in a rat abdominal wall model at various time points out to 16 weeks 98.  
All ECM scaffolds were associated with an early intense cellular response. However, 
each scaffold elicited a distinct morphological response that depended on the scaffold 
origin and processing technique. SIS-derived, non-cross-linked (Restore) showed rapid 
and intense cell-infiltration, angiogenesis and tissue remodeling at early time points. By 
16 weeks, these scaffolds were largely degraded and replaced with a mixture of organized 
muscle cells, collagenous connective tissue, and small islands of adipose tissue. Non-
crosslinked dermis derived scaffold, GraftJacket, initially (out to 8 weeks) degraded 
slowly and was associated with chronic inflammation. By 16 weeks, the scaffold showed 
partial material degradation with the replacement by moderately organized dense 
collagenous tissue. The host response of ECM scaffolds that were crosslinked 
(CuffPatch, TissueMend and Permacol) was consistent with the classical response to non-
resorbable foreign materials, namely, low-grade chronic inflammation, minimal scaffold 
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degradation, fibrous encapsulation, presence of foreign body giant cells and/or 
accumulation of dense, poorly organized fibrous tissue.  
Recent studies using primate body wall model have shown that non-crosslinked 
porcine and human dermis derived ECM demonstrate a good remodeling response and 
robust cellular infiltration over time 87, 100. More recently, a biopsy specimen of human 
derived scaffold (GraftJacket) retrieved from a patient three months after rotator cuff 
repair augmentation showed that graft material was intact and filled with numerous 
elastic fibers and blood vessels 94. There was little to no inflammatory response along 
with extensive host cellular infiltration that was evident along the margins of the graft. 
The orientation of the collagen fibers indicated early organization of new tissue. 
Together these studies demonstrate that ECM scaffolds elicit a distinct histologic 
and morphologic response, which most likely depends on the processing technique, tissue 
origin and species, method of terminal sterilization and mechanical loading environment. 
Further, the temporal sequence of remodeling events of extracellular matrix devices, 
including the rate and extent of scaffold degradation, incorporation, and/or host tissue 
deposition is likely to be predictive of the clinical course and may dictate the optimal 
rehabilitation protocol and functional outcome of the clinical repair procedure 33.  
1.5.2 Animal Models for Rotator Cuff Repair 
Animal models have played an essential role part in the preclinical evaluation of 
ECM scaffolds for musculoskeletal soft tissue repairs that include Achilles tendon, flexor 
and rotator cuff tendons, knee joint ligaments and meniscus to name a few 4, 8, 11, 12, 27, 32, 
44, 66, 78, 99. It is important to point out that the actual commercial ECM scaffolds are not 
always identified in animal models, but rather a generic device is prepared for research 
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purposes. Thus far, most studies using animal models have investigated the use of ECM 
scaffolds as interpositional devices (scaffold bridging tendon and bone) 3, 23, 30, 31, 74, 80, 88, 
101. This section only discusses studies that have investigated the use of ECM scaffolds as 
augmentation devices (scaffold placed over tendon repair), the indication for which they 
have approved by the FDA. Table 1.5 list the animal models done using ECM scaffolds 
either as interpositional (i.e., scaffold forms a bridge between torn tendon and bone) or 
augmentation devices (i.e., scaffold is applied over primary tendon repair).  
 
Product Author Indication Model Tendon 
Restore 
Chen et al. Interpositional Rabbit Supraspinatus 
Dejardin et al. Interpositional Canine Infraspinatus 
Nicholson et al. Augmentation Ovine Infraspinatus 
Perry et al. Interpositional Rat Supraspinatus 
Schlegel et al. Augmentation Ovine Infraspinatus 
Zheng et al. Interpositional Rabbit Supraspinatus 
Zalvaras et al. Interpositional Rat Supraspinatus 
GraftJacket 
Adams et al. Interpositional Canine Infraspinatus 
Ide et al. Interpositional Rat Supraspinatus 
Zimmer Collagen Repair 
Patch Nicholson et al. Augmentation Ovine Infraspinatus 
(Permacol) 
Fresh autograft fascia lata Sano et al. Interpositional Rabbit Supraspinatus 
Table 1.5: Pre-clinical studies using ECM derived scaffolds for rotator cuff repair. (Adapted 
from Table II in Longo et al., 69 ) 
 
Schlegel et al., used a SIS patch (10 by 20 mm) to augment a full thickness 
infraspinatus tendon repair in an ovine shoulder model 90. The control was tendon repair 
without scaffold. The improvements in the biomechanical outcomes were not 
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investigated in this study. However, the authors reported that none of the repairs (with or 
without SIS augmentation) remained intact, demonstrating that SIS augmentation was 
insufficient to prevent anatomic failure of rotator cuff tendon repair in this animal model. 
More recently, Nicholson et al., investigated the effect of repair augmentation with SIS 
derived (Restore) and cross-linked porcine dermis derived scaffold in a partial width 
infraspinatus tendon injury model in sheep 79. The authors report an improvement in the 
biomechanical force of the augmented repairs compared to control (no scaffold) repairs at 
9 weeks. The dermis derived scaffold showed signs of chronic inflammation, minimal 
scaffold degradation and integration with the surrounding tissue, while SIS derived 
scaffolds showed evidence of resorption and remodeling. At 24 weeks, no differences in 
the biomechanical force were reported between groups. The tendon-to-bone insertion site 
of the augmented repairs showed signs of maturation at 24 weeks. These findings seem to 
be in contradiction to a recent host response study in a rat model wherein the authors 
found the cross-linked porcine dermis derived scaffold to be associated with a classical 
response to non-resorbable foreign materials at 16 weeks. These differences may be due 
to differences in the animal species (ovine vs. rat), application of use (tendon repair vs. 
body wall) and also duration of the study (24 weeks vs. 16 weeks).  
These studies though significant use different models of tendon injury which 
restricts our ability to compare the in vivo performance of the two scaffolds. Various 
researchers have recommended the standardization of injury model and surgical 
technique; study design and outcome measures that will help provide meaningful 
comparison and interpretation of animal studies 1, 33 
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1.5.3 Human Shoulder Repair Studies  
The performance of the scaffold as an augmentation device is in part also 
dependent on the surgical method of scaffold application, which includes the number, 
type and location of fixation sutures and pre-tensioning of scaffolds at the time of repair. 
Hence, human cadaver models are being used to evaluate the biomechanical efficacy of 
scaffolds as augmentation devices of primary tendon repair at time zero 13, 75. Barber et 
al., report the only human cadaver model to date that investigates the biomechanical 
performance of dermis derived, GraftJacket, as augmentation device for rotator cuff 
repairs. The study demonstrated a ~ 27% increase in the failure load and fewer failures at 
the tendon-suture interface for full thickness supraspinatus repairs augmented with 
GraftJacket 13.  
 
1.6. Clinical Studies  
Restore (porcine SIS), GraftJacket (non-crosslinked human dermis) and Zimmer 
Collagen Repair (cross-linked porcine dermis) are the only ECM products that have been 
have been clinically investigated as interpositional 38, 95 and augmentation devices for the 
treatment of rotator cuff tears in the peer-review literature. This section will briefly only 
discuss the clinical studies that have used scaffolds as augmentation devices.  
1.6.1 Restore  
Metcalf et al., demonstrated improved post operative outcomes for patients treated 
for massive chronic rotator cuff tears with Restore SIS as an augmentation device 
compared to their pre-operative condition in a two year follow-up study.  However, more 
recently, clinical studies have reported formation of non-infectious edema, swelling, pain 
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and increased skin temperature around the wound when using the Restore device 61, 73, 92. 
Zheng et al., have postulated these adverse outcomes are due to the existence of porcine 
cellular elements in the Restore device 102. The findings of these clinical trials suggest 
that uncross-linked porcine SIS Restore is not suited for repair augmentation of large to 
massive rotator cuff tears in the human condition.  
1.6.2 GraftJacket and Zimmer Collagen Repair Patch (Permacol) 
Burkhead et al., conducted a follow-up study (mean follow-up 1.2 years) of 
seventeen patients with massive rotator cuff tears, repaired and subsequently augmented 
with GraftJacket using a standardized open repair technique 21. They reported an 
improvement in the post-operative subjective pain and functional scores, as well as in the 
measured range of motion and strength were noted in the study population. Additionally, 
no infections, sterile inflammatory reactions or other complications were observed.  
Bond et al., followed (mean follow-up 2.3 years) 16 patients with massive, 
contracted, immobile rotator cuff tears treated by GraftJacket augmentation using an 
arthroscopic repair technique 16. Statistically significant improvements were also seen in 
the post-operative UCLA scores, pain, forward flexion and external rotation strength. 
Post-operative imaging in thirteen patients demonstrated complete incorporation of the 
graft into the native tissue.  
Badhe et al., conducted a follow-up study (mean follow-up 4.5 years) of ten 
patients with massive rotator cuff tears, augmented with Zimmer Collagen Repair patch 
(Permacol), using a standardized open repair technique 7. An improvement in the post-
operative subjective pain and functional scores, as well as in the measured range of 
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motion and strength were noted in the study population. Additionally, no infections, 
sterile inflammatory reactions or other complications were observed.  
To summarize, dermis derived scaffolds may be appropriate for augmentation of 
large to massive rotator cuff tears. However, each of these studies is limited by the lack 
of cohort of control patients who underwent repair but did not receive a scaffold. Further, 
Zimmer Collagen Repair patch when used an interpositional graft demonstrated synovitis 
inflammatory exudate, which may be due to cross-linking 95. Taken together these studies 
highlight the need of randomized clinical trials that will allow proper interpretation of the 
results and help evaluate the clinical efficacy of ECM scaffolds for the treatment of 
rotator cuff tears 
 
1.7 Indications for Clinical Use of ECM Scaffolds  
The paucity of controlled, human trials using ECM scaffolds makes it challenging 
to define the best indications for their use. Based on the geometry and reparability of the 
tear, Derwin et al., have proposed six grades of rotator cuff pathology that can be 
assigned clinically 33 (Table 1.6). They have recommended the use of an appropriate 
ECM scaffold as an augmentation device for Grade III and IV tears and as an 
interposition device in selected cases of Grade V disease. (At the current time, only ECM 
scaffolds derived from human sources have been cleared by the FDA as interpositional 
devices). It is suggested that the use of any scaffold is warranted in cases of chronic, 
medium, large-to-massive tears that are surgically reparable, but which otherwise have a 
high risk not to heal. Since primary repair (repair of tendon to bone) of small and 
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medium-sized acute cuff tears are likely to heal with proper surgical and post operative 
care in 90% of cases, the use of ECM scaffolds is not justifiable for such cases.  
It should be borne in mind, that the proper selection and use of ECM scaffolds do 
not guarantee the clinical success of rotator cuff repairs. There are myriad of factors that 
might affect tendon to bone healing, which include size of the tear 42, degree of muscle 
atrophy 42, tendon quality 29, 55, 86, passive tension 58, 81, repair tension 46, 47, use of nicotine 
43, use of non-steroidal anti inflammatory drugs 25, reduced acromiohumeral distance 89, 
post operative rehabilitation protocol 60 and early accelerated patient activity.  
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Grade Rotator Cuff Indications Current Treatment(s) Outcomes Graft Indication 
VI Massive and retracted irreparable tear with intra-articular pathology 
Open reverse total shoulder 
replacement (aggressive) Adequate but limited function Not indicated 
V 
Large, massive tear 
(3-5 cm, 2-3 tendons) 
Irreparable       
(unable to reappose to tuberosity with  
low tension)  
Open or arthroscopic attempt    
at repair, muscle transfer, 
debridement and/or partial repair 
High failure rate 
(50+ % re-tear and/ or low outcome 
scores) 
Interposition in 
selected 
instances 
IV 
Large, massive tear   
(3-5 cm, 2-3 tendons) 
Reparable 
Open or arthroscopic repair 
Moderate failure rate 
(30+ % re-tear;  85% pain-free but 
reduced function) 
Augmentation 
III Small to medium tear  
(< 3 cm, 1 tendon) 
Arthroscopic repair 
Moderate failure rate 
(5-10% re-tear; 85% pain-free but 
>50% reduced function) 
Augmentation 
II Partial thickness tear  
(articular or bursal surface, >50%) 
Arthroscopic decompression/ 
debridement 
-or- 
repair with acromioplasty 
40% failure within 5 yrs when 
debrided only; 
95% heal when repaired 
Not indicated 
I Partial thickness tear  
(articular or bursal surface, <50%) 
Arthroscopic decompression/ 
debridement 
-or- 
repair with acromioplasty 
95% heal when repaired Not indicated 
Table 1.6: Clinical grades of rotator cuff pathology. Adapted from Table II in Derwin et al., 33
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1.8. Concluding Remarks  
The rationale for using a scaffold for rotator cuff repair may include 
reinforcement of the repair and improvement in the rate and quality of biologic healing. 
Synthetic scaffolds are typically characterized by uniform and reproducible mechanical 
and material properties; however, these scaffolds lack the bioactivity seen in ECM 
derived scaffolds and often result in fibrous encapsulation following implantation. ECM 
derived scaffolds provide a supportive medium for constructive remodeling by providing 
a chemically and structurally instructive environment for host cells via their natural 
composition, three-dimensional structure and/or remodeling byproducts 9, 10, 82, which 
may improve the biology of repair healing. This has garnered the interest of the 
orthopedic community making it currently the most common tissue engineered strategy 
utilized to improve the functional outcomes of rotator cuff tears. 
For any scaffolds to serve as an augmentation device, they must have the 
necessary mechanical and suture retention properties to withstand the high in vivo tensile 
loads on the repair and resist suture failure at the scaffold-bone and/or scaffold-tendon-
suture interface. When choosing a scaffold for rotator cuff repair augmentation, the 
mechanical and suture retention properties of the human rotator cuff tendon should be 
used as targets to guide our choice of scaffolds for rotator cuff repair.  
In vitro mechanical studies help evaluate the extent to which ECM scaffolds have 
the ability to “off-load” the repair at the time of implantation. These studies suggest that 
in their present configuration, SIS and dermis derived scaffolds may not be capable of 
providing appreciable mechanical augmentation to rotator cuff repairs at the time of 
implantation (time zero). Further, even though, fascia lata has material properties 
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comparable to tendon, its poor suture retention properties limit its use as an augmentation 
device for rotator cuff repairs.  
Scaffolds when used as augmentation devices are believed to improve the initial 
biomechanical properties of the repair and offer some degree of load sharing in a manner 
that will reduce the incidence of tendon re-tear. While, human cadaver studies 
demonstrate the potential for scaffold augmentation to improve the initial biomechanical 
properties of a rotator cuff repair construct, the percent load carried by a scaffold when 
used for rotator cuff repair augmentation needs to be investigated. Further, the 
appropriate scaffold material properties and/or surgical application techniques for 
achieving optimal biomechanical performance in the setting of rotator cuff repairs are 
unknown.  
Animal models for evaluating the efficacy of ECM scaffolds need to be 
standardized. More specifically, standardization of the injury model, surgical technique, 
study design and outcome measures will allow meaningful comparison and interpretation 
of animal studies using different species.  
Despite the current clinical use of ECMs for rotator cuff repair, only a limited 
number of follow-up studies in human patients have been reported in the peer-reviewed 
literature. These studies highlight the need of randomized clinical trials that will allow 
proper interpretation of the results and help evaluate the clinical efficacy of ECM 
scaffolds for the treatment of rotator cuff tears.  
 In summary, several ECM scaffolds are now available in the armamentarium of 
surgeons. There is burgeoning need to design and develop basic and clinical science 
studies that will address questions related to the indications for use, surgical application, 
 
 
 23 
rehabilitation protocols, in vivo remodeling and efficacy of these scaffolds. ECM 
scaffolds may have enormous therapeutic potential, but it will require a conscientious and 
orchestrated effort of manufacturers, clinicians and researchers to develop and validate 
ECM technology as a safe and effective treatment for improving the healing of rotator 
cuff tears.  
 
1.9. Allograft Fascia Lata ECM  
The in vitro mechanical, biochemical and cellular properties of several ECMs 
were described in Section 1.4. The properties of human fascia lata will be highlighted 
again here, to provide rationale for its development and investigation for tendon 
augmentation in this dissertation. Specifically, human fascia lata is a tendinous structure 
procured from the deep fascia of the thigh at a region that corresponds to the iliotibial 
band (Figure 1.3). Although fascia ECM has not been previously evaluated as a tendon 
augmentation scaffold in a formal clinical study, nor is it currently marketed as an ECM 
device for rotator cuff repair, human fascia lata has a clinical history of use as an 
autograft or allograft in the reconstruction of various soft tissues, including pectoralis 
major tendon 93, hallucis longus tendon 103, and achilles tendon 51.  
Derwin et al., investigated the mechanical properties of fascia and several 
commercially-available ECM scaffolds indicated for rotator cuff repair augmentation 35. 
When pulled to failure under uniaxial tension, fascia exhibited an elastic modulus (532 ± 
106 MPa) similar to canine infraspinatus tendon (405 ± 86 MPa) and stretched only ~3% 
before stiffening and bearing any significant load. Additionally, fascia ECM has been 
shown to have a biochemical composition and histological structure similar to tendon 34. 
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The hydroxyproline and chondroitin sulfate/dermatin sulfate GAG concentrations in 
fascia are similar to canine infraspinatus tendon (Table 1.4) 34.  
Hence, based on similarity with tendon scaffolds derived from human fascia lata, 
may be appropriate for use as an augmentation device for tendon repair. 
.  
 
Figure 1.3: A) Allograft fascia lata ECM procured from the deep fascia of the thigh at a region 
that corresponds to the iliotibial band B) Pictorial depiction of the anatomical location of fascia 
lata  
 
 
 
Figure 1.4: (A) Image of H&E stained section of native fascia ECM, demonstrating the bilayer of 
collagen fascicles that are orthogonally-oriented and (B) stereomicrograph of the deep layer of 
fascia, which resembles a flat sheet of tendon 
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1.10 Summary  
Currently, no commercially available ECM scaffold has the appropriate 
mechanical properties that would allow mechanical augmentation of the repair at the time 
of implantation. Hence, there is a critical need for an ECM scaffold that provides 
adequate strength as well as stimulates and enhances healing potential. Allograft fascia 
lata, a tendinous structure procured from the deep fascia of the thigh at a region that 
corresponds to the iliotibial band (Figure 1.3), has structural, material and biochemical 
properties comparable to tendon. Hence, fascia lata may be an attractive biomaterial for 
use as an augmentation device for rotator cuff repairs. However, fascia lata has poor 
suture retention properties (~ 10 N) compared to the suture retention of human rotator 
cuff tendon (200 - 240 N). Hence, there is a need to improve the suture retention strength 
of fascia in a manner that that will make it comparable to the suture retention properties 
of human rotator cuff tendon (200 - 240 N), which may then allow its use as an 
augmentation device for rotator cuff repairs.  
Scaffolds when used as augmentation devices are believed to improve the initial 
biomechanical properties of the repair and offer some degree of load sharing in a manner 
that will reduce the incidence of tendon re-tear. While the biomechanical benefit 
achieved by using scaffolds as augmentation devices has recently been reported using 
cadaver models, no studies have investigated the degree of load sharing provided by a 
scaffold used for rotator cuff repair augmentation. Furthermore, the manner in which 
loads on an augmented rotator cuff repair are distributed amongst the various components 
of the repair is not known, nor is the relative biomechanical importance of the various 
components of the augmented rotator cuff repair. Hence, there also remains an allied 
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need to develop an improved understanding of the basic biomechanics of scaffold 
augmented rotator cuff repairs.  
 
1.11 Specific Aims 
The long term goal of the research is to develop effective strategies for successful 
repair of large, chronic rotator repairs. The objective of this dissertation is to engineer the 
mechanical properties (suture retention strength and stiffness) of allograft fascia lata in 
order to develop an extracellular matrix (ECM) derived scaffold with robust mechanical 
properties for use in musculoskeletal soft tissue repair. An allied objective will also be to 
develop and validate a simple quasi-static spring-network model for rotator cuff repairs 
that will help elucidate the basic biomechanics of scaffold augmented rotator cuff repairs. 
The central hypothesis is that engineered fascia lata will have suture retention strength 
and stiffness similar to the human rotator cuff tendon, even after in vivo implantation. 
The rationale for this work is that engineering the mechanical properties of allograft 
fascia lata will support the translation of a tendon-like, strong, robust scaffold for 
augmenting tendon repairs in humans. And, the development of a spring-network model 
will help design and develop effective scaffolds and surgical strategies for the treatment 
of rotator cuff repairs. We will test the central hypothesis and achieve the objectives of 
this proposal via the following specific aims:  
 
Specific Aim 1: Engineer the suture retention strength and stiffness of allograft 
fascia lata ECM at time zero using stitching as a method of reinforcement (Chapters 
2 and 3) 
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Polymer braids with two different compositions, 100% Poly L- Lactic Acid 
(PLLA) and mix of PLLA and Poly Glycolic Acid (PGA) (6PLLA/2PGA) was used to 
reinforce fascia patches. Mechanical testing was performed to assess the suture retention 
strength, stiffness and fatigue behavior of the reinforced fascia scaffolds at time zero. The 
reinforced fascia scaffolds were designed to have time zero mechanical properties (suture 
retention load)  comparable to the suture retention load of human rotator cuff tendon                
(≥ 250N) and higher than non-reinforced fascia ECM. 
 
Specific Aim 2: Investigate the host response and time-dependent changes in 
mechanical properties of reinforced fascia scaffolds after implantation in a rat 
model (Chapter 3) 
Polymer braids with two different compositions, 100% Poly L- Lactic Acid 
(PLLA) or 6PLLA/2Poly Glycolic Acid (PGA) was used to reinforce fascia patches. 
Mechanical testing was performed to assess suture retention and stiffness and of 
reinforced fascia scaffolds after 4 and 12 weeks implantation in a rat subcutaneous 
model. The biocompatibility of the constructs was also verified using histological 
analysis at the same time points. The hypotheses were:  
Hypothesis 2a: The mechanical properties of reinforced fascia scaffolds will decrease 
after in vivo implantation, and the decrease will be more predominant in scaffolds 
reinforced with 6PLLA/2PGA, but the suture retention load of reinforced fascia scaffolds 
will remain ≥ 250N.  
Hypothesis 2b: The host response to reinforced fascia scaffolds will be similar to non-
reinforced fascia characterized by the presence of lymphocytes and macrophages but with 
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an increased presence of foreign body giant cells due to the presence of the polymer 
braid.  
 
Specific Aim 3: Develop and validate a quasi-static spring-network model for 
simplified rotator cuff repairs (Chapters 4, 5 and 6) 
The approach was to model the individual components of the rotator cuff repair as 
non-linear springs and estimate parameters of the individual springs by non-linear least-
squares analysis of the load-displacement data determined from isolated mechanical tests 
of each individual component. The model was developed based on the physics of springs 
in series and parallel and validated by comparing the predicted model force to 
experimental results. The validated model was then used to predict the degree of load 
sharing provided by the scaffold, conduct a parametric sensitivity analysis and 
parametrically simulate the model for different clinical scenarios.  
The proposed research is innovative because it combines a tendon-like, allograft 
ECM with biocompatible polymer fibers in braided form using stitching as a method 
reinforcement, to achieve a scaffold that is mechanically suitable for rotator cuff repair. 
Through this research we expect to identify an appropriate reinforcing braid and establish 
the mechanical efficacy of polymer reinforced fascia scaffold as an augmentation device 
for rotator cuff repair. The development of the spring-network model of rotator cuff 
repair will provide for the first time, information about the load-sharing ability of 
augmentation scaffolds used for rotator cuff repair, and offer unique insight into how 
changes to various components of the repair may influence the biomechanical 
performance of the repair construct. These results are expected to have a positive impact 
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because they will support translation of polymer reinforced fascia scaffold for tendon 
repair in humans, offering the orthopedic surgeon with a robust allograft scaffold for 
increasing the likelihood of clinical success of large, debilitating, and chronic rotator cuff 
tears frequently encountered by the aging population. Additionally, the development of a 
spring-network model is expected to direct and inform the design of new repair strategies 
and may have broader implications for understanding the basic mechanics of scaffold 
augmentation of other soft tissue repairs as well. 
 
1.12 Brief Outline of the Dissertation 
Chapter 2 - Pilot Studies: This chapter describes preliminary studies that establish 
stitching as a method for engineering the mechanical properties of fascia lata ECM. 
Chapter 3 - Development of Allograft Fascia Lata as an Extracellular Matrix Derived 
Scaffold for Musculoskeletal Soft Tissue Repairs: This chapter will characterize the 
mechanical properties, namely, suture retention load and stiffness, and fatigue behavior 
of reinforced fascia scaffolds at time zero and investigate the host response and time 
dependent changes in mechanical properties of reinforced fascia scaffolds after 
implantation in a rat model. The contents of this chapter will be submitted as a 
manuscript to the Journal of Biomedical Materials Research.  
Chapter 4 - Formulation and Development of Spring-Network Model for Rotator Cuff 
Repairs: This chapter will focus on the formulation and development of quasi-static 
spring-network models for non-augmented and augmented human and canine rotator cuff 
repairs.  
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Chapter 5 - Validation of Spring-Network Model for Rotator Cuff Repairs: This chapter 
will present studies to validate the developed model in Chapter 4, demonstrate the 
calculation of confidence intervals for the model predictions using error propagation 
analysis, predict the degree of load sharing provided by the scaffold, and present an 
approximate parametric sensitivity analysis to identify which component(s)/parameter(s) 
most influences the mechanical behavior predicted by the augmented repair model. 
Various parts of this chapter have been previously published in Clinical Biomechanics. 
2010 25(8); 751-8 
Chapter 6 – The Biomechanical Role of Scaffolds in Augmented Rotator Cuff Repairs: 
This chapter will present parametric simulation studies that use the developed spring-
network model for human rotator cuff repairs to predict the  manner in which simulated 
changes to components of the tendon repair, such as reduced tendon quality, altered 
surgical technique and different scaffold designs, influence the biomechanical 
performance (yield load and stiffness) of the repair construct and also predict the  percent 
load carried by the scaffold augmentation component of the repair construct in each of 
these simulated clinical scenarios. The contents of this  chapter has been submitted as a 
manuscript titled “ The Biomechanical Role of Scaffolds in Augmented Rotator Cuff 
Repairs to the Journal of Bone and Joint Surgery and is currently under review.  
Chapter 7 - Summary and Future Directions: This chapter will summarize the key 
findings of this dissertation and suggest possible studies for future investigation.  
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Chapter II 
 
 
PILOT STUDIES 
 
You can see a lot by just looking………Yogi Berra 
 
 
 
2.1 Introduction 
Fascia lata has been to shown to have structural, material and biochemical properties 
comparable to tendon, which makes it an attractive biomaterial for use as an 
augmentation device for rotator cuff repairs. However, compared to suture retention of 
human rotator cuff tendon (200-240 N) 6, 15 ; fascia lata has poor suture retention 
properties (~10 N) (un-published data, Derwin laboratory), which precludes its use for 
such an application.  An objective of this dissertation is to engineer the mechanical 
properties (suture retention strength and stiffness) of acellular allograft (human derived) 
fascia lata in order to develop an extracellular matrix (ECM) derived scaffold with robust 
mechanical properties for use in musculoskeletal soft tissue repair. More specifically, 
Specific Aim 1 of this study is to engineer the suture retention strength and stiffness of 
allograft fascia lata ECM at time zero using stitching as a method of reinforcement. To 
engineer the suture retention load of fascia lata, a suture retention load of ≥ 250  N was 
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selected as the design criteria as it exceeds the suture retention properties of human 
rotator cuff tendon (200 - 240 N). A secondary criterion was also to engineer fascia lata 
without significantly altering its native three-dimensional architecture.  
Currently, there are no technologies (for example, electrospinning and cross 
linking) that allow engineering the mechanical properties of an ECM scaffold without 
altering its native three-dimensional architecture 10, 12, 17-19, 21. Stitching, an existing textile 
procedure is one such technology that would allow engineering the mechanical properties 
of fascia lata without disrupting its native architecture. The concept of stitch 
reinforcement is not new, and it has long been used to develop composites for industrial 
applications 3, 8. However, its use for the reinforcement of an ECM derived biomaterial 
has never been explored, which demonstrates the novel nature of the proposed work. 
Stitching is a very simple process, which involves penetrating a needle with a stitching 
thread through a layer(s) of a material. Since, the objective of the proposed research was 
to develop a scaffold for musculoskeletal soft tissue repairs, braids made from FDA 
approved bioresorbable polymeric biomaterials (for example, polylactic acid and 
polyglycolic acid) were selected as the stitching thread. Resorbable (that which can be 
broken down and assimilated back into the body) braids were selected to avoid a 
persistent long-term inflammatory response in vivo and thereby facilitate a favorable 
host-tissue response to the polymer reinforced scaffold.  
Together, stitch type, stitch configuration (pattern), stitch density (stitch length) 
and stitching thread influence the mechanical properties of stitched constructs 14, 20. The 
mechanical properties of the braid (stitching thread) are further affected by the braid 
processing steps and braiding parameters. This chapter describes preliminary studies that 
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establish stitching as a method for engineering the mechanical properties of fascia lata 
ECM. Figure 2.1 gives the brief overview of the chapter. Briefly, the studies include 1) 
identification of a stitch configuration (pattern) that will give a suture retention load               
≥ 250N, 2) investigating the effect of standard braid processing steps on the suture 
retention load of reinforced fascia scaffolds, 3) investigating the effect of braiding 
parameters on the suture retention load of reinforced fascia scaffolds, 4) modification 
(refinement) of existing stitch pattern to make it suitable for full thickness rotator cuff 
repairs and 5) investigating effect of stitch length on suture retention load of reinforced 
fascia scaffolds.  
 
 
Figure 2.1: Overview of pilot studies  
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2.2 Stitch Type 
While there are different stitch types, namely, loop stitch, chain stitch and lock 
stitch, the lock stitch is the most widely used stitch and was considered more apt for this 
application since it will minimize damage to the fascia matrix. More importantly, it was 
the only stitch possible with the available sewing machine. Figure 2.2 explains the 
formation of a lock stitch.  
 
 
 
Figure 2.2: Lock stitch formation: 1) this step is generally known as needle rise. At this stage of 
stitch formation the thread is not loaded, 2) the needle begins to penetrate the material and the 
thread on the needle side begins to form a loop, 3) the needle completely penetrates the material 
and loop widens. At this stage, the needle begins its upward travel, 4) as the needle travels up the 
widened loop loops the bobbin thread and 5) the needle is completely out of the material and the 
lock stitch is formed. Adapted from Weimer et al., 20 
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 The human fascia lata used in the pilot studies described in this chapter was 
procured and processed by the Musculoskeletal Transplant Foundation (MTF, Edison, 
NJ) from donors aged 18 - 55 years old. More specifically, fascia lata was harvested 
aseptically from cadavers, cleaned of superficial connective tissue and underlying 
muscle. Fascia was then subjected to an antibiotic/antifungal soak treatment in a 
phosphate buffered saline (PBS) containing 1.6 µg/ml of amphotericin B, 30 µg/ml of 
imipenem cilastatin, and 6 µg/ml gentamicin sulfate for 4 hours at 37° C on a shaker 7.  
The packaged, frozen fascia pieces sent to the Derwin laboratory were again 
washed in an antibiotic cocktail (ABX) at 37o C with stirring for 20 hours. The antibiotic 
cocktail consisted of 3.2 mg/ml Amphotericin B (Sigma-Aldrich, Sr. Louis, MO) and             
6 mg/ml Gentamicin Sulphate (Lonza, Walkersville, MD, USA) in 1X PBS 7. 
Subsequently, fascia was rinsed twice for 20 minutes each in 1X PBS at room 
temperature with constant stirring. The ABX cleaned fascia pieces were then lyophilized 
using a freeze dry system maintained at - 40o C and 300 mBar for 24 hours (Model No. 
7522800, Labconco, Kansas City, MO, USA). All experiments were done using 
lyophilized fascia pieces.  
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2.3 Pilot Study 1: Identification of Stitch Configuration (Pattern) 
2.3.1 Objective 
The objective of this study was to identify a stitch pattern that has a suture 
retention load ≥ 250 N at time zero.  
2.3.2 Experimental Design  
Reinforced fascia scaffolds were prepared by stitching fascia patches (4 x 4 cm) 
with black braided silk suture [USP (The United States Pharmacopoeia Convention)     
Size 2 - 0, Harvard Apparatus, USA] in a controlled manner with five unique, two-
dimensional patterns. The suture retention load of reinforced scaffolds were determined 
at time zero (n = 1 per pattern). Details for preparation of the fascia, scaffold fabrication 
and experimental method are described below.  
2.3 3 Methods 
Scaffold Fabrication  
Reinforced fascia patches were  prepared by stitching the lyophilized fascia 
patches (4 x 4 cm) with black braided silk suture (USP Size 2 - 0, Harvard Apparatus, 
USA) in five stitch patterns using a commercial sewing machine (Alphasew, Mini-
Walker Zig Zag, Model: PW 400 - ZZ, USA). The five stitch patterns included: (A) two 
rectangle double stitched; (B) three rectangle double stitched; (C) four rectangle single 
stitched; (D) peripheral stitched and (E) perpendicular stitched (Figure 2.3). All patterns 
were stitched with a 2 mm stitch length.  
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Figure 2.3: Stitch patterns for 4 x 4cm reinforced fascia scaffold (A): Two Rectangle Double 
Stitched; (B) Three Rectangle Double Stitched; (C) Four Rectangle Single Stitched; (D) 
Peripheral Stitched and (E) Perpendicular Stitched  
 
Failure Testing  
The suture retention load of reinforced fascia scaffolds fabricated in the five stitch 
patterns (n = 1 per pattern) were evaluated by attaching the sides of the scaffold to a 
stainless steel ring via peripheral simple sutures [Fiberwire, USP Size 2, Arthrex, Naples, 
FL] in order to simulate the side tensioning seen when scaffolds are used clinically 
(Figure 2.4). The other edge of the scaffold was then preloaded to 2 N and subsequently 
loaded to failure in displacement control at the rate of 30 mm/min. All testing was 
performed in ambient air at 22° C. The failure data were zeroed at 2 N. The suture 
retention load was defined as the ultimate tensile load attained by the scaffold. The 
failure mechanism was recorded for each specimen. 
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Figure 2.4: Side-tension test: The sides of the scaffold were attached to a stainless steel ring with 
simple suture configuration to simulate the side tensioning when scaffolds are used clinically.  
 
 Statistical Analysis 
Because of the single sample size of this pilot study, statistical analysis was not 
possible. 
2.3.4 Results and Discussion  
The suture retention load of fascia patches reinforced with any design showed at 
least a fourfold increase in the suture retention load of non-reinforced fascia (Figure 2.5). 
The suture retention load of the perpendicular stitch design was able to achieve the 
desired suture retention load of ≥ 250  N and was also relatively higher than that obtained 
using other stitch patterns (Table 2.1). The mode of failure for all samples occurred by 
the breaking of the reinforcing suture secondary to slipping of the reinforcing suture 
through the fascia matrix. Based on the results of this pilot study the perpendicular stitch 
pattern was selected for future investigations.  
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Figure 2.5: Load-displacement curve of fascia patches reinforced in the five stitch patterns. The 
perpendicular stitch pattern was able to achieve the desired suture retention load of ≥ 250 N and 
was also relatively higher than suture retention load of other patterns.  
 
 
Stitch Pattern Suture Retention Load (N) 
Non-Reinforced 54 
Two Rectangle Double Stitched  189 
Three Rectangle Double Stitched  203 
Four Rectangle Single Stitched  175 
Peripheral Stitched 155 
Perpendicular Stitched 270 
Table 2.1: Suture retention load of fascia patches reinforced in the five stitch patterns (n=1 per 
pattern). 
 
 
2.4 Braids as Stitching Threads 
Black braided silk sutures are known to elicit an acute inflammatory response in 
vivo and in some cases albeit few, an allergic response were also noted 1, 5, 9, 11, 16. Hence, 
for further development studies braids made from resorbable polymer biomaterials were 
used. It is believed that the use of resorbable biomaterials will most likely avoid a long-
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term inflammatory response in vivo and thereby facilitate a favorable host-tissue 
response to reinforced fascia scaffold.   
A braid is essentially a tubular structure that is produced by intertwining or 
weaving three or more parallel strands in such a way that each group of strands               
(strand is a group of filaments) pass alternately over and under a group of strands laid up 
in the opposite direction as shown in Figure 2.6 A.  
 
Figure 2.6: Different types of braids (A) typical braid; (B) typical braid with core and (C) typical 
braid without core 
 
 
Braids can be broadly classified as braids with core (Figure 2.6 B) and without 
core (Figure 2.6 C). Figure 2.7 depicts the typical construction of a braid with a core.  
Such a braid may be referred to as nXX with mYY core (where n and m are the number 
of strands used for the sheath and core respectively and XX, YY are the type of materials 
with which the braid is constructed). The braid in Figure 2.7 is an 8XX with a 2YY core.  
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Figure 2.7: Typical construction of a braid with core: The number of filaments in a strand and the 
number of strands in the sheath and core can vary depending on braid design.  
 
 
Braids with a core were selected for reinforcing fascia as it allowed developing a 
braid having braid diameter (braid diameter ~ 300 - 400 microns) and a tensile strength of 
≥ 40 N.   
The mechanical properties of the braid are affected by the braid processing steps 
and braiding parameters, which in turn may impact the mechanical properties of 
reinforced fascia scaffolds. Hence, the next two studies (Pilot Study 2 & 3) will 
investigate the effect of standard braid processing steps and braiding parameters on the 
suture retention load of reinforced fascia scaffolds.  
 
 
 
 
 
30 Filaments 1 Strand 
8 Strands 
2 Strands 
Sheath
Core
Braid 
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2.5 Pilot Study 2: Effect of Standard Braid Processing Steps 
2.5.1 Background 
The reinforced fascia scaffold may be likened to a composite lamina with fascia 
extracellular matrix (ECM) as the matrix and the braid as the reinforcing fibers. Hence, 
the selection of an appropriate braid with good handling characteristics and mechanical 
properties is critical to the performance of the reinforced fascia scaffolds. Braids 
routinely undergo post braiding processing techniques, which include but are not 
restricted to hot stretching, scouring, annealing, tipping, packaging and sterilization. Hot 
stretching reduces the braid diameter and prevents unraveling of the braid after cutting, 
often called “brooming” effect. Hot stretching also affects the elongation of the braid. 
Scouring eliminates spin finishes that are applied to yarns during braiding and also helps 
in the removal of dust particles and oil droplets that may be deposited during braiding. 
Annealing increases the crystallinity (in case of polymers) and tipping is needed for good 
needle attachment. Annealing and tipping are optional treatments that are included 
depending on the intended application of the braid. Sterilization is necessary if the 
intended application is for in vivo use. These processing techniques may alter the 
mechanics of the braid and subsequently affect the performance of the reinforced fascia 
scaffolds.  
2.5.2 Objective 
The objective of this study was to investigate the effect of standard braid processing 
steps, namely, hot stretching, scouring and sterilizing on the suture retention load of 
reinforced fascia scaffolds.  
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2.5.3 Experimental Design  
Polymer braid having a configuration of 6PLLA/2PGA with 2PGA core (6 
strands Poly L-Lactic Acid (PLLA) and 2 strands Poly Glycolic Acid (PGA) in sheath, 
and 2 strands PGA in the core; 1 strand = 30 filaments) was used for this investigation 
(Concordia Medical, Warwick, Rhode Island, USA). Hereafter, 6PLLA/2PGA with 
2PGA core braid will be referred to as 6PLLA/2PGA. Four braid processing steps were 
investigated, namely, “no” hot stretch, hot stretch (HS), hot stretch scoured/ dried (HSS), 
and hot stretch/scoured/dried/ sterilized (HSSS) (Table 2.2). Sterilization was by ethylene 
oxide. Reinforced fascia lata scaffolds were prepared by stitching lyophilized fascia strips 
(2 x 5 cm) and patches (4 x 4 cm) with each braid. The suture retention load of the 
reinforced scaffolds were determined (n= 2 - 5 per treatment). Details of scaffold 
fabrication and experimental method are described below.  
2.5.4 Methods 
 Scaffold Fabrication 
Table 2.2  gives the mechancial properties of each braid investigated.  Fasica 
strips (2 x 5 cm) and patches (4 x 4 cm) were reinforced with these braids using a 
commercial sewing machine (Alphasew, Mini-Walker Zig Zag, Model: PW 400-ZZ, 
USA). A peripheral stitch pattern was used to prepare the reinforced fascia strips             
(Figure 2.3 D). The reinforced fascia patches were stitched in the perpendicular pattern 
(Figure 2.3 E) determined from Pilot Study 1. All scaffolds were fabricated with a 2 mm 
stitch length.  
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Braid type  
Tensile load 
(N) 
Elongation 
(%) 
“No” Hot stretch 31.7 25.4 
Hot stretched, un-scoured 
(HS) 30.9 17.1 
Hot stretched, 
scoured/dried (HSS) 30.7 19.4 
Hot stretched, 
scoured/dried sterilized 
(HSSS) 28.7 21.5 
Table 2.2: Specifications of the 6PLLA/2PGA braids subjected to conventional braid processing 
steps. Braids were manufactured and characterized by Concordia Medical, Warwick, Rhode 
Island, USA.  
 
 
 Failure Testing  
The suture retention load of reinforced fascia strips was evaluated using a suture 
retention test with simple suture configuration (USP Size 2 Fiberwire, Arthrex, Naples, 
FL) (n=3 - 5/treatment) (Figure 2.8 A). Briefly, scaffolds were preloaded to 2 N followed 
by constant rate distraction to failure at 12.5 mm/min 4. The suture retention load of 
reinforced fascia patches was evaluated using a tension-with-side-constraint test                      
(n = 2/treatment) (Figure 2.8 B).  Briefly, scaffolds were attached via 12 peripheral 
simple sutures (USP Size 2 Fiberwire, Arthrex, Naples, FL) to a jig that allowed 10 N of 
static tension to be applied to the sides of the patch in order to simulate the pre-tensioning 
that occurs when these patches are used clinically. The other edges were then preloaded 
to 2 N, pre-conditioned for 10 cycles from 5 - 15 N at 0.25 Hz and subsequently loaded to 
failure in displacement control at the rate of 30 mm/min. For both types of tests, the 
failure data was zeroed at 2 N. The suture retention load was defined as the ultimate 
tensile load attained by the scaffold. The failure mechanism was recorded for each 
specimen. 
 
 
 54 
 
 
Figure 2.8: Suture Retention Test: (A) Strip Test and (B) Tension-with-Side Constraint test.  
 
 
 
 Statistical Analysis  
A one-factor analysis of variance (ANOVA) was used to test for differences in the 
suture retention load between groups of reinforced fascia strips. A two-sample t-test was 
used to test for differences in the suture retention load between reinforced fascia patch 
groups. For all statistical analysis, a p value of ≤ 0.05 was considered significant.   
2.5.5 Results and Discussion 
The mode of failure for all samples occurred by the breaking of the braid 
secondary to slipping of the braid through the fascia matrix. The standard fiber 
processing steps of hot stretching, scouring and sterilizing did not significantly affect the 
suture retention load of reinforced fascia strips (Figure 2.9, p = 0.585).  
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Figure 2.9: Suture retention load of strip fascia reinforced with 6PLLA/2PGA braids processed 
with four braid processing steps (1) “no” Hot Stretch (HS); (2) Hot Stretch (HS); (3) Hot Stretch 
Scoured (HSS) and (4) Hot Stretched Scoured Sterilized (HSSS). No significant differences        
(p > 0.05) were found in the suture retention load of strip fascia reinforced with the polymer 
braids. 
 
 
However, the suture retention load of patches reinforced with hot 
stretched/scoured ethylene oxide sterilized polymer braid (HSSS) was significantly lower 
(244 ± 19N) than scaffolds reinforced with hot stretched/scoured (HSS) (330 ± 10N) 
polymer braids (p < 0.05) (Figure 2.10).  
 
 
Figure 2.10: Suture retention load of patch fascia reinforced with Hot Stretch/Scoured (HS) and 
Hot Stretched Scoured Sterilized (HSSS) 6PLLA/2PGA braids. Ethylene oxide sterilization 
appeared to negatively impact the suture retention load of patches reinforced with HSSS braids   
(p < 0.05).  
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There seems to be no explanation at this point of time for the apparent drop in the 
suture retention of scaffolds reinforced with hot stretched/scoured ethylene oxide 
sterilized polymer braid (HSSS) seen in the patch configuration and not in the strip 
configuration. However, given the fact that the mechanical properties of the braids did 
not decrease after sterilization (Table 2.2), it may be reasonable to assume that these 
disparate outcomes may be due to low sample size and not due to a real negative effect of 
sterilization. Hot stretching reduces the braid diameter and prevents unraveling of the 
braid after cutting, scouring eliminates spin finishes and oil droplets that may be 
deposited during braiding and sterilization is necessary if intended application is for              
in vivo use. Because these processing steps are desirable for scaffold development and 
were shown not to negatively impact the performance of reinforced fascia scaffolds, they 
were included for future braid processing.  
 
2.6. Pilot Study 3: Effect of Braiding Parameters 
2.6.1 Background 
A braid consists of an intersection repeat of groups of twisted and entangled fibers 
called yarn. Pick ‘P’ is the repeat of the yarn groups on the braid and pick count is the 
number of ‘P’ per unit length in a single line parallel to the braid axis (Figure 2.11). The 
pick count, braid pattern, braid design and denier of the fibers, to name a few, are 
braiding parameters that are known to affect the mechanics of the braid, which in turn 
may influence the mechanical performance of the reinforced fascia scaffold 13. This study 
aims to investigate the effect of a subset of these parameters, namely, pick count, 
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presence of core, and denier of the fibers on the performance of the reinforced fascia 
scaffolds. Such a study will help identify braid parameter(s) to be used for future studies.  
 
Figure 2.11: Schematic representation of pick ‘P’ of a braid. Adapted from Omeroglu S et al, 
2006 13 
 
 
 
2.6.2 Objective 
The objective of the study was to test for differences in the suture retention load 
of scaffolds reinforced with 6PLLA/2PGA polymer braids (Pilot Study 2) having a lower 
pick count, lower pick count with extra PGA core, double denier with no core and extra                          
hot stretch (HS) and scaffolds reinforced with 100% PLLA braid (8 strands Poly L-Lactic 
Acid (PLLA) and 2 strands Poly L-Lactic Acid (PLLA) in the core;                                              
1 strand = 30 filaments) (Concordia Medical, Warwick, Rhode Island, USA). Hereafter, 
100% PLLA braid will be referred to as 100% PLLA. All braids were hot stretched and 
scoured, but were not sterilized.  
2.6.3 Experimental Design  
Fascia patches (4 x 4 cm) were reinforced with various 6PLLA x 2PGA and 100% 
PLLA braids (mentioned above) (Concordia Medical, Warwick, Rhode Island, USA) in a 
perpendicular stitch pattern (Figure 2.3 E). The suture retention load and stiffness of the 
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reinforced fascia scaffolds were determined at time zero (n= 2 - 3 per configuration). 
Details of scaffold fabrication and all experimental methods are described below.  
2.6.4 Methods 
 Scaffold Fabrication 
Fascia patches (4 x 4 cm) were reinforced with hot stretched/scoured 
6PLLA/2PGA polymer braids having a lower pick count, lower pick count with extra 
PGA core, double denier with no core and extra hot stretch (HS) and 100% PLLA braid 
in a perpendicular stitch pattern using a commercial sewing machine (Figure 2.3 E) 
(Alphasew, Mini-Walker Zig Zag, Model: PW 400 - ZZ, USA). All scaffolds were 
fabricated with a 2 mm stitch length.  
 Failure Testing 
The suture retention load of reinforced fascia patches were evaluated using a 
tension-with-side-constraint test (n = 2 - 3/configuration) (Figure 2.8 B) described in 
Pilot Study 2. The suture retention load was defined as the ultimate tensile load attained 
by the scaffold. The failure mechanism was recorded for each specimen. 
 Statistical Analysis  
Because of the small sample size of this pilot study, statistical analysis was not 
conducted. 
2.6.5 Results and Discussion  
The mode of failure for all samples occurred by the breaking of the braid 
secondary to slipping of the braid through the fascia matrix. Figure 2.12 gives the average 
suture retention load for patch fascia reinforced with the various braids investigated.  
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Figure 2.12: Suture retention load of fascia patches reinforced with hot stretched/scoured 
6PLLA/2PGA polymer braids having a lower pick count, lower pick count with extra PGA core, 
double denier with no core and extra hot stretch (HS) and 100% PLLA braid.  Fascia patches 
reinforced with hot stretched/scoured (HSS) polymer braid was used as a reference (see Figure 
2.10).  
 
 
The data suggest that fascia scaffolds reinforced with 6PLLA/2PGA braid having 
a lower pick count with extra PGA core had the highest suture retention load                    
(416 ± 37 N). While, the suture retention load of scaffolds reinforced with the 100% 
PLLA braid was 353 ± 54 N. Since, fascia reinforced with 6PLLA/2PGA braid 
demonstrated superior mechanical performance it was selected for future investigations. 
A 100% PLLA braid was also chosen for future studies (Table 2.3) based on the 
similarity in construction, diameter and texture to the 6PLLA/PGA braid choice, and the 
precedent of an FDA-approved 100% PLLA suture (Orthodek, USP Size 2 - 0 , Teleflex 
Medical, CT, USA).  
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Parameter  100% PLLA 6PLLA/2PGA 
Tensile strength 38N 44N 
% Elongation 30 22 
Diameter (microns) 400 380 
Sheath 8 strands PLLA 6 strands PLLA 
Core 2 strands PLLA 3 strands PGA 
Picks per inch (PPI) 32 34 
Table 2.3: Specifications of the custom 100% PLLA and 6PLLA/2PGA polymer braids to be 
used for future studies. Braids were manufactured and characterized by Concordia Medical, 
Warwick, Rhode Island, USA. (PLLA: Poly L-Lactic Acid and PGA: Poly Glycolic Acid)  
 
 
2.7. Pilot Study 4: Stitch Pattern Modification (Refinement) 
2.7.1 Background 
 Pilot Study 1 demonstrated that the perpendicular stitch pattern (Figure 2.3 E)    
was able to achieve the desired suture retention load of ≥ 250N at time zero. However, 
the fabrication of this pattern is cumbersome and involves significant damage to the 
fascia matrix. The size of the patch (4 x 4 cm) is also not optimal for full thickness rotator 
cuff repairs seen clinically in human patients.  
2.7.2 Objective 
 Hence, the objective of this study was to modify the perpendicular stitch pattern 
(Pilot Study 1) to make it suitable for full thickness rotator cuff tendon repairs. The 
design criteria/objectives were: 1) the patch should have a suture retention load of                  
≥250 N in the tension-with-side-constraint test at time zero, 2) the stitch pattern must 
include at least two reinforcing lines between the surgical sutures and the edge of the 
patch, and must allow the surgeon to readily locate the lines of reinforcement and 3) the 
pattern must easily be fabricated minimizing time of fabrication, mass of polymer fibers 
and the number of stop/starts.  
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2.7.3 Experimental Design  
Reinforced fascia lata scaffolds were prepared by stitching fascia patches                 
(5 x 5 cm) with 100% PLLA braid (Teleflex Medical, CT, USA) in a controlled manner 
with unique, two-dimensional patterns. The suture retention load of reinforced scaffolds 
were determined at time zero (n = 1 per pattern). Details of scaffold fabrication and 
experimental method are described below.  
2.7.4 Methods 
 Scaffold Fabrication 
Fascia patches (5 x 5 cm) were reinforced with hot stretched 100% PLLA 
polymer braid (Teleflex Medical, CT, USA) in five stitch patterns using a commercial 
sewing machine (Alphasew, Mini-Walker Zig Zag, Model: PW 400-ZZ, USA). The 
patterns are not being presented herein due to proprietary and confidentiality concerns. 
All scaffolds were fabricated with a 2 mm stitch length. 
 Failure Testing  
The suture retention load of patch reinforced scaffolds were evaluated using a 
tension-with-side-constraint test (n = 2/configuration) (Figure 2.8 B) described in                
Pilot Study 2. The suture retention load was defined as the ultimate tensile load attained 
by the scaffold. The failure mechanism was recorded for each specimen.  
2.7.5 Results and Discussions  
 The stitch pattern that met the desired design objectives had the following 
dimensions: Overall dimensions of the patch: 5 x 5 cm; Inside footprint of braid 
reinforcement: 2.8 x 3.4 cm and outside footprint of braid reinforcement: 3.6 x 4.2 cm. 
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This pattern was selected for future investigations and will now on be referred as the 
preferred pattern. Compared to the perpendicular pattern that took 30 minutes for scaffold 
fabrication (Pilot Study 1), scaffold fabrication with the preferred pattern was 
accomplished in 10 - 15 minutes per patch, with a maximum of two start/stops.  
 
2.8. Pilot Study 5: Effect of Stitch Length  
2.8.1 Objective 
 The effect of the stitch length on the mechanical performance of reinforced 
scaffolds was then investigated using the preferred pattern. The study also quantified the 
amount of braid used for stitching the fascia patches (5 x 5 cm) in the preferred pattern 
with two stitch lengths, 2 mm and 4 mm, respectively.  
2.8.2 Methods 
 Scaffold Fabrication  
Fascia patches (5 x 5 cm) were reinforced with hot stretched 100% PLLA 
polymer braid (Teleflex Medical, CT, USA) in the preferred pattern using a commercial 
sewing machine (Alphasew, Mini-Walker Zig Zag, Model: PW 400 - ZZ, USA). All 
scaffolds were fabricated with a 2 mm and 4 mm stitch length.  
 Failure Testing  
The suture retention load of patch reinforced scaffolds were evaluated using a 
tension-with-side-constraint test (n = 2/stitch length) (Figure 2.8 B) described in Pilot 
Study 2. The suture retention load was defined as the ultimate tensile load attained by the 
scaffold. The failure mechanism was recorded for each specimen.  
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2.8.3 Results and Discussions 
Approximately 2.5 yards of braided fibers are used for a 4mm stitch length             
(Table 2.4). Decreasing the stitch length provides no mechanical benefit (Figure 2.13) 
and increases both the number of perforations of the fascia and the amount of braid used 
(Table III), e.g., a 2 mm stitch length uses approximately 3.5 yards of braid.  Hence, 
future studies will use a 4 mm stitch length in order to minimize the number of 
perforations of the fascia and the amount of braid used. 
 
Braid Amount  
2mm 
Stitch 
Length 
4mm 
Stitch 
Length 
Spool (yards) 2.4 1.6 
Bobbin (yards) 0.85 0.9 
Total (yards) 3.5 2.5 
Table 2.4: Amount of braid used per scaffold stitched in the preferred pattern with different stitch 
lengths (n = 2 per group). 
 
 
 
 
Figure 2.13: Suture retention load of patch fascia reinforced with 100% PLLA braids with 2 mm 
and 4 mm stitch lengths. There is no significant improvement in the mechanical performance of 
scaffold stitched with a 2 mm and 4 mm stitch length.   
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2.9 Summary  
In summary, hot stretching, scouring and ethylene oxide sterilization, which are 
desirable braid processing steps for scaffold development, were shown not to negatively 
impact the mechanical performance of reinforced fascia scaffolds; hence they were 
included for future braid processing. Fascia reinforced with 6PLLA/2PGA braid                    
(6 strands Poly L-Lactic Acid (PLLA) and 2 strands Poly Glycolic Acid (PGA) in sheath, 
and 2 strands PGA in the core; 1 strand = 30 filaments) demonstrated superior 
mechanical performance and hence was selected for future investigations. A 100% PLLA 
braid (8 strands Poly L-Lactic Acid (PLLA) and 2 strands Poly L-Lactic Acid (PLLA) in 
the core; 1 strand = 30 filaments) was also chosen for future studies (Table 2.3) based on 
the similarity in construction, diameter and texture to the 6PLLA/PGA braid choice, and 
the precedent of an FDA-approved 100% PLLA suture (Orthodek, USP Size 2-0, 
Teleflex Medical, CT, USA).  A preferred stitch pattern with a 4 mm stitch length was 
also identified, which allowed scaffold fabrication in 10-15 minutes per patch with a 
maximum of two start/stops, minimized the amount of braid per patch (~2.5 yards) and 
most importantly achieved a suture retention load of ≥ 250N at time zero. These pilot 
investigations resulted in a patent application, Reinforced Tissue Graft, US Patent 
Application PCT/US 2009/038570, filed in March 2009 2. The next chapter describes 
studies that characterize the in vitro mechanical properties and fatigue behavior of 
scaffolds reinforced with the two selected polymer braids. As well, the study will 
investigate the host response and time-dependent changes in mechanical properties of 
reinforced fascia scaffolds with either braid after implantation in a rat model. 
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Chapter III 
 
 
DEVELOPMENT OF ALLOGRAFT FASCIA LATA AS AN 
EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR 
MUSCULOSKELETAL SOFT TISSUE REPAIRS  
 
 
The silly question is the first intimation of some totally new development….. 
Alfred North Whitehead 
 
 
 
3.1 Introduction  
 
Although surgical treatment and rehabilitation strategies continue to evolve, high 
repair failure rate (20 - 90 %) of rotator cuff tears continue to pose a significant challenge 
to the clinicians researchers, at large. Currently, extracellular matrix (ECM) materials are 
being investigated as a tissue engineered strategy for the treatment of these tears. ECM 
derived scaffolds are attractive as they have a natural three-dimensional architecture and 
provide a chemically and structurally instructive environment, which may improve the 
biology of repair healing.  
To also serve an augmentation device, scaffolds must have robust mechanical and 
adequate suture retention properties that will allow some degree of load sharing with the 
tendon repair at the time of implantation and for some period of post-operative healing. 
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In vitro uniaxial mechanical tests (unconstrained) have shown that presently, only fascia 
lata has material properties comparable to tendon tissue 10. Furthermore, fascia lata also 
has biochemical and structural properties similar to tendon. Hence, fascia lata seems to be 
an attractive biomaterial for use as an augmentation device for rotator cuff repairs. 
However, fascia lata has poor suture retention properties (~10 N) (unpublished data from 
Derwin laboratory) compared to the suture retention of human rotator cuff tendon               
(200 - 240 N) 20 . Hence, the suture retention strength of fascia needs to be improved in a 
manner that that will make it comparable to the suture retention properties of human 
rotator cuff tendon (200 - 240 N), which may then allow it to be used as an augmentation 
device for rotator cuff repair.  
Hence, the overall goal of this work was to engineer the suture retention strength 
and stiffness of allograft fascia lata in order to develop an extracellular matrix (ECM) 
derived scaffold with robust mechanical properties for use in musculoskeletal soft tissue 
repair. Specifically, braided, resorbable, polymer fibers were stitched into fascia ECM in 
a unique, controlled manner. Fascia scaffolds were reinforced with the pattern and 
polymer braids chosen based on pilot studies (Chapter 2), namely, the preferred stitch 
pattern and two braid compositions, 100% Poly L- Lactic Acid (PLLA) or 6PLLA/2Poly 
Glycolic Acid (PGA).  
The specific aims of this study were 1) to characterize the mechanical properties, 
namely, suture retention load and stiffness, and fatigue behavior of reinforced fascia 
scaffolds at time zero, and 2) to investigate the host response and time-dependent changes 
in mechanical properties of reinforced fascia scaffolds after implantation in a rat model. 
The hypotheses were that 1) The time zero mechanical properties (suture retention load) 
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of the reinforced fascia scaffolds will be ≥ 250N and  higher than non-reinforced fascia 
ECM, but not different between the braid types, 2) The mechanical properties of 
reinforced fascia scaffolds will decrease after in vivo implantation, and the decrease will 
be more predominant in scaffolds reinforced with 6PLLA/2PGA, but the suture retention 
load of reinforced fascia scaffolds will remain ≥ 250N, and 3) The host response to 
reinforced fascia scaffolds will be similar to non-reinforced fascia characterized by the 
presence of lymphocytes and macrophages but with an increased presence of foreign 
body giant cells due to the presence of the polymer braid.  
 
3.2 Experimental Design  
The experimental design for the study is shown in Figure 3.1 Briefly, reinforced 
fascia lata scaffolds were prepared by stitching fascia patches (5 x 5 cm) with 100% 
PLLA or 6PLLA/2PGA polymer braids in a controlled manner with a unique, two-
dimensional pattern. The suture retention load, stiffness and fatigue behavior of 
reinforced scaffolds were determined at time zero (n = 8 - 11 per braid group). The suture 
retention load and stiffness of reinforced scaffolds were also determined following four 
and twelve weeks dorsal subcutaneous implantation in a rat model (n = 11 per braid 
group per time point). To evaluate host response at four and twelve weeks, 1x1 cm pieces 
of non-reinforced and reinforced fascia scaffold were implanted into an abdominal wall 
defect in a subset of the same rats (n= 4 per braid group per time point). Details for 
preparation of the reinforced fascia scaffolds and all experimental methods are described 
below.  
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Figure 3.1: Experimental design for the study 
 
3.3 Methods 
3.3.1 Scaffold Fabrication 
The human fascia lata used in this study was procured and processed by the 
Musculoskeletal Transplant Foundation (MTF, Edison, NJ) from donors aged 18-55 years 
old. More specifically, fascia lata was harvested aseptically from cadavers, cleaned of 
superficial connective tissue and underlying muscle and then subjected to an 
antibiotic/antifungal soak treatment in a phosphate buffered saline (PBS) containing            
1.6 µg/ml of amphotericin B, 30 µg/ml of imipenem cilastatin, and 6 µg/ml gentamicin 
sulfate for 24 hours at 37°C on a shaker 10.  This soak has also been shown to remove 
most of the cellular material from the fascia matrix (Table 1.4) and is considered an 
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“acellularization” treatment; although fragments of double stranded DNA do remain 
(Figure 3.2). After 24 hours, fascia was rinsed two times in PBS for 20 minutes each at 
room temperature on a shaker and then lyophilized. Subsequently, individual lyophilized 
fascia pieces were packaged and sent to the Derwin laboratory.    
 Reinforced fascia scaffolds were prepared by stitching lyophilized fascia patches 
(5 x 5 cm) with custom made 100% PLLA or 6PLLA/2PGA polymer braids (Concordia 
Medical, Warwick, Rhode Island, USA) using a commercial sewing machine (Alphasew, 
Mini-Walker Zig Zag, Model: PW 400 - ZZ, USA) (Figure 3.3). The stitch pattern 
(preferred) and stitch length (4 mm) was the same for all scaffolds and chosen based on 
pilot studies (Chapter 2). Table 3.1 provides the specific details of the polymer braids 
used. The polymer braids were hot stretched, scoured, ethylene oxide sterilized and 
vacuum dried by the manufacturer. Scaffolds intended for in vivo implantation were 
stitch reinforced under aseptic conditions in a clean room. 
 
 
Figure 3.2: Representative (A) Hematoxylin-Eosin (H&E) and (B) DAPI stained sections of 
processed allograft fascia lata. Fragments of double stranded DNA (blue strands) do remain after 
processing (100X)  
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Figure 3. 3: Representative sections of stitched fascia reinforced with 100% PLLA A): Lock 
stitch formation on deep side of fascia ECM and B) Lock stitch formation on superficial side of 
fascia ECM.   
 
 
 
 
Parameter 100% PLLA 6PLLA/2PGA 
Sheath 8 ends PLLA 6 ends PLLA and 2 ends PGA 
Core 2 ends PLLA 3 ends PGA 
Diameter (microns) 400 400 
Tensile Strength (N) 43.4 43 
Percent Elongation (%) 35.5 21.9 
Picks per inch 34.3 32.4 
Denier 120 75 
Filament 30 30 
Denier per filament (dpf) 4 2.5 
PLLA content (% weight) 100 66 
PGA content (% weight) -- 34 
Table 3.1: Technical specifications of custom 100% PLLA and 6PLLA/2PGA braids used to 
reinforce the fascia scaffolds. Braids were manufactured and characterized by Concordia 
Medical, Warwick, Rhode Island, USA. 
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3.3.2 Time Zero Mechanical Properties   
Failure Testing  
The suture retention load and stiffness of non-reinforced (n=4) and reinforced 
fascia scaffolds (n = 11/12 braid type) were evaluated using a tension-with-side-
constraint test (Figure 3.4). Briefly, scaffolds were attached via 12 peripheral simple 
sutures (USP 2 Fiberwire, Arthrex, Naples, FL) to a jig that allowed 10N of static tension 
to be applied to two opposing sides of the patch in order to simulate the pre-tensioning 
that occurs when these patches are used clinically for rotator cuff repair. The other sides 
were then preloaded to 2 N, pre-conditioned for 10 cycles from 5-15 N at 0.25 Hz and 
subsequently loaded to failure in displacement control at the rate of 30 mm/min. All 
testing was performed in a saline bath at 37° C. The suture retention load was defined as 
the ultimate tensile load attained by the scaffold. Stiffness was defined as the slope of the 
load-displacement curve between 50-150 N. The failure mechanism was recorded for 
each specimen. 
 
 
Figure 3.4: Tension-with-side constraint test shown with a 4 x 4 cm non-reinforced fascia patch 
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Cyclic Fatigue  
A fatigue test was performed to evaluate the performance of reinforced fascia 
scaffolds under cyclic loading conditions (n = 8/braid type). The scaffolds were attached 
via 12 peripheral simple sutures (USP Size 2 Fiberwire, Arthrex, Naples, FL) to a jig that 
allowed 10N of static tension to be applied to 2 opposing sides of the patch while the 
other sides were loaded in dynamic tension (Figure 3.4). A 1-N preload was applied to 
pretension the specimen. The specimen was then cyclically loaded under force control 
from 5 to 150 N for 5000 cycles at 0.25 Hz with the use of a half sinusoidal waveform. 
The cyclic data were zeroed at 10 N to match the static tension that had been applied to 
the sides of the scaffolds at the onset of testing. Stroke elongation of the nth cycle was 
defined as the difference between the peak of the nth cycle and the valley at the 
beginning of the nth cycle. Cyclic elongation of the nth cycle was defined as the 
difference in the displacement between the valley at the end of the nth cycle and the 
valley at the beginning of the first cycle. Cyclic stiffness of the nth cycle was calculated 
as the change in force of the nth cycle (nominally 145 N) divided by the change in 
displacement from the valley at the beginning of the nth cycle to the peak of the nth 
cycle. 
3.3.3 In Vivo Implantation  
 Twelve simple suture loops (USP Size 2 Fiberwire, Arthrex, Naples, FL) were 
added around the periphery of reinforced fascia patches (n = 22 patches/braid type) to 
simulate the clinical presence of suture with the use of a scaffold. A sterile polypropylene 
screen was sutured to one side of the scaffold constructs in four locations using                           
5 - 0 Prolene (Figure 3.5). The purpose of the screen was to prevent folding of the 
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scaffold onto itself during the implantation period, and to cover the Fiberwire knots so as 
to minimize subcutaneous irritation. All preparatory procedures were performed under 
aseptic conditions in a clean room. 
 
 
Figure 3.5: Scaffold attached to screen for in vivo implantation 
 
 Surgical Procedure  
 All surgical procedures were conducted in compliance with the Animal Welfare 
Act Regulations and other Federal statutes relating to animals and experiments involving 
animals and adheres to principles set forth in the Guide for Care and Use of Laboratory 
Animals, National Research Council, 1996.  All surgical procedures were performed by 
an orthopedic resident, Mena Mesiha, MD at the Cleveland Clinic.  
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Rat Dorsal Subcutaneous Implantation 
 
Figure 3.6: Surgical procedure for dorsal subcutaneous implantation 
 
  
 Forty-four adult, male retired breeders Sprague Dawley rats were used for this 
study (450 - 550 gm, Harlan, Indianapolis, IN). Each rat was anesthetized with isoflurane 
(maintained at 2 - 3%) and the dorsum was prepared for aseptic surgery. A 4 cm dorsal 
midline incision was made to expose the underlying areolar layer. Flaps were developed 
on either side of the midline by sharply detaching the areolar layer insertion from the 
spinal processes to expose the underlying lumbar fascia and muscle. A 5 x 5 cm 
reinforced fascia construct (scaffold plus sutures) was hydrated in sterile saline for 20 
minutes and then placed in the dorsal subcutaneous pouch with the polypropylene screen 
oriented superficially (Figure 3.6 A) (n = 22 rats/braid type). The deep side of the 
construct was laid against the lumbar fascia and muscle but not attached to the animal. 
The areolar layer was then closed in a running stitch configuration using 4 - 0 Vicryl 
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suture (Figure 3.6 B & 3.6 C) and the overlying dermis was then closed using surgical 
staples (Figure 3.6 D).  
Rat Abdominal Wall Defect Implantation 
 In a subset of the same rats used for dorsal subcutaneous implantation (n=8 
rats/braid type), the abdomen was also prepared for aseptic surgery. Via a ventral midline 
incision, a partial-thickness 1x1 cm defect was created in the anterior sheath adjacent to 
the linea alba. The anterior sheath was removed and the underlyimg rectus muscle, 
transversalis fascia, and peritoneum were left intact. A 1 x 1 cm piece of reinforced fascia 
(n = 8 pieces/braid type) was rehydrated in sterile saline for 20 minutes and secured into 
the defect at the four corners using 5 - 0 Prolene (Figure 3.7). On the contralateral side of 
the linea alba, a second 1x1 cm defect was created in the anterior sheath and a replaced 
with a 1x1 cm piece of non-reinforced fascia as a control. The skin incision was closed 
using 4 - 0 Vicryl suture and the rat was allowed to recover from anesthesia under a 
heating lamp. 
 
 
Figure 3.7: Rat abdominal wall defect implantation 
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Post-operative Care  
For analgesia, each rat received 0.15 mg/kg buprenorphine post-operatively, 12 
hours later, and thereafter as needed for break through pain. Rats were housed 
individually for the duration of the study and were observed for any signs of dehiscence, 
redness and inflammation around the incision sites.  
Euthanasia and Tissue Harvest 
 At four and twelve weeks, rats were sacrificed via carbon dioxide asphyxiation                 
(n = 11 per braid type per time point). The reinforced fascia scaffold implanted in the 
dorsal subcutaneous pouch was explanted, carefully detached from the polypropylene 
screen, wrapped in saline soaked gauze and stored at 4o C for up to 24 hours prior to 
mechanical testing. Scaffold samples implanted in the abdominal wall defect sites were 
harvested (n = 4 per braid per time point), fixed in 10% neutral buffered formalin (NBF) 
for 24 hr and routinely processed for paraffin embedding.  
3.3.4 Post-Implantation Mechanical Properties 
 
 The suture retention load and stiffness of the explanted, reinforced fascia scaffolds 
were tested using the tension-with-side-constraint test described in Section 3.3.2 (n = 11 
per braid type per time point). The Fiberwire suture loops were placed into the scaffolds 
prior to implantation, which were used for affixing the constructs to the testing jig. 
3.3.5 Histological Analysis 
 
Five-micron thick longitudinal sections were cut from four samples per group per 
time point and stained with hematoxylin and eosin (H&E) One representative H & E 
section per sample was semi-quantitatively scored by a board-certified pathologist 
 
 
 79 
(Carmela Tan, MD, Cleveland Clinic) according to a scoring system adapted from ISO 
Standard 10993-6 (Table 3.2). The sections were scored for the presence of inflammatory 
cells, i.e., neutrophils, eosinophils, lymphocytes, plasma cells, macrophages, and foreign 
body giant cells. Non-inflammatory outcomes namely, fibroblast-like cells, 
vascularization and amount of cellular infiltrate into the graft from the periphery 
(cellularity) were also scored.  
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Cell 
type/response 
Score 
0 1 2 3 4 
In
fla
m
m
at
or
y 
ce
ll 
ou
tc
om
es
 Eosinophils 0 Rare (1-5/hpf) 5-10/hpf Heavy infiltrate Packed 
Lymphocytes 0 Rare (1-5/hpf) 5-10/hpf Heavy infiltrate Packed 
Plasma cells 0 Rare (1-5/hpf) 5-10/hpf Heavy infiltrate Packed 
Macrophages 0 Rare (1-5/hpf) 5-10/hpf Heavy infiltrate Packed 
Giant cells 0 Rare (1-5/hpf) 3-5/hpf Heavy infiltrate Packed 
N
on
-in
fla
m
m
at
or
y 
ou
tc
om
es
 Total Cellularity -- < 25% 26-50% 51-75% > 75% 
Fibroblasts 0 Rare (100/hpf) 100-1000/hpf 
Heavy 
infiltrate Packed 
Vascularization 0 
Minimal 
capillary 
proliferation, 
focal, 1-3 buds 
Groups of 
4-7 
capillaries 
with 
supporting 
fibroblastic 
structures 
Broad 
band of 
capillaries 
with 
supporting 
structures 
Extensive 
band of 
capillaries 
with 
supporting 
fibroblastic 
structures 
Table 3.2: Histologic scoring system adapted from ISO 10996-6 standard, hpf = high powered 
field (40x) 
 
 
3.3.6 Statistical Analysis  
 
A two-sample t-test was used to test for differences in the suture retention load, 
stiffness, and stroke and cyclic elongation at the first cycle of loading, between reinforced 
fascia groups at time zero. The cyclic elongation and stiffness profiles were compared 
between reinforced groups at time zero, first for cycles 1 - 2500 and then for cycles 2500 
- 5000. Cycle 2500 was chosen as the delimiter because it was the last data point acquired 
before at least one sample failed. To perform the profile comparisons, the cyclic data 
were log transformed, and quadratic mixed models were used to compare the profiles 
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between the two groups. For the post-implantation mechanical properties, a two-factor 
analysis of variance (ANOVA) with post hoc Tukey test was used test for differences in 
suture retention load and stiffness between groups across time. A p-value of ≤ 0.05 was 
considered significant. For histologic analysis, we were primarily interested in detecting 
differences in foreign body giant cells between groups at each time point, and not in the 
interaction between group and time. Hence, Kruskal-Wallis ANOVA on ranks was used 
for histologic outcomes at each time point. For histologic analysis, no adjustment was 
made for multiple comparisons, and a p-value of ≤ 0.05 was considered significant.   
3.3.7 Power Analysis and Sample Size Justification 
 
The study was powered primarily to detect significant differences between groups 
as a function of implantation time. A power analysis was performed to detect a minimum 
difference of 50% between the means with an expected standard deviation of 35%. A 
sample size of eleven per braid type per time was estimated, which would allow us to 
detect differences with alpha = 0.05 and power = 0.8.  
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3.4 Results  
3.4.1 Time Zero Mechanical Properties 
Failure Testing 
The suture retention load of fascia patches reinforced with either braid exceeded 
300 N, which is a six fold increase over non-reinforced fascia (Figure 3.8).  Fascia 
reinforced with 6PLLA/2PGA braid has a significantly higher suture retention load                  
(p < 0.05) but no difference in stiffness than fascia reinforced with 100% PLLA braid 
(Table 3.3). The mode of failure for all samples occurred by the breaking of the braid 
secondary to slipping of the braid through the fascia matrix.  
 
 
Figure 3.8: Average time zero suture retention load of fascia reinforced with 100% PLLA or 
6PLLA/2PGA braid. The suture retention load of fascia patches reinforced with either braid 
exceeded 300N, which is a six fold increase over non-reinforced fascia (54 ± 14 N) and also 
greater than the suture retention of human rotator cuff tendon (200 - 240 N)  Like letters indicate 
statistical significance between groups (p < 0.05). 
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Table 3.3: Mechanical properties of fascia reinforced with 100% PLLA or 6PLLA/2PGA at time zero and after in vivo implantation: Average 
values (standard deviation). Statistical differences between groups are noted in the text and related figures. 
Property 
100% PLLA 6PLLA/2PGA 
Time Zero 4 wks 12 wks Time Zero 4 wks 12 wks 
Suture Retention Load (N) § 315(23) 315(56) 323(62) 415(51) 262(60) 242(54) 
Stiffness (N/mm) § 21(2) 17(3) 18(4) 22(2) 15(3) 14(2) 
First Cycle Stroke Elongation (mm) * 7.3(0.2) ---- 
8.1(0.8) 
---- 
First Cycle Cyclic Elongation (mm) * 5.6(0.3) 7.4(0.8) 
Cycles to failure * 
3 of 8 did   
not fail after 
5000 cycles ---- 
8 of 8 did not 
fail after 5000 
cycles 
---- 
3250(650) n=5 
§  Data obtained from failure testing, n = 10 - 12 per group 
* Data obtained from cyclic testing, n = 8 except where noted 
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 Cyclic Fatigue  
At the first cycle of loading, scaffolds reinforced with 100% PLLA had an 
average stroke elongation of 7.3 ± 0.2 mm and cyclic elongation of 5.6 ± 0.3 mm, which 
was significantly less than the average stroke elongation (8.1 ± 0.8mm) and cyclic 
elongation (7.4 ± 0.8 mm) of scaffolds reinforced with 6PLLA/2PGA (p ≤ 0.025,              
Table 3.3). 
There were no significant differences in the cyclic elongation (p = 0.75) or 
stiffness (p = 0.56) profiles between groups over the first 2500 cycles. However, the 
cyclic elongation (p = 0.0003) and stiffness (p = 0.0002) profiles were significantly 
different between groups for cycles > 2500 (Figures 3.9 A & 3.9 B).  
Three of eight reinforced scaffolds in the 100% PLLA group and eight of eight 
reinforced scaffolds in the 6PLLA/2PGA group did not fail after 5000 cycles of cyclic 
loading (Table 3.3). The remaining five of eight reinforced fascia scaffolds in the 100% 
PLLA group failed at an average of 3250 ± 650 cycles, with the mode of failure being 
breaking of the braid secondary to slipping of the reinforcing braid through the fascia 
matrix.  
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Figure 3.9: Average time zero (A) cyclic elongation and (B) cyclic stiffness of fascia scaffolds 
reinforced with 100% PLLA or 6PLLA/2PGA braid. There were no significant differences in the 
cyclic elongation or stiffness profiles between groups over the first 2500 cycles. However, the 
cyclic elongation and stiffness profiles were significantly different between groups for cycles            
> 2500.  
 
 
 
 
 86 
3.4.2 Gross Observations 
The fiber reinforcing braids were clearly visible within the fascia scaffolds at four 
and twelve weeks. There were no obvious changes in the size of the scaffold, and the 
fascia matrix did not seem to be grossly resorbed at either time points (Figure 3.10 A). 
Scaffolds implanted in the abdominal wall defect were clearly distinguishable from the 
underlying muscle at both time points (Figure 3.10 B).  
 
Figure 3.10: Gross observations at tissue harvest, in this case 12 weeks: (A) 5x5 cm reinforced 
fascia ECM scaffold attached to screen at dorsal implantation site and (B) 1x1 cm reinforced 
(left) and non-reinforced control (right) fascia ECM scaffold at abdominal wall defect site. 
 
3.4.3 Descriptive Histology  
All scaffolds elicited a chronic inflammatory response composed of lymphocytes, 
plasma cells and macrophages. Eosinophils were conspicuous in and around the scaffolds 
of all experimental groups at the four week time point but these had mostly disappeared 
by twelve weeks. Neutrophils were absent. A foreign-body giant cell response was 
evident and concentrated to the area of polymer reinforcement at four weeks and 
persisted at twelve weeks. In the non-reinforced fascia scaffolds, multinucleated giant 
cells were few and were found only around possible foreign bodies. The fascia matrix in 
all groups exhibited variable regions of cellularity, and most of the cellular infiltrates in 
the central region of the scaffolds by twelve weeks were accounted for by spindle-shaped 
fibroblasts, lymphocytes and macrophages interspersed between the collagen bundles 
(Figures 3.11 & 3.12).  
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Figure 3.11: Histologic images of fascia scaffolds at 4 weeks stained with hematoxylin-
eosin.  Representative images of non-reinforced fascia (A, C, E, G) and 100% PLLA reinforced 
fascia (B, D, F, H).  
A, B (Magnification 15x): The scaffolds appeared intact and composed of longitudinal 
collagenous bands without (A) and with polymers (B, asterisks).  
C, D (Magnification 100x): The cellular infiltrates were more pronounced at the periphery of the 
scaffold, though sparse infiltrates were seen throughout the fascia matrix. Minimal 
disorganization of the collagenous scaffold was observed.  
E, F (Magnification 400x):  The chronic inflammatory cellular infiltrates were composed 
predominantly of lymphocytes and plasma cells with scattered eosinophils (arrows) in both 
groups.  
G, H (Magnification 600x): Foreign-body giant cell reaction in the non-reinforced fascia was 
minimal and superficial in location (G). In the reinforced scaffolds, multinucleated giant cells are 
concentrated around the polymer reinforcing braids (H, asterisks), which appear as birefringent 
material in cross-section and longitudinal orientation.  
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Figure 3.12: Histologic images of fascia scaffolds at 12 weeks stained with hematoxylin-
eosin.  Representative images of non-reinforced fascia (A, C, E) and 100% PLLA reinforced 
fascia (B, D, F). 
A, B (Magnification 15x): The fascia scaffolds appeared intact with more pronounced cellular 
infiltrates than at four weeks.  
C, D (Magnification 100x): Cellular infiltrates were observed in the peripheral and central regions 
of the scaffold.  
E, F (Magnification 200x): The scaffolds were infiltrated by spindle-shaped fibroblast-like cells, 
macrophages and lymphocytes in variable distribution. Vascularization (arrows) of the grafts was 
mild and comparable between groups.  
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3.4.4 Histological Outcomes 
 
The individual and average scores of the non-inflammatory and inflammatory 
outcomes from each experimental group at both time points are presented in Table 3.4 & 
3.5, respectively. There was an increase in the number of foreign body giant cells 
(FBGC) in the reinforced fascia groups compared to non-reinforced fascia (p = 0.01) at 
both time points. However, there were no significant differences in the amount of other 
inflammatory cellular infiltrates, i.e., neutrophils, lymphocytes, plasma cells and 
macrophages between groups at either time point. There were no differences in the 
cellularity, density of fibroblasts-like cells or vascularity between groups at either time 
point.  
 
Time 
Point 
Experimental 
Group 
Non-Inflammatory Cell Outcomes 
Vascularization Fibroblasts Cellularity 
4 
w
ee
ks
  
Native  1,1,1,1 1,1,1,1 1,1,1,1 
(1) (1) (1) 
100% PLLA 
Reinforced 
1,1,1,1 1,1,1,1 1,1,1,2 
(1) (1) (1.25) 
6PLLA/2PGA 
Reinforced  
1,1,1,1 1,2,2,2 1,2,2,3 
(1) (1.75) (2) 
12
 w
ee
ks
 
Native  1,1,1,1 1,1,1,2 1,1,1,2 
(1) (1.25) (1.25) 
100% PLLA 
Reinforced 
1,1,1,1 1,1,1,3 1,1,1,3 
(1) (1.5) (1.5) 
6PLLA/2PGA 
Reinforced  
1,1,1,2 1,2,3,4 1,2,2,4 
(1.25) (2.5) (2.25) 
Table 3.4: Histological scores (mean) for non-inflammatory outcomes  
n = 4 per group per time point  
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Time 
Point 
Experimental 
Group 
Inflammatory Cell Outcomes 
Eosinophils Lymphocytes Plasma Cells Macrophages 
Giant 
Cells 
4 
w
ee
ks
  
Native  1,1,2,2 2,2,3,3 1,3,3,3 1,2,2,2 1,1,1,1
a,b 
(1.5) (2.5) (2.5) (1.75) (1) 
100% PLLA 
Reinforced 
1,2,2,2 1,1,2,2 2,3,3,3 2,2,2,2 3,3,3,3a 
(1.75) (1.5) (2.75) (2) (3) 
6PLLA/2PGA 
Reinforced  
1,1,2,2 2,2,2,3 1,1,2,2 2,3,3,4 2,3,3,3b 
(1.5) (2.25) (1.5) (3) (2.75) 
12
 w
ee
ks
 
Native  0,0,0,0 2,3,3,3 1,1,2,2 1,2,2,3 1,1,1,1
c,d 
(0) (2.5) (1.5) (2) (1) 
100% PLLA 
Reinforced 
0,0,1,1 2,2,2,4 1,2,2,2 1,2,2,3 2,3,3,3c 
(0.5) (2.5) (1.75) (2) (2.75) 
6PLLA/2PGA 
Reinforced  
0,0,0,0 2,2,2,3 0,1,2,2 0,1,2,2 2,3,3,3d 
(0) (2.25) (1.25) (1.25) (2.75) 
    Table 3. 5: Histological scores (mean) for inflammatory cell outcomes 
Like letters indicate significant differences for giant cells between groups at each time point (p = 0.01) 
             n = 4 per group per time point 
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3.4.5 Post-Implantation Mechanical Properties 
The mode of failure for all samples occurred by breaking of the reinforcing braid 
secondary to slipping of the braid through the fascia matrix (Figure 3.13).  
 
 
Figure 3.13: Mechanism of slipping of braid through fascia matrix: With application of force (F), 
the braids in the matrix begin slipping through the fascia matrix ultimately leading to breaking of 
braid.  
 
The suture retention load of fascia reinforced with 100% PLLA did not change 
after 12 weeks of implantation, whereas the suture retention load of fascia reinforced with 
6PLLA/2PGA significantly decreased (~40%) after four and twelve weeks                                     
(Figure 3.14 A, Table 3.3). The stiffness of fascia reinforced with either braid 
significantly decreased after implantation (Figure 3.13 B, p ≤ 0.0001), but the decrease 
was significantly greater at 12 weeks in scaffolds reinforced with 6PLLA/2PGA (~35%) 
than scaffolds reinforced with 100% PLLA (~15%) (Figure 3.14 B, Table 3.3)                        
(p ≤ 0.0001). Hence by twelve weeks, scaffolds reinforced with 6PLLA/2PGA had 
significantly less suture retention strength and stiffness than scaffolds reinforced with 
100% PLLA.  
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Figure 3.14: (A) Suture retention load and (B) stiffness of fascia reinforced with 100% PLLA or 
6PLLA/2PGA braid after in vivo implantation. Fascia reinforced with 100% PLLA demonstrates 
no significant change in suture retention load after 12 weeks of implantation, whereas the suture 
retention load of fascia reinforced with 6PLLA/2PGA significantly decreased (~40%) after in 
vivo implantation. There is a significant decrease in the stiffness of fascia reinforced with either 
braid; however, the decrease is more pronounced in scaffolds reinforced with 6PLLA/2PGA 
(~35%) than scaffolds reinforced with 100% PLLA (~15%).  
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3.5 Discussion  
The goal of this study was to develop a novel extracellular matrix (ECM) derived 
scaffold with robust mechanical properties for use in musculoskeletal soft tissue repair. 
Specifically, the suture retention strength and stiffness of allograft fascia lata was 
engineered by stitching braided, resorbable polymer fibers into fascia extracellular matrix 
(ECM) in a unique, controlled manner. Two types of polymer reinforcing braids (100% 
PLLA or 6PLLA/2PGA braid) were investigated. At time zero, reinforced fascia 
scaffolds had a six-fold increase in suture retention strength compared to non-reinforced 
fascia, and the suture retention of fascia reinforced with 6PLLA/2PGA was significantly 
greater than fascia reinforced with 100% PLLA braid. Reinforced fascia scaffolds from 
both braid groups had similar cyclic loading profiles up to 2500 cycles, however, only 
scaffolds reinforced with 6PLLA/2PGA consistently survived loading to 5000 cycles. 
The mechanical properties of reinforced fascia scaffolds changed over time following       
in vivo implantation, and by twelve weeks scaffolds reinforced with 6PLLA/2PGA had 
significantly less suture retention strength and stiffness than scaffolds reinforced with 
100% PLLA. The host response to all fascia scaffolds was characterized by the 
infiltration of inflammatory and non inflammatory fibroblast-like cells. Giant cells were 
more predominant in the reinforced fascia scaffolds and concentrated around the polymer 
braids. 
At time zero, reinforced fascia ECM had a six-fold increase in suture retention 
strength compared to non-reinforced fascia and exceeds the suture retention properties of 
human rotator cuff tendon (~250 N) 20. Contrary to our hypothesis, however, the suture 
retention of fascia reinforced with 6PLLA/2PGA was significantly greater than fascia 
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reinforced with 100% PLLA braid despite both braids having similar ultimate tensile 
strength (Table 3.1). One possible explanation for this outcome was that the 
6PLLA/2PGA braid was noted to be qualitatively smoother than the 100% PLLA braid, 
which may have allowed for tighter stitching and more efficient load-sharing by the 
6PLLA/2PGA braid across the whole range of displacement. The similarity in stiffness 
between both reinforced fascia groups at lower-displacements despite 6PLLA/2PGA 
being a stiffer braid (Table 3.1), suggests that the initial mechanism of scaffold loading is 
not primarily dictated by the mechanics of the braids, but more likely a function of 
friction/slipping at the interface between the braids and the ECM. 
Reinforced fascia scaffolds from both braid groups had similar cyclic loading 
profiles up to 2500 cycles, though scaffolds reinforced with 100% PLLA experienced 
significantly less stroke and cyclic elongation on the first cycle of pull. Between groups 
differences in stroke elongation at cycle one seem to contradict the results from failure 
testing which showed similarity in stiffness between reinforced fascia groups at lower-
displacements. Given the relatively low sample size for both types of tests (n = 8 to 12), 
this discrepancy could simply be a statistical anomaly. Since the groups otherwise had 
similar loading profiles up to 2500 cycles, we conclude that any differences that may 
exist between groups at cycle one are small and not clinically meaningful. Regardless, it 
is important to emphasize that when reinforced scaffolds were subjected to 5 - 150 N of 
cyclic load, they stretch 7 - 8 mm the first time they are pulled, and have 6 - 7 mm of 
cyclic (presumably permanent) elongation when they are unloaded. (This elongation is 
not likely to be eliminated simply by pre-tensioning the scaffold in the operating room, 
because it occurred as a result of loading to 150 N). After the first cycle of loading, the 
 
 
 95 
fibers have presumably “set”, the scaffold stiffens, and cyclic elongation progresses at a 
slower rate. For example, reinforced scaffolds demonstrate ~12 mm of cyclic elongation 
after 1000 cycles to 150 N. Only scaffolds reinforced with 6PLLA/2PGA consistently 
survived loading to 5000 cycles, which may again be due a tighter stitch afforded by the 
6PLLA/2PGA braid allowing for a more efficient load-sharing and better resistance to 
fatigue failure.  
After four and twelve weeks of implantation, the suture retention load of fascia 
reinforced with 6PLLA/2PGA significantly decreased (~40%). Because the suture 
retention load of fascia reinforced with 100% PLLA did not change in the same time 
frame, we hypothesize that the loss of suture retention with the 6PLLA/2PGA braid 
(contains 34% PGA by weight) was primarily due to degradation of PGA and subsequent 
weakening of the overall braid construct. PLLA and PGA are aliphatic polyesters that 
degrade by hydrolytic chain scission of the esters linkage 16. PGA is a hydrophilic and 
degrades on the order of days to weeks, whereas PLLA is hydrophobic and degrades on 
the order of months 19, 26. The absence of any further loss of suture retention in scaffolds 
reinforced with 6PLLA/2PGA braid between four and twelve weeks suggests that the 
majority of the PGA in the 6PLLA/2PGA braid was degraded by four weeks post-
implantation. 
The stiffness of both groups of reinforced scaffolds decreased following four 
weeks of in vivo implantation. The reduction in scaffold stiffness is likely, at least in part, 
a consequence of the influx of macrophages and giant cells, which are known to secrete 
matrix metalloproteinases (MMP) -2, -3, -9, -12 2, 14. Further it has also been shown that 
ECM collagen degradation occurs by action of matrix metalloproteinases (MMP) -1,- 8,  
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-13, -14 and through phagocytosis by macrophages and fibroblasts 1, 8, 9, 15, 21, 25. Together, 
these could have reduced the mechanical properties of fascia ECM following in vivo 
implantation as seen by other investigators 12, 24. In reinforced fascia scaffolds 
degradative enzyme activity would likely be particularly pronounced around the braids 
where giant cells were predominantly localized, which could result in dramatically 
reduced stiffness of the fascia matrix locally, leading to reduced interface friction 
between the fascia and the braids. The greater loss of stiffness of fascia reinforced with 
6PLLA/2PGA braid (35%) compared to fascia reinforced with 100% PLLA braid (15%) 
may be explained by a possible concomitant decrease in mechanical properties of the 
6PLLA/2PGA braid as a consequence of PGA hydrolysis. That the stiffness of the 
scaffolds did not further decrease from four to twelve weeks of implantation suggests the 
degradative (inflammatory) phase may be resolving or at least balanced by the presence 
of non-inflammatory cells involved in new tissue deposition. This conclusion is 
supported by studies which have shown that soft tissue repairs are weakest at 3 - 4 weeks 
after surgery as the inflammatory phase is transitioning to the remodeling phase of wound 
repair 4, 27. 
The host response to all fascia scaffolds was characterized by the infiltration of 
macrophages, giant cells, lymphocytes, plasma cells and non inflammatory fibroblast-like 
cells. In particular, giant cells were more predominant in the reinforced fascia scaffolds 
and concentrated around the polymer braids. The presence of giant cells around PLLA 
braids has been shown previously 11 and is expected as the macrophages attempt to 
phagocytose the “foreign” polymeric materials. We speculate that the giant cell response 
would persist until the braids are fully hydrolyzed. Although eosinophils are known to be 
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present as an inflammatory infiltrate associated with cutaneous wounds 5, 6, and as a 
response to allergic conditions or during parasitic infections 18, their presence at four 
weeks and resolution at twelve weeks in scaffolds from all groups remains unclear. Their 
presence could be related to processing steps, as they were not seen in a previous study 
from our laboratory where the fascia scaffolds were rinsed in water for 24 hours prior to 
implantation 17. However, their transient presence did not seem to have any deleterious 
effect on scaffold integrity. The chronic lymphocytic infiltrate in all fascia scaffolds may 
represent an immune reaction to the xenograft, possibly due to remnant cellular elements 
that remain in the fascia even after processing. It is hypothesized that fascia ECM would 
elicit less lymphocyte infiltrate than seen here, if used as an allograft in human patients. 
Finally, the presence of fibroblast-like cells in all fascia scaffolds is suggestive of host 
remodeling and new tissue deposition. 
The current study is not without limitation. First, the dorsum of the rat does not 
fully mimic the intra-articular environment of the human shoulder, nor were the scaffolds 
mechanically loaded. Synovial fluid and/or mechanical loading could affect the rate and 
extent of braid degradation and scaffold remodeling. Second, the host response of the 
reinforced fascia scaffolds was not evaluated in the context of a rotator cuff injury. 
However, the rat body wall defect model is an established preclinical model for 
evaluating the host response to biomaterials 23 and is useful for comparative studies. 
Third, the change in the surface morphology, molecular weight, crystallinity and 
mechanical properties of the braids themselves after in vivo implantation were not 
investigated but would be useful to know in order to design braids that have desired 
mechanical properties and degradation profiles. Lastly, twelve weeks was the latest time 
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point investigated. A longer time would allow us to evaluate the effect of braid 
degradation and fascia matrix remodeling on the mechanical properties of the reinforced 
fascia scaffolds.  
The overall goal of this work was to engineer the suture retention strength and 
stiffness of allograft fascia lata in order to develop an extracellular matrix (ECM) derived 
scaffold with robust mechanical properties for general use in musculoskeletal soft tissue 
repair, and more specifically rotator cuff repairs. The precise design criteria of scaffolds 
for such applications are difficult to specify because the mechanical demands in the 
clinical scenario are variable and unknown. As a guidance, however, one might consider 
the suture retention properties of human rotator cuff tendon (~250 N) 20, the maximum 
expected loads on a rotator cuff repair post-operatively (~180 N) 13, 22, the number of duty 
cycles that a rotator cuff repair may be exposed to in the early post-operative period (it is 
estimated that during the first six weeks of post-operative rehabilitation, a human rotator 
cuff repair might experience ~60 cycles/day = ~2500 cycles), and the amount of medial 
tendon retraction that might increase the likelihood of repair failure (5 - 10 mm) as 
possible design criteria 7, 22. Here, it has been demonstrated that the suture retention load 
of reinforced fascia scaffolds remained ≥ 250 N, even after twelve weeks of in vivo 
transplantation. Furthermore, the scaffold augmentation component is estimated to carry 
only 20 - 30% of the load on a tendon repair (i.e., ~50 - 60 N) (Chapter 4) 3. Although 
reinforced fascia scaffolds in this study were not cycled to these lower levels of load, the 
data support the possibility that the cyclic elongation of reinforced fascia scaffolds at                   
50 N cyclic loads would remain on the order of 5 mm or less, even after 2500 cycles. 
Together these results suggest that fascia scaffolds reinforced with either braid have 
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robust load-deformation properties that are possibly sufficient to provide mechanical 
augmentation to rotator cuff repairs and modulate tendon retraction in a manner that 
reduces the incidence of tendon re-tear.  
In summary, this study presents fiber reinforcement by stitching as a novel and 
versatile method for engineering the suture retention strength and stiffness of allograft 
fascia lata, which may be extended to other extracellular matrix derived materials as well. 
Conceptually, this approach retains the biologic advantages of a naturally-derived 
extracellular matrix, while improving its mechanical performance for demanding 
musculoskeletal applications. The in vitro and in vivo studies performed herein suggest 
the potential of the reinforced fascia scaffolds to provide and sustain mechanical 
augmentation of tendon repairs. The extent to which reinforced fascia scaffolds can in 
fact limit tendon retraction in the context of rotator cuff repair is the subject of an 
ongoing work in a human shoulder cadaver model in our laboratory. However, a full 
understanding of the clinical efficacy of these novel materials will require pre-clinical 
and clinical studies.  
The next chapter will present the formulation and development of a spring-
network model for rotator cuff repairs.  
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Chapter IV 
 
 
FORMULATION AND DEVELOPMENT OF A SPRING-NETWORK 
MODEL FOR ROTATOR CUFF REPAIRS 
 
It is a test of true theories not only to account for but also to predict phenomena…. 
                                                                William Whewell 
 
 
 
4.1 Introduction  
Rotator cuff tears affect 40% or more of those over age 60 26, 33, 38 and are a 
common cause of debilitating pain, reduced shoulder function and weakness. Despite 
advances in the surgical treatment of these tears, high surgical failure rates that range 
from 20 to 90% have been reported 1, 6, 7, 15-17, 20 due to various factors 5, 8, 18, 19, 21, 27, 28, 34, 
35.  
Currently, natural and synthetic scaffolds are being used as devices to augment 
soft tissues repaired by sutures or suture anchors during the repair of large to massive 
rotator cuff tears 4, 9, 10. While significant advances have been made in the development of 
scaffolds for use as augmentation devices, no studies have investigated the degree of load 
sharing provided by a scaffold used for rotator cuff repair augmentation. Furthermore, the 
manner in which loads are distributed amongst the various components on an augmented 
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rotator cuff repair is not yet known, nor is the relative biomechanical importance of the 
various components of the augmented rotator cuff. Hence, there is a need to develop a 
model that will help answer the aforementioned questions. This dissertation aims to 
develop quasi-static spring - network models of simplified rotator cuff repairs, (2) 
validate the models by comparing the predicted model force to experimental 
measurements of force for human and canine rotator cuff repairs, and (3) use the models 
to predict the degree of load sharing provided by a scaffold used for rotator cuff repair 
augmentation.  
This chapter will focus on the formulation and development of the quasi-static 
spring - network models. The model structure for non-augmented and augmented human 
and canine rotator cuff repairs will be discussed. The description, mechanical testing, 
modeling and parameter estimation of the individual components of the repair will also 
be presented.  Finally, model equations for the aggregate models will be formulated 
based on the physics of “springs” connected in series and parallel. Since, the models are 
developed from in-vitro mechanical testing of repair constructs carried out at a slow 
loading rate, the models were assumed to have a quasi-static behavior.  
 
4.2 Current Models for Rotator Cuff Tears 
Finite element models (FE) have been employed to determine the general stress 
field in intact, torn and surgically repaired rotator cuff tendon. Luo and co-workers were 
the first to use a two-dimensional (2D) finite element model to demonstrate the presence 
of stress concentration on the articular side of the supraspinatus tendon 24. Wakabayashi 
et al., also established a 2D finite model, which included the tendon insertion and showed 
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high stress distributions towards the insertion site as the arm was abducted 36. Sano et al.,  
have reported the stress distribution patterns in the human supraspinatus tendon with 
partial thickness tears 29. Others have used a FE model to compare the stress distribution 
pattern in the supraspinatus tendon after repair using a transosseous and suture anchor 
fixation technique 30 14. More recently, Seki et al., using a three-dimensional (3D) finite 
element have reported the stress distribution pattern in the intact supraspinatus tendon 31. 
Further, Adams and co-workers investigated the changes in the rotator cuff tendon 
excursion and muscle moment arms using an explicit 3D finite element model of the 
glenohumeral joint 2. 
Although these studies allow investigating the stress distribution patterns of the 
rotator cuff tendons under complex loading conditions, they do not allow predicting the 
biomechanics (stiffness and yield load) of repair constructs during different loading 
scenarios and surgical repair techniques. More importantly, the response of the repair 
construct to the change in a parameter of interest (e.g., stiffness) cannot be examined 
using these models. In contrast, a parametric simulation study is possible with simpler 
spring - network models in an efficient and less computationally expensive manner than 
sophisticated finite element models. Additionally, spring - network models do not require 
explicitly stating the boundary conditions, which is a critical step in the finite element 
approach, as these conditions are implicitly included in the mechanical behavior of the 
individual springs.  
Additionally, spring - network models have routinely been used to investigate the 
biomechanics of flexor tendon repairs 23 and load transfer from prosthetic stem to 
surrounding bone 12. Hence, a spring - network model was selected to examine the 
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biomechanics of rotator cuff repairs. Such a model will also allow prediction of the 
biomechanics (stiffness and yield load) of repair constructs during different loading 
scenarios and/or in the context of surgical repair techniques as will be discussed in 
Chapter 5.   
 
4.3. Approach 
From the physical observation of non - augmented and augmented rotator cuff 
repairs, the assembly of the individual spring components into an aggregate model was 
based on the analogy of springs in series and parallel. The individual components of the 
repair constructs representing the tendon attachment to bone, the tendon itself, the 
scaffold along with its attachment to bone, and the scaffold attachment to the tendon were 
modeled using a single phase non-linear equation or biphasic non-linear equation. The 
parameters of the non-linear equations representing the individual components were then 
estimated by non-linear least-squares analysis of the component-specific load-
displacement data. Finally, the model equations were formulated using the physics of 
springs in series and parallel.  The detailed methods are described below.  
 
4.4 Model Structure 
4.4.1 Non-Augmented Rotator Cuff Repair (Repairs sans Scaffolds) 
A non-augmented rotator cuff repair is a repair wherein the tendon is re-apposed 
to the bone using a surgical technique without the use of a scaffold as an augmentation 
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device. Such a repair is shown in Figure 4.1 for human (Figure 4.1 A) and canine repairs           
(Figure 4.1 B), respectively.   
The non-augmented repairs were modeled as two springs in series, namely, the 
bone-suture-tendon interface (spring#1) and the tendon itself (spring#2) (Fig 4.1 C)  
 
 
Figure 4.1: Schematics of non-augmented (A) human, (B) canine and augmented (D) human, (E) 
canine rotator cuff repairs and their corresponding analogies with the spring models (C, F). The 
dotted lines represent suture markers that were placed on the tendon, and the black dot represents 
the optical marker that was placed on the bone, for optical displacement measurements during 
mechanical testing. Adapted from Figure 1 in  Aurora et al, 3 
 
4.4.2 Augmented Rotator Cuff Repair (Repairs with Scaffolds)  
Augmented rotator cuff repairs are repairs wherein the scaffolds placed over the 
tendon repair and sutured to bone at one end and to the tendon at the other. Such a repair 
is shown in Figure 4.1 for human (Figure 4.1 D) and canine repairs (Figure 4.1 E), 
respectively.   
The augmented rotator cuff repairs were modeled as five springs connected in 
series and parallel as shown in Figure 4.1 F. The tendon (spring#2) was split into two half 
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springs, spring#2’ and spring#2”. The bone-screw-scaffold-suture component (spring#3) 
and the medial suture- tendon interface (spring#4) were in series with each other and 
together in parallel with the primary tendon repair (spring 1 and 2’). This four spring 
construct was then placed in series with the other half tendon spring#2”, to conform the 
model for augmented rotator cuff repairs.  
 
4.5 Experimental Mechanical Testing of the Individual Components 
The experimental displacement data for spring#1 (bone-suture-tendon) and   
spring#2 (tendon only) were gathered from mechanical tests carried out on human and 
canine non-augmented repairs, respectively. The experimental displacement data for 
spring#3 (bone-screw-scaffold-suture) and spring#4 (medial suture-tendon) was collected 
from independent (isolated) mechanical tests. The detailed methods and testing protocol 
are described as follows: 
4.5.1 Spring#1 (Bone-Suture-Tendon) 
 For the human repairs, a strip of the superior infraspinatus tendon (12 mm wide) 
was released and repaired to the greater tuberosity using a double row transosseous 
technique with two Mason Allen sutures per row (Figure 4.1 A) 25. Similarly, repair of 
the canine shoulders involved release and repair of the infraspinatus tendon to the greater 
tuberosity using two transosseous Mason Allen sutures. All repairs were performed by an 
orthopedic surgeon, Jesse A. McCarron, MD, Cleveland Clinic. For mechanical testing of 
all repairs, the muscle belly was freeze-clamped and the repair was cycled between 5-100 
N at 0.25 Hz and subsequently loaded to failure at 30 mm/min 11, 25. The distance 
between an optical marker placed on the humeral head and in the tendon just medial to 
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the repair sutures provided local displacements across the bone-suture-tendon interface 
(Figures 4.1 A & 4.1 B). 
4.5.2 Spring#2 (Tendon only) 
 The distance between two optical markers placed on the tendon provided local 
displacements in the tendon. These displacement data were obtained from mechanical 
testing of non-augmented human and canine repairs (n = 5, respectively) (Figures 4.1 A 
& 4.1 B). The displacements of spring#2 were divided in half to obtain the displacements 
of spring#2’ and spring#2” used in the augmented repair models.  
4.5.3 Spring#3 (Bone-Screw-Scaffold-Suture) 
A prototypic polymer scaffold (12 mm wide, by 40 mm long, by 0.8 mm thick)    
(X-Repair, Synthasome Inc., San Diego, CA) was screwed to a wood block on one end 
and sutured with 3 simple stitches to a rod on the other end (Figure 4.2 A). The construct 
was preloaded to 5 N and subsequently loading to failure at 30 mm/min. The 
displacements of spring#3 were obtained using actuator position from these isolated 
mechanical tests (n = 5).  
 
 
Figure 4.2: Schematic of the experimental load-displacement testing for (A) spring#3 (bone-
screw-scaffold-suture) and (B) spring#4 (medial suture-tendon interface).  
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4.5.4 Spring#4 (Medial Suture-Tendon) 
 Three modified Mason Allen sutures were placed in either isolated human 
superior infraspinatus tendon or canine infraspinatus tendon and secured over a rod using 
a double half-hitch suture configuration (six throws) (Figure 4.2 B). All repairs were 
performed by Andrew Baker, Principal Research Engineer, Derwin Laboratory at the 
Cleveland Clinic. The associated muscle was freeze-clamped and the suture interface was 
cyclically loaded (5-30 N) for 20 cycles at 0.25 Hz and subsequently loaded to failure at 
30 mm/min. The displacements of spring#4 were obtained using actuator position from 
these isolated mechanical tests (n = 5, respectively). 
 
4.6 Modeling the Individual Components of the Repair 
The mechanical behavior of the individual components of the repair constructs 
was examined by plotting the component-specific load-displacement (L-D) data obtained 
from in vitro mechanical tests (Section 4.5). Noting the non-linearity of the individual 
components of the repair construct, a non-linear equation was selected that would reliably 
approximate the observed non-linear behavior. The form of the non-linear equation was 
selected by plotting component specific L-D data on a log-log scale and finding the 
exponential correlation. Based on these results, a power-law equation (of the form            
F = F0 + Axb) was selected to model the individual components of the repair constructs. 
The appropriateness of this power-law equation to reliably approximate the non-linear 
behavior of the individual components was then verified by finding the exponential 
correlation [along with 95% Confidence Intervals (CI)] of the linearized form of the 
power-law equation, using a linear least-squares analysis in MATLAB (MathWorks, 
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Natick, MA, USA). If the correlation was not acceptable (experimental data were not 
within the 95% CI), the mechanical behavior of the individual components was modeled 
using an alternate (biphasic) non-linear equation. For simplicity, only the modeling of the 
individual components of canine repairs is being presented here. However, a similar 
approach was adopted for modeling the individual components of the human repair 
constructs, and results for both types of repairs will be presented in Chapter 5.  
A representative load-displacement (L-D) plot, typical of all the individual 
components of canine repairs is shown in Figure 4.3. The plot exhibits a non-linear 
behavior observed in soft tissues including tendon and ligaments 37. The mechanical 
behavior is characterized by an initial toe region and a subsequent linear region where the 
mechanical behavior of the component gradually evolves into a region of quasi-linear 
behavior with the gradual application of load.  
 
 
Figure 4.3: Representative load-displacement plot, typical of all individual components of canine 
repairs 
 
This shape of the L-D curves verifies the need to model the individual 
components of repairs using a non-linear equation.  An appropriate non-linear equation 
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was determined by plotting component specific L-D data on a log-log scale. Figure 4.4 is 
a representative log-log plot of the load-displacement data of the bone-suture-tendon 
component (spring#1) of canine repairs.  
 
Figure 4.4: Representative log-log plot of the bone-suture-tendon component (spring#1) of 
canine repairs.  
 
 
The log-log plot (Figure 4.4) indicates a strong linear correlation (R2 = 0.9) 
between log (load-displacement) data of the bone-suture-tendon component (spring#1) of 
canine repairs. Similarly, linear correlations were obtained for from the log-log plots for 
all the individual components of the canine repair constructs (not shown). This suggests 
that the individual components could be modeled by a non-linear equation that can be 
linearized to verify its appropriateness to model the individual components. A power-law 
equation [Eqn. (1)] is one such equation that can easily be linearized and has been used to 
model non-linear behavior for various applications 22, 32. Hence, a power-law equation 
was selected to model the non-linear behavior of the individual components of the canine 
repairs.  
F = F0+ Axb………………………………………………(1) 
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Where, F0, A, b, B, c  are parameters of the model equation. 
The linearized formulation of Eqn. (1) is  
 log�F-F0�= blog(x)+ log(A) ………………………….(2) 
The ability of the power-law equation Eqn. (1) to reliably model the individual 
components of the canine repairs constructs was then determined by plotting   log (F-F0) 
vs. log (x) and performing a linear least-squares regression of Eqn. (2) in 
MATLAB.(Mathworks, Natick, MA, USA). The results of the linear least-squares 
regression for the individual components of canine repairs is presented in the next 
section. 
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4.7 Linear Least-Squares Regression of the Individual Components  
 
Figure 4.5: Plot of load-displacement experimental data for (A) the bone-suture-tendon 
component (spring#1), (B) the tendon only component (spring#2), (C) the bone-screw-scaffold-
suture component and (D) the medial suture-tendon interface of canine repairs. The exponential 
correlation [Eqn. (1)] results (dotted blue line) and the 95% confidence intervals (dotted red lines) 
are also shown.  
 
Figure 4.5 shows the linear least-squares regression of the linearized power-law 
formulation Eqn. (2) for the individual components of canine repairs. These results 
suggest that the power-law equation [Eqn. (1)] is able to reliably model the non-linear 
mechanical behavior of the tendon only component (spring#2) (Figure 4.5 B) and the 
bone-screw-scaffold-suture component (spring#3) (Figure 4.5 C) of canine repairs. The 
experimental data of these components remained within 95% confidence intervals (CI) of 
the correlation.  
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However, the bone-suture-tendon component (spring#1) (Figure 4.5 A) and the 
medial suture-tendon interface (spring#4) (Figure 4.5 D) do not appear to be reliably 
modeled using the power-law equation [Eqn. (1)], as evidenced by large portion of the 
experimental data outside the 95% CI for these components. These plots suggest that 
these components seem to follow a two asymptotic exponential phases that may be best 
modeled using a two-phase non-linear model.  
4.7.1 Biphasic (Two-Phase) Non-Linear Equation 
Figure 4.6 shows the linear least-squares regression of the linearized power-law 
formulation Eqn. (2) performed separately on the two exponential asymptotic phases of 
the bone-suture-tendon component (spring#1) and the medial suture-tendon interface 
(spring#4) of canine repairs. These plots confirm the two-phase (biphasic) non-linear 
behavior of these components. The experimental data of these components in the two 
asymptotic phases remained within 95% confidence intervals (CI) of the separate 
correlations.  
 
Figure 4.6: Plot of load-displacement experimental data for (A) the bone-suture-tendon 
component (spring#1) and (B) the medial suture-tendon interface (spring#4) of canine repairs. 
The exponential correlation [Eqn. (1)] results (solid blue line) and the 95% confidence intervals 
(dotted blue lines) for the two asymptotic exponential phases are also shown.  
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The observed biphasic (two-phase) behavior of these components is commonly 
found in the kinetic analysis of catalytic mechanisms in chemical reaction engineering 13. 
A common approach in reaction engineering analysis is to use the Langmuir isotherm 
equation to estimate kinetic parameters and elucidate mechanisms following a similar 
biphasic non-linear as seen in Figure 4.6. Hence, it was believed that the biphasic trend of 
the bone-suture-tendon component (spring#1) and the medial suture-tendon interface 
(spring#4) of canine repairs may be reliably modeled using a modified form of the 
Langmuir equation as in Eqn. (3). 
F = F0 + Axb
1+Bxc
 …………………………………………(3) 
Henceforth, the power-law equation [Eqn. (1)] will be referred to as the single 
phase non-linear equation and the two-phase non-linear equation [Eqn. (3)] as the 
biphasic equation. For the human repairs, the tendon only component (spring#2), the 
bone-screw-scaffold-suture component (spring#3) and the medial suture-tendon interface 
(spring#4) were modeled using the single phases non-linear equations, while the bone-
suture-tendon component (spring#1) was modeled using the biphasic non-linear equation.  
 
4.8 Non-Linear Parameter Estimation   
The parameters of the non-linear equations representing the individual 
components of the repairs were then estimated using non-linear least-squares analysis of 
the component specific experimental load-displacement data. While linear least-squares 
analysis employs a closed-end form solution of equations, non-linear least-squares 
analysis requires an iterative solution. A robust non-linear least-squares approach relies 
on an optimal selection of the starting guess to minimize convergence problems and 
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eliminate the possibility of obtaining local minima (sub-optimal solution). To minimize 
convergence problems, parameters of the individual spring components were first 
estimated through the linear least-squares regression method described in Section 4.6 
(Table 4.1) and were used as the initial (starting) guesses for parameter estimation using a 
non-linear least-squares approach. 
 
Canine Linear Fitting Parameters 
Spring  Fo A b 
1 
1.5E+01 
(4.3E+00) 
1.3E+02                             
(6.4E+00) 
8E-01
(5E-02) 
 2' NS 
5E+02 
(2E+01) 
1.4E+00 
(1.0E-01) 
3 NS 
1E+02  
(3E+00) 
7.4E-01 
(3.0E-02) 
4 NS 
6.4E+01 
(4.8E-01) 
5.3E-01 
(6.0E-03) 
  2" NS 
5E+02     
(2E+01) 
1.4E+00 
(1.0E-01) 
Table 4.1: Linear Least-Squares Parameter Estimation: Estimated parameters and standard errors 
(for a 95% confidence-level) of the individual component of canine repairs. Significant figures 
were reported based on the magnitude of the standard errors, which represent the 95% confidence 
level. “NS” implies that the parameter is Not Significantly different from zero at 95% confidence 
level. 
 
 
The parameters of the non-linear equations were then estimated using non-linear 
least-squares analysis of the component specific experimental load-displacement data up 
to the yield load. The yield load was defined as the first relative maximum load achieved 
during the experimental mechanical tests. All non-linear least-squares analysis was 
performed using Sigma Stat 3.5 (SYSTAT, Chicago, USA). Table 4.2 (A) shows the 
estimated parameters and the standard errors (95% confidence-levels) for the individual 
components of the canine rotator cuff repairs. Table 4.2 (B) presents the corresponding p-
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values for the individual components of the canine rotator cuff repairs. The p-values 
indicate the probability that a given parameter is not significantly different from zero.  
 
 
 
(A)   Canine Non-Linear Fit Parameters 
Spring Fo A b B c 
1 1E+01  (6E+00) 
8E+02  
(5E+02) 
2E+00 
(4E-01)  
4E+00  
(3E+00) 
1.5E+01 
(3.6E-01)  
  2' NS 3.5E+02 (4.6E+01)  
1E+00  
(2E-01) N/A N/A 
3 -3.5E+01  (2.8E+00) 
9.5E+01 
(2.6E+00)  
7.0E-01  
(1E-02) N/A N/A 
4 4E+00   (2E+00) 
1.7E+02 
(1.1E+01)  
1.3E+00 
(1E-02)  
1.3E+00 
(1.4E-01)  
1.5E+00 
(1E-01)  
  2" NS 3.5E+02 (4.6E+01)  
1E+00  
(2E-01) N/A N/A 
(B)   Canine Non-Linear Fit  P-values 
1 0.012 0.095 0.0001 0.18 <0.001 
 2' 0.74 <0.0001 <0.0001 -- -- 
3 <0.001 <0.001 <0.001 -- -- 
4 0.045 <0.0001 <0.0001 <0.0001 <0.0001 
  2" 0.74 <0.0001 <0.0001 -- -- 
Table 4.2: Non-linear least-squares estimates for (A) parameters standard errors (95% 
confidence-levels) and (B) corresponding p-values of the individual components for canine 
repairs. Significant figures were reported based on the magnitude of the standard errors, which 
represent 95% confidence levels. “NS” implies that the parameter is Not Significantly different 
from zero at the 95% confidence level. N/A implies parameter does not exist for the individual 
component because of the form of the equation used to fit the data. 
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4.9 Model Formulation  
Single equations were formulated for human and canine non-augmented and 
augmented rotator cuff repairs based on the physics of springs connected in series and 
parallel. Single equations were formulated as is robust numerical approach that ensures 
convergence to a unique solution (See Appendix A for details for formulation of the 
model equations). The estimated parameters for the individual components (Section 4.8) 
were used to solve the fully assembled model equations. Since the model structure and 
the formulation of single equations for the rotator cuff repairs were the same for human 
and canine repairs, only the formulation of the model equations for non-augmented and 
augmented canine repairs is presented here.  
4.9.1 Modeling the Mechanical Behavior of Non-Augmented Rotator Cuff Repairs 
 
Figure 4.7: Schematics of canine (A) non-augmented and (B) augmented rotator cuff repairs and 
their corresponding analogies with the spring models (C, D). This figure is an excerpt of Figure 
4.1  
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As described in Section 4.4,  canine non-augmented rotator cuff repairs              
(Figure 4.7 A) were modeled as two non-linear springs connected in series, namely, the 
bone-suture-tendon interface (spring#1) and the tendon itself (spring#2) (Figure 4.7 B). 
The load-displacement behavior of this arrangement of springs is governed by the 
following equations: 
F1(x1)  -   F2(x2) = 0…………………...………………….(4) (x1)  +  (x2) = d……………………………………………(5) 
In other words, there are two equations (4) and (5) with two unknowns, where: 
F1  = Force in the bone-suture-tendon interface (spring#1) 
F2  = Force in the tendon only component (spring#2) 
x1  = Displacement of the bone-suture-tendon interface (spring#1),  
x2  = Displacement of the tendon only component (spring#2), and   
d   = Displacement of the non-augmented repair construct (from experimental 
investigations) 
As described in Section 4.6, the mechanical behavior of the bone-suture-tendon 
interface (spring#1) for canine repairs was modeled using the biphasic non-linear 
equation and the tendon only component (spring#2) using the single phase non-linear 
equation, respectively:  
F1 =  F10 +  A1x1b11+ B1x1c1 …………………………………… …(6) 
 F2  =  F20 +  A2x2b2………………………………………….(7) 
Where Fk0, Ak, b,k Bk, c k are component specific parameters estimated by non-linear-
least squares analysis of component specific data (Table 4.2)  
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This problem can be efficiently rendered into a single-equation problem as 
described in Appendix A, which greatly simplifies its numerical solution and validation 
analysis. 
4.9.2 Modeling the Mechanical Behavior of Augmented Rotator Cuff Repair 
As described in Section 4.4, canine augmented rotator cuff repairs (Figure 4.7 C) 
were modeled as five springs connected in series and parallel. The tendon (spring#2) was 
split into two half springs, spring#2’ and spring#2”. The bone-screw-scaffold-suture 
component (spring#3) and the medial suture- tendon interface (spring#4) were in series 
with each other and together in parallel with the primary tendon repair (spring 1 and 2’). 
This four spring construct was then placed in series with the other half tendon spring#2”, 
to conform the model for augmented rotator cuff repairs (Figure 4.7 D).  
The load-displacement behavior of this arrangement of springs is governed by the 
following equations: 
F1(x1) -   F2'(x2') = 0………………………………………(8) 
F3(x3) -   F4(x4) = 0………………………………………. (9) 
F1(x1) - F2'�x2'� + F3(x3) - F4(x4) - F2"(x2") =  0…………………………(10) 
  (x1  + x2') - (x3  + x4) =  0……………………………….(11)  (x1  +x2') +  x2"  = (x3  +x4) +  x2"  =  d……………….…..(12) 
In other words, there are five equations (8-12) with five unknowns, with  𝐹𝑖 
represents the force in spring “i” and  𝑥𝑖   the corresponding displacement 
Fi  = Force in the spring ‘i’  
x1  = Displacement of spring ‘i’ 
d   = Displacement of the augmented repair construct 
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 As described previously, the mechanical behavior of the bone-suture-tendon 
interface (spring#1) and the tendon-only component (spring#2) of canine repairs were 
modeled as a biphasic [Eqn. (6)] and single phase non-linear equations [Eqn. (7)], 
respectively. Furthermore, the bone-screw-scaffold-suture component (spring#3) was 
modeled using a single-phase non-linear equation and the medial suture-tendon interface 
(spring#4) using a biphasic non-linear equation:  
F3 =  F30 +  A3x3b3……………………………………………(13) 
F4  =  F40 + A4x4b41+ B4x4c4 ………………………………………(14) 
 
Where: 
F3  = Force in the bone-screw-scaffold-suture component (spring#3) 
F4  = Force in the medial suture-tendon interface (spring#4) 
x3  = Displacement of the bone-screw-scaffold-suture component (spring#3) 
x4 = Displacement of the medial suture-tendon interface (spring#4) and  
Fk0, Ak, b,k Bk, c k are component specific parameters estimated by non-linear-least 
squares analysis of component specific data (Table 4.3).  
As demonstrated in Appendix A, the equations for both non-augmented and 
augmented repairs can be efficiently re-arranged to render a compact reduced system of 
non-linear equations. The resulting system of equations can be solved numerically under 
static equilibrium conditions using a robust (i.e., will always converge to a unique 
solution) non-linear solver for a system of non-linear equations available in MATLAB 
(MathWorks Inc, Natick, MA, USA). Similar equations were formulated for human 
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augmented rotator cuff repairs and efficiently re-arranged to render a compact reduced 
system of non-linear equations. The scripts employed for the numerical solutions can be 
found in Appendix B. 
 
4.10 Summary  
 In summary, this chapter establishes the model structure of non-augmented and 
augmented rotator cuff repairs, which are applicable to both human and canine models. 
The non-linear equations that reliably approximate the mechanical behavior of the 
individual components of rotator cuff repair constructs were determined. The parameters 
of the non-linear equations for each of the individual components were then estimated 
using the non-linear least-squares method. Finally the model equations were formulated 
based on the physics of springs in series and in parallel. The next chapter will validate the 
model, demonstrate the calculation of the 95% confidence intervals for the model 
predictions using error propagation analysis, predict the degree of load sharing provided 
by the scaffold, and present an approximate parametric sensitivity analysis to identify 
which component(s)/parameter(s) most influences the mechanical behavior predicted by 
the augmented repair model.  
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Chapter V 
 
 
VALIDATION OF SPRING-NETWORK MODEL FOR ROTATOR 
CUFF REPAIRS  
 
The logic of validation allows us to move between the two limits of dogmatism and 
skepticism…Paul Ricoeur 
 
 
 
5.1 Introduction  
As mentioned in the previous chapter, there remains a need to develop a model 
that will help elucidate the basic biomechanics of rotator cuff repairs. Hence, the Specific 
Aim 3 of this dissertation was to develop quasi-static spring-network models of 
simplified rotator cuff repairs. More specifically, the objectives of this work is to (1) 
develop quasi-static spring-network models of simplified rotator cuff repairs, (2) validate 
the models by comparing the predicted model force to experimental measurements of 
force for human and canine rotator cuff repairs, and (3) use the models to predict the 
degree of load sharing provided by a scaffold used for rotator cuff repair augmentation.   
Chapter 4 focused on the formulation and development of the quasi-static spring-
network model. This chapter will present studies to validate the model, demonstrate the 
calculation of confidence intervals for the model predictions using error propagation 
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analysis, predict the degree of load sharing provided by the scaffold, and present an 
approximate parametric sensitivity analysis to identify which component(s)/parameter(s) 
most influences the mechanical behavior predicted by the augmented repair model.  
 
5.2 Experimental Mechanical Testing of the Repairs  
 
Figure 5.1: Schematics of human and canine non-augmented and augmented cuff repairs. The 
dotted lines represent suture markers that were placed on the tendon, and the black dot represents 
the optical marker that was placed on the bone, for optical displacement measurements. 
 
All human and canine rotator cuff repairs described below were done using USP 
Size 0 and USP Size 2 Fiberwire sutures respectively (Arthrex Corporation, Naples, FL, 
USA). All repairs were performed by an orthopedic surgeon, Jesse A. McCarron, MD, at 
the Cleveland Clinic. 
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5.2.1 Non-Augmented Rotator Cuff Repairs 
 Human (n = 5) and canine (n = 5) cadaveric shoulders were used to perform non-
augmented rotator cuff repairs. For the human repairs, a strip of the superior infraspinatus 
tendon (12 mm wide) was released and repaired to the greater tuberosity using a double 
row transosseous technique with two Mason Allen sutures per row (Figure 5.1 A) 
4.Similarly, repair of the canine shoulders involved release and repair of the infraspinatus 
tendon to the greater tuberosity using two transosseous Mason Allen sutures              
(Figure 5.1 B).  
5.2.2 Augmented Rotator Cuff Repairs 
 The contra lateral human (n = 5) and canine (n = 5) cadaveric shoulders were 
used to perform augmented rotator cuff repairs. For both human (Figure 5.1 C) and 
canine (Figure 1 D) specimens, a primary rotator cuff repair was performed as described 
above. The repairs were augmented with a 12 mm x 35 mm prototypical polymer scaffold 
(X-Repair, Synthasome Inc., San Diego, CA), fixed to the bone laterally with a screw and 
sutured medially to the tendon using three modified Mason Allen sutures 3, 4. 
For mechanical testing of all repairs, the muscle belly was freeze-clamped and the 
repair was cycled between 5 – 100 N at 0.25 Hz and subsequently loaded to failure at             
30 mm/min 3, 4. Optical markers placed in the bone and on the tendon were used to 
determine the displacement of the repair constructs. Experimental data for the non-
augmented and augmented human rotator cuff repairs have been published previously3, 4. 
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5.3 Parameter Estimation  
The parameters of the individual spring components were estimated by non-linear 
least square analysis of the component specific load-displacement data of the individual 
spring components up to the yield load either to a single phase or biphasic non-linear 
equation [Chapter 4 (Section 4.6)]. The yield load was defined as the first relative 
maximum load achieved during the experimental test. The non-linear least-squares 
analysis was performed using Sigma Stat 3.5 (SYSTAT, Chicago, USA).  
 
5.4 Formulation of the Model  
The formulation of the model has been explained in Chapter 4. Briefly, the model 
was developed by representing the individual components of the repair as non-linear 
springs.  Each non-linear spring was modeled using either a single phase non-linear 
equation or a biphasic non-linear equation, depending on the equation goodness of fit 
(Chapter 4). Model equations were then formulated for the non-augmented and 
augmented rotator cuff repair models using the physics of springs in series and parallel 
and solved using parameters estimated for the individual components of the repairs.  
 
5.5 Model Validation  
To predict the force response of non-augmented and augmented rotator cuff 
repairs, the fully assembled model equations were solved under static equilibrium 
conditions using standard non-linear equation solver, (fsolve/fzero) provided with the 
optimization toolbox in MATLAB (MathWorks, Natick, MA, USA). The model was 
validated by comparing the model predicted force to experimental measurements of the 
  132 
force of human and canine rotator cuff repairs for a given displacement. The 95% 
confidence intervals for the model predictions were calculated using the error 
propagation formula 
kp
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∂
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e
iF is the experimental measured force value, 
m
iF is the model predicted force 
for a displacement xi and n is the number of data points. The predictions of the model 
were considered acceptable if the experimental data fell within the 95% confidence 
intervals of the predicted force response of the model and the RMSE (% of the average 
experimental yield load) values of the model predicted force was less than or equal to 
5%. Five percent was chosen based on the consideration that, on average, model 
predictions could be reported with at least two significant figures. 
 
5.6 Parametric Sensitivity Analysis  
A parametric sensitivity analysis was used to identify which of the 
component(s)/parameter(s) most influenced the mechanical behavior of the augmented 
repair model. The sensitivity of each parameter was investigated by calculating the 
sensitivity coefficient ‘S’ defined as 
o
i
o
k
xk
xp F
p
p
F
S
i
ik
⋅
∂
∂
=,   ∀  i = 1… N……………..(5) 
Where 
o
kp  and 
o
iF are the baseline values of the kth parameter and the ith force 
measurement respectively. The partial derivatives were estimated numerically by central 
differences. The clinical interests and application of this model lie in predicting the 
change in the mechanics of rotator cuff repair with a change in surgical procedure and/or 
scaffold design. Hence, the parametric sensitivity analysis was carried out only for the 
parameters A and b of the bone-suture-tendon component (spring#1), bone-screw-
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scaffold-suture component (spring#3) and the medical suture-tendon interface (spring#4), 
which are considered to be associated with such modifications. 
The model validation and predictions for non-augmented and augmented rotator 
cuff repairs, using both human and canine experimental data will be presented. The 
validated non-augmented and augmented repair models will then be compared to each 
other to investigate the mechanical role of scaffold augmentation. The distribution of 
forces in the individual components of the augmented repair will also be assessed through 
the model. This data will predict the degree of load sharing offered by using a prototype 
polymeric scaffold as an augmentation device for rotator cuff repairs. Finally, the results 
of the parametric sensitivity analysis will also be presented.  
 
5.7 Results  
5.7.1 Parameter Estimation 
Table 5.1 (A) and 5.2 (A) shows the estimated parameters and the standard errors 
(95% confidence-levels) for the individual components of the human and canine rotator 
cuff repairs, respectively. Table 5.1 (B) and 5.2 (B) presents the corresponding p-values 
for the individual components of human and canine rotator cuff repairs, respectively. The 
p-values indicate the probability that a given parameter is not significantly different from 
zero.  
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 (A)   Human Non-Linear Fit Parameters 
Spring Fo A b B c 
1 2E+01 (1E+01)  
3E+02  
(2E+02) 
2E+00   
(1E+00) 
2E+00 
(1E+00)  
2E+00  
(1E+00) 
  2' NS 3E+02  (3E+01) 
5E-01  
(1E-01) N/A N/A 
3 -3.5E+01 (2.8E+00)  
9.5E+01 
(2.6E+00)  
70E-01  
(1E-02) N/A N/A 
4 -4.0E+01  (1E+01) 
1.3E+02 
(1.3E+01)  
5E-01  
(3E-02) N/A N/A 
  2" NS 3E+02  (3E+01) 
5E-01  
(1E-01) N/A N/A 
(B)   Human Non-Linear Fit  P-values 
1 0.19 0.093 0.025 0.18 0.051 
 2' 0.88 <0.001 <0.001 -- -- 
3 <0.001 <0.001 <0.001 -- -- 
4 0.002 <0.001 <0.001 -- -- 
  2" 0.88 <0.001 <0.001 -- -- 
Table 5.1: Non-linear least-squares estimates for (A) parameters and standard errors (95% 
confidence-levels and (B) corresponding p-values of the individual components for human 
repairs. Significant figures were reported based on the magnitude of the standard errors, which 
represent 95% confidence levels. “NS” implies that the parameter is Not Significantly different 
from zero at the 95% confidence level. N/A implies parameter does not exist for the individual 
component because of the form of the equation used to fit the data. 
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(A)   Canine Non-Linear Fit Parameters 
Spring Fo A b B c 
1 1E+01  (6E+00) 
8E+02  
(5E+02) 
2E+00 
(4E-01)  
4E+00  
(3E+00) 
1.5E+01 
(3.6E-01)  
  2' NS 3.5E+02 (4.6E+01)  
1E+00  
(2E-01) N/A N/A 
3 -3.5E+01  (2.8E+00) 
9.5E+01 
(2.6E+00)  
7.0E-01  
(1E-02) N/A N/A 
4 4E+00   (2E+00) 
1.7E+02 
(1.1E+01)  
1.3E+00 
(1E-02)  
1.3E+00 
(1.4E-01)  
1.5E+00 
(1E-01)  
  2" NS 3.5E+02 (4.6E+01)  
1E+00  
(2E-01) N/A N/A 
(B)   Canine Non-Linear Fit  P-values 
1 0.012 0.095 0.0001 0.18 <0.001 
 2' 0.74 <0.0001 <0.0001 -- -- 
3 <0.001 <0.001 <0.001 -- -- 
4 0.045 <0.0001 <0.0001 <0.0001 <0.0001 
  2" 0.74 <0.0001 <0.0001 -- -- 
Table 5.2: Non-linear least-squares estimates for (A) parameters and standard errors (95% 
confidence-levels) and (B) corresponding p-values of the individual components for canine 
repairs. Significant figures were reported based on the magnitude of the standard errors, which 
represent 95% confidence levels. “NS” implies that the parameter is Not Significantly different 
from zero at the 95% confidence level. N/A implies parameter does not exist for the individual 
component because of the form of the equation used to fit the data. 
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5.7.2 Non-Augmented Repairs  
 
Figure 5.2: Experimental load displacement data, model predictions, and model 95% confidence 
intervals for (A) human non-augmented repairs, (B) human augmented repairs, (C) canine non-
augmented repairs and (D) canine augmented repairs.  
 
Figures 5.2 A and 5.2 C show the experimental load displacement data for the 
human and canine non-augmented repairs respectively, as well as the model predictions 
and the 95% confidence interval for the model predictions. The two spring non-
augmented rotator cuff repair model appears to reliably reproduce the experimental data 
for both human and canine non-augmented rotator cuff repairs. Except for a small portion 
of the data corresponding to two human repairs at large displacement values, the 
experimental data remained within the 95% CI limits, for both the human and canine 
models. The RMSE for the human non-augmented rotator cuff repair model (14 N) is 8% 
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of the average experimental yield load (180 N) and the RMSRE is 7%. Ninety-seven 
percent of the model predictions for the human non-augmented rotator cuff repair can be 
reported with at least two significant figures. The RMSE for the canine non-augmented 
rotator cuff repair model (15 N) is 11% of the average experimental yield load (140 N) 
and the RMSRE is 12% (Table 5.3). Eighty-four percent of the model predictions for the 
canine non-augmented rotator cuff repair can be reported with at least two significant 
figures  
 Non-augmented repairs Augmented repairs 
 Human  Canine Human  Canine 
RMSE (N) 14 15 8 12 
RMSE (%) 8% 11% 3% 6% 
RMSRE (%) 7% 12% 19% 14% 
Percent 
model 
predictions 
with at least 
two 
significant 
figures 
97% 84% 93% 85% 
Table 5.3: The root mean square error (RMSE) as a % of the average experimental yield load, the 
root mean square relative error (RMSRE) and the percent model predictions with at least two 
significant figures for human and canine rotator cuff repair models.  
 
5.7.3 Augmented Repairs  
Figures 5.2 B and 5.2 D show the experimental load displacement data for the 
human and canine augmented repairs respectively, as well as the model predictions and 
the 95% confidence interval for the model predictions. The five spring augmented rotator 
cuff repair model appears to reliably reproduce the experimental data for both human and 
canine augmented rotator cuff repairs. Except for a small portion of the data 
corresponding to two human repairs at large displacement values, the experimental data 
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remained within the 95% CI limits, for both the human and canine models. The RMSE 
for the human augmented rotator cuff repair model (8 N) is 3% of the average 
experimental load (250 N) and the RMSRE is 19%. Ninety-three percent of the model 
predictions for the human augmented rotator cuff repair can be reported with at least two 
significant figures. The RMSE for the canine augmented rotator cuff repair model (12 N) 
is 7% of the average experimental yield load (180 N) and the RMSRE is 14% (Table 5.3). 
Eighty-five percent of the model predictions for the canine augmented rotator cuff repair 
can be reported with at least two significant figures.  
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5.7.4 Comparison of Non-Augmented Vs. Augmented Repair Model  
 
Figure 5.3: Model predictions for non-augmented versus augmented human rotator cuff repair. 
 
 
Figure 5.3 compares the model predictions for the non-augmented versus 
augmented rotator cuff repairs for the human model. The model suggests that scaffold 
augmentation will stiffen the repair construct, but only after displacements exceed 2 mm. 
Further the model suggests that scaffold augmentation increases the yield load of the 
repairs. Similar results were found when comparing model predictions for the canine 
models (data not shown). 
 
 
 
 
 
  141 
5.7.5 Load Sharing 
 
Figure 5.4: Load distribution in the different components of the augmented human rotator cuff 
tendon repair. 
 
 
Figure 5.4 shows the distribution of load between the augmentation components 
(spring#3 and spring#4) and the underlying tendon repair component (spring#1 and 
spring#2’) as predicted by the model for human augmented rotator cuff repairs. The 
model suggests for displacements of 2 mm or less, the tendon repair component carries 
~80% of the total load acting on the augmented repair construct. Thereafter, the load 
carried by the tendon repair component is predicted to decrease from 80% to 73% of the 
total load. In other words, the augmentation component is predicted to carry between         
20 - 27% of the total load acting on the augmented rotator cuff repair for the entire range 
of displacements. Similar results were found when comparing model predictions for 
canine augmented rotator cuff repairs (data not shown). 
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5.7.6 Parametric Sensitivity Analysis  
The sensitivity analysis was carried out only for parameters A and b of bone-
screw-scaffold-suture component (spring#3) and the medical suture-tendon interface 
(spring#4), which may be considered to represent modifications associated with changes 
in surgical procedure and/or scaffold design.  
 Figures 5.5 A and 5.5 B show the parametric sensitivity coefficients for the 
parameter ‘A’ corresponding to springs#1, #3 and #4 for both human and canine 
augmented rotator cuff repair models.  
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Figure 5.5: Parametric sensitivity plots for the parameters ‘A’ corresponding to springs#1, #3 
and #4 for both human (A) and canine (B) augmented rotator cuff repair models.  
 
Both models are most sensitive to perturbations in parameter ‘A’ for spring#1. 
The model appears to be less sensitive to parameter ‘A’ in springs#3 and #4. A value of 
0.5 for a given sensitivity coefficient suggests that a 100% change for the corresponding 
parameter from its baseline value (
o
kp ) would result in a 50% change in the model 
response from its baseline value (
o
iF ) (See Section 5.6).  
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Figure 5.6 A and 5.6 B shows the parametric sensitivity coefficients for the 
parameter ‘b’ corresponding to springs#1, #3 and #4 for both human and canine 
augmented rotator cuff repair models. Similarly to the results observed for parameter ‘A’, 
both models are more sensitive to perturbations in parameter ‘b’ for spring#1 than for 
springs#3 and #4.  
 
 
Figure 5.6: Parametric sensitivity plots for the parameters ‘b’ corresponding to springs#1, #3 and 
#4 for both human (A) and canine (B) augmented rotator cuff repair models.  
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5.8 Discussion  
There has been much interest in developing scaffolds as devices to augment the 
repair of large to massive rotator cuff tears. However, to date no studies have investigated 
the degree of load sharing provided by a scaffold used for rotator cuff repair 
augmentation. Furthermore, the manner in which loads on an augmented rotator cuff 
repair are distributed amongst the various components of the repair is not yet known. 
Finally, the relative biomechanical importance of various components of the rotator cuff 
repair construct is also unknown. Aiming to answer these questions, this study was 
designed to meet three objectives. The first objective was to develop quasi-static spring-
network models of simplified rotator cuff repairs, which was accomplished through 
formulating non-linear models based on the physics of springs in series and parallel 
(Chapter 4). The second objective was to validate the models by comparing the model 
predicted forces to experimental measurements for human and canine rotator cuff repairs.  
The results indicate that except for a small portion of the data corresponding to 
two human repairs at large displacement values, the experimental data remained within 
the 95% CI limits, for both the human and canine models. The RMSE (% of the average 
experimental yield load) of both human and canine augmented rotator cuff repair models 
was less than or equal to 6 %. The RMSE of both human and canine non-augmented 
rotator cuff repairs was slighter higher (8 - 11 %) as was the RMSRE of both human and 
canine rotator cuff repair models (7 - 19 %). The generally higher values for RMSRE 
arise primarily from large relative differences between the model predictions and 
experimental data at the low displacement measurements. However, more than 90 % and 
80 % of the model predictions for the human and canine rotator cuff repair models 
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respectively can be reported with at least two significant figures. This suggests that the 
models can provide a reliable prediction of the expected performance of the rotator cuff 
repairs. The models also predicted an increase in the yield load but not initial stiffness of 
repairs augmented with a prototypic polymeric scaffold, which is in agreement with the 
findings of our experimental repairs with this same scaffold 3,4. In summary, these results 
demonstrate the validity of the formulated models for predicting the biomechanics of 
these simplified human and canine rotator cuff repairs.  
 The final objective was to predict the degree of load sharing provided by a 
scaffold used for rotator cuff repair augmentation. The model predicts that the 
augmentation component (i.e., the scaffold plus its attachments to tendon and bone) will 
carry between 20 - 30 % of the total load acting on the repair construct for the entire 
range of displacement. A corollary to this result is that the underlying tendon repair 
carries the majority of the total load (70 - 80 %) acting on the augmented rotator cuff 
repair component for the entire range of displacement. This finding suggests that this 
particular scaffold, together with its attachments components, is less stiff than the tendon 
and its repair.  
 The model appears to be most sensitive to perturbations in the parameters ‘A’ and 
‘b’ of spring#1 (the bone-suture-tendon interface). These results highlight the 
biomechanical importance of the suture attachment site, and suggest that the greatest 
improvements in the force carrying capacity of a tendon repair may be achieved by 
improving the bone-suture-tendon interface. At this time we are unable to explain the 
reversal in trend seen in the sensitivity curve of parameter ‘b’ for spring#1 for both 
human and canine augmented rotator cuff repair models, but this result may be related 
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more to an interdependence among the model parameters than to the actual mechanics of 
the repair. It should be noted that these model parameters do not carry any particular 
physical significance; rather they are derived from non-linear least squares analysis.  
 The parameter ‘A’ for spring#1, for both the human and canine models [Table 5.1 
and 5.2], has a large standard error compared to those of the remaining model parameters. 
This result is attributed to the inherent variability associated with performing a surgical 
repair.  Further, spring#1 for both human and canine models and spring#4 for the canine 
model were most reliably modeled using the biphasic non-linear equation whereas all 
other spring components in both human and canine rotator cuff repairs were most reliably 
modeled using the single-phase non-linear equation. The need for a biphasic equation to 
model the load-displacement behavior of the suture interface components may be due to 
the combined mechanisms of stretch of the tendon and slip of the suture from the tendon 
that occur in these components. The fact that spring#4 of the human model was not best 
modeled by the biphasic non-linear equation as other suture interfaces may be due to the 
difference in the architecture of the human infraspinatus tendon compared to that of the 
canine infraspinatus tendon. Unlike the organized nature of collagen fibers of the canine 
infraspinatus tendon, the collagen fibers of the human infraspinatus tendon are more 
randomly organized, particularly in the region medial to the insertion site 1, 2. This 
random organization of the collagen fibers in the human tendon may minimize suture slip 
and thus explain why a single phase non-linear equation was better for fitting the medial 
suture-tendon interface (spring#4) of the human model.  
 The study is not without limitations. First, compared to the clinical scenario, the 
experimental repairs used to develop our models were greatly simplified and idealized. 
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An isolated tendon released and repaired acutely, with only one type of surgical 
technique and one type of scaffold, and tested under only one loading condition was 
modeled. This was done in order to formulate a conceptual model to predict trends 
associated with augmentation of rotator cuff, but limits the direct translation of our data 
to human rotator cuff tendon repairs which involve chronically degenerate tissues and are 
inherently multidimensional and structurally variable. Secondly, the model was 
developed from mechanical testing performed under in vitro conditions, which may not 
reflect the biomechanics of in vivo repairs that are subjected to biological processes. 
Third, the model parameters for springs#1 and 2 were obtained from failure testing of 
specimens that were first subjected to a cyclic loading protocol. Hence, the models 
cannot be used to predict the biomechanics of repairs on the first initiation of load 
following surgical repair. And finally, the model predictions of the mechanical 
performance of the repairs is only valid up to and including the point of maximum (yield) 
load. Hence, the model cannot be used to predict failure loads of the repair.  
 In summary, the study has developed and validated simple spring-based non-
linear models for predicting the trends associated with scaffold augmentation of rotator 
cuff repairs.  The ability of the models to predict the biomechanics of non-augmented and 
augmented rotator cuff repairs from both human and canine strengthens the 
interpretation, application and relevance of our observations. For the simplified repairs 
modeled herein, the total load was distributed ~70 - 80% to the tendon repair component 
(i.e., tendon plus its suture attachment to bone) and ~20 - 30% to the augmentation 
component (i.e., the scaffold plus its attachments to tendon and bone). This finding 
suggests that this particular scaffold, together with its attachments components, is less 
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stiff than the tendon and its repair. The model results and sensitivity analysis suggests 
that although the scaffold contributes to the overall mechanical properties of the repair 
construct, the greatest improvements in the force carrying capacity of a tendon repair may 
be achieved by improving the properties of the bone-suture-tendon interface. The next 
chapter will use this model to conduct a parametric simulation study with the aim to 
predict the manner in which changes to the individual components of the repair, 
representing different surgical techniques and scaffold devices, may influence the 
biomechanics of the repair construct. 
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Chapter VI 
 
THE BIOMECHANICAL ROLE OF SCAFFOLDS IN AUGMENTED 
ROTATOR CUFF REPAIRS  
 
It is tough to make predictions, especially about the future……Yogi Berra 
 
 
 
6.1 Introduction 
Scaffolds have been the most common strategy investigated to date for the 
treatment of rotator cuff tears. Currently, scaffolds derived from various natural and 
synthetic biomaterials are being marketed as augmentation devices for rotator cuff repairs 
at the time of surgery 2, 4, 5. Based on the mechanical connotation of their intended use, it 
is commonly believed that when applied appropriately, these devices may provide some 
degree of load sharing of forces across the tendon repair site and thus decrease the 
likelihood of tendon re-tear. Although significant advances have been made in the 
development of scaffolds for rotator cuff repair augmentation, there is limited 
experimental data  to support the notion that scaffold augmentation of a tendon repair will 
actually improve the biomechanical performance of the repair construct 3, 6. Even though 
these studies demonstrate the potential for scaffold augmentation to improve the initial 
biomechanical properties of a rotator cuff repair construct, the appropriate scaffold 
material properties and/or surgical application techniques for achieving optimal 
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biomechanical performance in the setting of rotator cuff repairs are unknown. 
Furthermore, no studies to date have investigated the percent load carried by a scaffold 
when used for rotator cuff repair augmentation.  
To address these questions and enhance our understanding of the basic mechanics 
of scaffold augmentation, a spring-network model for non-augmented and augmented 
human rotator cuff repairs was developed and validated (Chapter 4 & 5) 1. The objectives 
of the current study are now to use this model to predict: (1) the manner in which 
simulated changes to components of the tendon repair, such as reduced tendon quality, 
altered surgical technique and different scaffold designs, influence the biomechanical 
performance (yield load and stiffness) of the repair construct and (2) the percent load 
carried by the scaffold augmentation component of the repair construct in each of these 
simulated clinical scenarios.  
 
6.2 Methods 
Chapter 4 and 5 explained the development and validation of a spring-network 
model for rotator cuff repairs. Briefly, the non-augmented repair was modeled as two 
springs in series (Figure 6.1 A and 6.1 B), while the augmented repair was modeled as a 
combination of five springs in series and parallel (Figure 6.1 C and 6.1 D). The individual 
components of the repair were modeled as non-linear springs (Table 6.1).  
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Figure 6.1: Schematics of (A) non-augmented and (B) augmented human rotator cuff repair 
along with their corresponding analogies (C & D) with spring models.  
 
 
Spring Physical Component of Repair Construct  
1 Tendon-to-Bone Repair (bone-suture-tendon interface) 
2, 2’, 2’’ Tendon (Springs 2’ and 2’’ are two half springs of Spring 2) 
3 Scaffold Augmentation Component (bone-screw-scaffold-
suture) 
4 Scaffold-Tendon Attachment (scaffold-suture-tendon 
interface) 
Table 6.1: Definition of Individual Springs in the Rotator Cuff Repair Model 
 
For the human rotator cuff repairs models the springs representing the tendon 
(spring#2), scaffold augmentation component (spring#3) and scaffold-tendon attachment 
(spring#4) were modeled using a single phase non-linear equation [Eqn.(1)]  
 F =F0 + A xb ………………………………………….(1) 
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And the spring representing the tendon-to-bone repair (spring#1) was modeled 
using a biphasic non-linear equation [Eqn. (2)].   
F =F0 + 
A xb
1+ B xc
   ……………………………………(2) 
In this chapter the human rotator cuff repair spring-network models will be varied 
parametrically to simulate clinically relevant scenarios, namely, changes in tendon 
quality, altered surgical technique(s) and different scaffold designs.  
 
 
Figure 6.2: Schematics of the components of augmented rotator cuff repairs being simulated. (A) 
tendon-to-bone repair (spring#1) [bracketed] (B) scaffold augmentation component (spring #3) 
and (C) scaffold-tendon attachment (spring #4). Adapted from Figures 1 and 2 in Aurora et al., 1 
 
 
More specifically, parameter ‘A’ of the tendon-to-bone repair (spring#1) (Figure 
6.2 A), the scaffold augmentation component (spring#3) (Figure 6.2 B) and the scaffold-
tendon attachment (spring#4) (Figure 6.2 C) of human rotator cuff repairs was varied 
from its respective baseline value, while keeping other parameters at their respective 
baseline values. The baseline values are those estimated by non-linear least square 
analysis of the component specific load-displacement data of the individual spring 
components up to the yield load either to a single phase (for spring#3 & #4) or biphasic 
non-linear equation (for spring#1). While, the parameter ‘A’ itself does not have any 
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particular physical significance; it is a proportionality constant associated with changes in 
load-displacement characteristics of a given spring component and hence can be varied to 
simulate different clinical scenarios, such as weak and/or strong tendon-to-bone fixation, 
degenerative tendon tissue or compliant/stiff scaffolds. 
Specifically, to simulate changes in tendon quality and/or surgical repair 
technique, parameter ‘A’ of the tendon-to-bone repair (spring#1) or the scaffold-tendon 
attachment (spring#4) was varied ± 50% from baseline (Table 6.2). To simulate a change 
in the scaffold design, which could include changes to the scaffold mechanical properties 
and/or its method of fixation, parameter ‘A’ of the scaffold augmentation component 
(spring#3) was varied ± 25% and ± 50% from baseline (Table 6.2). The biomechanical 
performance of the repair constructs, i.e., the yield load and stiffness, and the percent 
load carried by the scaffold augmentation component (spring#3), were evaluated for each 
of the parametrically simulated model conditions. (The model was fit to the experimental 
data only up to the point of “yield load”, where “yield load” was defined at the first 
instantaneous drop in load of at least 10% during the experimental tests. Hence, the 
maximum load predicted by the model simulations is equivalent to this “yield load”). All 
results are reported with respect to the non-augmented repair condition in order to 
estimate value of using scaffold augmentation for the simulated clinical indications.  
 
 
 
 
 
  155 
Spring 
Parametric 
Variation Baseline 
Parametric 
Variation 
-25% -50% +25% +50% 
1 -- 1.5E+02 3E+02 -- 4.5E+02 
3 7.1E+01 4.8E+01 9.5E+01 1.2E+02 1.43E+02 
4 -- 6.5E+01 1.3E+02 -- 1.95E+02 
Table 6.2: Values of parameter ‘A’ of tendon-to-bone repair (spring#1), scaffold augmentation 
component (spring#3) and scaffold-tendon attachment (spring#4) varied by ± 25% and ± 50% 
from baseline values (highlighted)  
 
 
6.3 Results 
6.3.1 Parametric Variation in Parameter ‘A’ of the Tendon-to-Bone Repair 
(spring#1) 
 Parameter ‘A’ of the tendon-to-bone repair (spring#1) was varied to simulate 
changes in tendon quality and/or surgical repair technique. Results are shown in             
Figure 6.3 and summarized in Table 6.3. For non-augmented repair constructs, the model 
predicted a yield load of 384 N and stiffness of 105 N/mm. These are the baseline 
properties to which all simulated conditions are compared.  
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Clinical Scenario Parameter 'A' Variation  Repair Type 
Percent Change from 
Non-Augmented 
(Primary Repair)  
Percent Load 
Carried by the 
Scaffold 
Augmentation 
Component                  Yield load Stiffness 
Tendon-to-Bone Repair Varied (Spring #1) 
Reduced tendon 
quality, i.e., repair of 
chronic degenerative 
tendon to bone 
50% decrease 
Non-augmented -43% -62% N/a 
Augmented with 
a prototypical 
scaffold 
-4% -21% 45% 
Improved repair 
strategy of tendon 
attachment to bone 
50% increase 
Non-augmented 34% 38% N/a 
Augmented with 
a prototypical 
scaffold 
43% 32% 25% 
Scaffold Augmentation Component Varied (Spring #3) 
Change in scaffold 
mechanical properties 
and/or its method of 
fixation 
Prototypical Polymer 
Augmented 
25% 16% 31% 
25% decrease 20% 4% 28% 
50% decrease 12% no change 20% 
25% increase 29% 18% 34% 
50% increase 32% 20% 36% 
Scaffold-Tendon Attachment Varied (Spring #4) 
Reduced tendon 
quality and/or 
reduced repair 
strategy of scaffold 
attachment to tendon 
50% decrease 
Augmented with 
a prototypical 
scaffold 
14% no change 22% 
Improved repair 
strategy of scaffold 
attachment to tendon 
50% increase 31% 19% 36% 
Table 6.3: All results are reported with respect to the non-augmented repair condition (Yield load: 384 N, Stiffness: 105 N/mm), in order 
to estimate value of scaffold augmentation for the simulated clinical scenarios.  
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Decreasing parameter ‘A’ of the tendon-to-bone repair (spring #1) by 50% 
decreases the yield load (43%) and stiffness (62%) of non-augmented repairs. When an 
augmentation scaffold is used, the same decrease in parameter ‘A’ resulted in only a 
modest decrease in yield load (4%) and stiffness (21%) compared to the non-augmented 
baseline condition (Figure 6.3 A). In this scenario, the scaffold augmentation component 
carries approximately 45% of the total load on the construct (Figure 6.3 B) (Table 6.3). 
Conversely, increasing parameter ‘A’ of the tendon-to-bone repair (spring #1) by 
50% increases the yield load (34%) and stiffness (38%) of non-augmented repairs          
(Figure 6.3 A). When an augmentation scaffold is used, the same increase in parameter 
‘A’ resulted in a similar increase in yield load (43%) and stiffness (32%) as when no 
scaffold is used (Figure 6.3 A). In this scenario, however, the scaffold component carries 
approximately 25% of the total load on the construct (Figure 6.3 B) (Table 6.3).  
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(A) 
 
(B) 
Figure 6.3: Parametric variation in parameter ‘A’ of the tendon-to-bone (TB) repair (spring#1). 
(A) The biomechanical performance of the non-augmented and augmented repair constructs and 
(B) The percent load carried by the scaffold augmentation component for simulated tendon-to-
bone repair.  
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6.3.2 Parametric Variation in Parameter ‘A’ of the Scaffold Augmentation 
Component (spring#3) 
 
Parameter ‘A’ of the scaffold augmentation component (spring#3) was varied to 
simulate a change in the scaffold design, which could include changes to the scaffold 
mechanical properties and/or its method of fixation. Results are shown in Figure 6.4 and 
summarized in Table 6.3. Augmenting the repair with a prototypical polymer scaffold 
results in a repair construct with higher yield load (25%) and stiffness (16%) than the 
non-augmented repair (Figure 6.4 A), and the scaffold component carries approximately 
31% of the total load on the construct (Figure 6.4 B).  
Decreasing parameter ‘A’ of the scaffold augmentation component by 25% and 
50% reduces the properties of the augmented construct to similar levels as the non-
augmented baseline repair (Figure 6.4 A), and the percent total load carried by the 
scaffold reduces to 20% (Figure 6.4 B).  
Increasing parameter ‘A’ of the scaffold augmentation component by 25% and 
50% does not appreciably increase the yield load, stiffness or load sharing capability of 
the augmented construct over the properties obtained with the prototypical polymer 
scaffold (Figures 6.4 A & 6.4 B)  
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(A) 
 
(B) 
Figure 6.4:  Parametric variation in parameter ‘A’ of the scaffold augmentation component 
(spring#3) (A) The biomechanical performance of the augmented repair constructs and (B) The 
percent load carried by the scaffold augmentation component for simulated scaffold augmentation 
component.  
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6.3.2 Parametric Variation in Parameter ‘A’ of the Scaffold-Tendon Attachment 
(spring#4) 
 
Parameter ‘A’ of the scaffold-tendon attachment (spring#4) was varied to 
simulate changes in tendon quality and/or scaffold attachment technique. Results are 
shown in Figure 6.5 and summarized in Table 6.3. For repairs augmented with a 
prototypical polymer scaffold, decreasing parameter ‘A’ of the scaffold-tendon 
attachment by 50% reduces the properties of the augmented repair construct to similar 
levels as the non-augmented baseline repair, and the percent total load carried by the 
scaffold reduces to 22%  (Figure 6.5 A).  
Increasing parameter ‘A’ of the scaffold-tendon attachment by 50% does not 
appreciably increase the yield load, stiffness or load sharing capability of the augmented 
construct over the properties obtained with the prototypical polymer scaffold and the 
baseline condition for spring#4 (Figure 6.5 B). In other words, changes to the properties 
of the repair construct with variation in the scaffold-tendon attachment properties were 
essentially the same as when the properties of the scaffold augmentation component 
(spring#3) were varied to the same degree   (Figures 6.5 A  & 6.5 B)  
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(A) 
 
(B) 
Figure 6.5: Parametric variation in parameter ‘A’ of the scaffold-tendon attachment (spring#4).  
(A) The biomechanical performance of the augmented repair constructs and (B) The percent load 
carried by the scaffold augmentation component for simulated scaffold-tendon attachment.  
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6.4 Discussion  
 
Scaffold augmentation may be a viable strategy to improve the initial 
biomechanical properties of a rotator cuff repair construct and thereby reduce the 
incidence of repair failure. However, numerous questions remain about the appropriate 
scaffold properties, surgical application techniques and load-sharing abilities of a scaffold 
when used in a rotator cuff repair construct. To investigate these questions and enhance 
our understanding of the basic mechanics of scaffold augmentation, a spring-network 
model was developed and validated for non-augmented and augmented human rotator 
cuff repairs 1. The objectives of the current study were to use this model to predict:             
(1) the manner in which simulated changes to components of the tendon repair, such as 
reduced tendon quality, altered surgical technique and different scaffold designs, 
influence the biomechanical performance (yield load and stiffness) of the repair construct 
and (2) the percent load carried by the scaffold augmentation component of the repair 
construct in each of these simulated clinical scenarios. The model was developed and 
validated from our in-vitro experimental study of non-augmented and augmented human 
rotator cuff repairs, performed using a polymer scaffold designed to have stiffness and 
ultimate load comparable to human rotator cuff tendon 6. Except for a small portion of the 
data at large displacement values, the experimental data fell within the 95% confidence 
interval of the model thus validating the model as a predictive tool for investigating the 
basic mechanics of scaffold augmentation 1.  
The model predicts that augmenting a tendon repair with a polymer scaffold 
designed to have tendon-like mechanical properties results in a repair construct with 
modestly higher yield load (25%) and stiffness (16%) than the non-augmented repair 
condition. The model also predicts that the scaffold component of the repair construct 
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carries 31% of the total load on the repair. The model predicts only slight further 
increases in repair construct stiffness or yield load when the mechanical properties of the 
scaffold augmentation component and/or it’s attachment to tendon are increased. 
Decreasing the properties of the scaffold augmentation component itself, and/or its 
attachment to the repaired tendon, reduces the properties of the of the over-all augmented 
repair construct to similar levels as the non-augmented repair. Together, these findings 
suggest that to provide modest improvements to the stiffness and yield load of non-
augmented repairs in healthy tendon tissue, the scaffold must have mechanical properties 
similar to that of tendon tissue. However, the results also suggest that applying a scaffold 
with supra-physiologic stiffness will not translate into yet stiffer or stronger repairs.  
Importantly, the model predicts that in the presence or absence of an 
augmentation scaffold, the mechanical properties of the over-all repair construct are most 
influenced by the properties of the primary tendon-to-bone repair. The model predicts 
that decreasing the properties of the tendon-to-bone repair (i.e., repair of a chronic 
degenerative tendon, fixation in osteopenic bone, or a poorly performed surgical repair 
technique) will appreciably decrease the yield load (43%) and stiffness (62%) of the 
construct. The model predicts that scaffold augmentation in this setting can largely 
mitigate this drop in properties and that the scaffold will carry approximately 45% of the 
total load on the repair construct. This result suggests that scaffold augmentation would 
be particularly advantageous when repairing poor quality tendon. Conversely, the model 
also predicts that increasing the properties of the tendon-to-bone repair (perhaps 
representing an improved tendon-to-bone repair strategy), will appreciably increase the 
yield load (34%) and stiffness (38%) of the repair construct even without scaffold 
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augmentation. In this case, scaffold augmentation provides minimal further improvement 
in construct properties, although 25% of the total load on the over-all construct would 
still be carried by the scaffold component of the repair. It is important to note that 
because the mechanical properties of the primary tendon-to-bone repair most influence 
the overall mechanical performance of the repair construct, using a surgical repair 
technique that maximizes the strength and stability of the direct tendon-to-bone fixation 
site is essential, even if repair augmentation with a scaffold is anticipated. Surgical repair 
strategies that compromise the fixation strength at the tendon-to-bone repair site in favor 
of improved scaffold fixation are unlikely to confer mechanical benefit to the over-all 
repair construct.  
Several limitations should be noted in interpreting the findings of the study. First, 
the objectives of the study were met by parametrically simulating a simplified rotator cuff 
repair model that was validated for one surgical repair technique, one type of scaffold and 
tested under one loading condition 1, 6. Hence, the results reported herein are dependent 
on the particular experimental conditions tested. Secondly, the parameter ‘A’ does not 
have any direct physical corollary. It is a proportionality constant associated with the 
load-displacement characteristics of a given spring component. While varying parameter 
‘A’ allowed us to simulate the model for clinical scenarios that may be representative of 
change in tendon quality, altered surgical techniques and/or scaffold designs, the absolute 
translation of our model predictions to clinical practice must be done judiciously. Thirdly, 
the model does not account for the biological processes of healing and remodeling. 
Hence, the results of the study are only applicable to the immediate post-operative period. 
Fourth, our results are limited to quasi-static loading and thus have relevance to activities 
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involving slow loading rates only. Finally, the model as validated only allows us to 
predict trends and relative changes as opposed to absolute values for failure loads and 
stiffness. Hence, there remains a need to experimentally verify the biomechanical 
efficacy of surgical techniques and scaffold designs regardless of how they perform when 
simulated in the current spring-network model.  
In summary, a previously validated human rotator cuff repair model was used to 
simulate changes in tendon quality, altered surgical technique(s) and different scaffold 
designs (Chapter 5) 1. This model allows predictions of the biomechanical performance 
of non-augmented and augmented repair constructs, as well as the percent load carried by 
the scaffold augmentation component for various clinically relevant scenarios. The model 
predicts that the yield load and stiffness of a rotator cuff repair at the time of surgery can 
be modestly increased by augmenting the repair with a scaffold which has tendon-like 
properties. However, the model also suggests that engineering a scaffold with supra-
physiologic stiffness will not translate into yet stiffer or stronger repairs. Importantly, the 
model also predicts that the mechanical properties of a repair construct are most 
influenced by the properties of the tendon-to-bone repair. This result illustrates the need 
to prioritize the primary tendon-to-bone repair site fixation, even if repair augmentation 
with a scaffold is anticipated. In the clinical setting of a weak tendon-to-bone repair, 
scaffold augmentation will significantly off-load the repair and largely mitigate the poor 
construct properties, based on the current model predictions.  
To our knowledge, this work provides for the first time, information about the 
load-sharing ability of augmentation scaffolds used for rotator cuff repair, and offers 
unique insight into how changes to various components of the repair may influence the 
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biomechanical performance of the repair construct. Given the increasing prevalence of 
scaffold devices being developed and marketed for rotator cuff repair, the information 
provided by this study is of great clinical relevance as surgeons endeavor to further 
understand the role of scaffolds for rotator cuff repair augmentation. Importantly, the 
model simulations can be used to direct and inform the design of new repair strategies 
aimed at improving the biomechanical performance of rotator cuff repairs and may have 
broader implications for understanding the basic mechanics of scaffold augmentation of 
other soft tissue repairs as well. The simulations suggest that future efforts in the field of 
rotator cuff repair augmentation could be directed toward strategies that strengthen the 
tendon–to-bone repair or toward engineering scaffolds with tendon-like mechanical 
properties that also promote rapid or effective biologic healing. 
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Chapter VII 
 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Work is the greatest thing in the world, so we should always save some of it for 
tomorrow….…Don Herald 
 
 
 
7.1 Summary  
 
Despite advances in the development of extracellular matrix (ECM) scaffolds for 
rotator cuff repair, no commercially available ECM scaffold has been shown to have 
appropriate mechanical properties to provide mechanical augmentation to the repair at the 
time of implantation. Additionally, numerous questions about the appropriate scaffold 
properties, surgical application techniques and load-sharing abilities of a scaffold when 
used as an augmentation device for rotator cuff repairs are unknown. To address the 
critical need for an ECM scaffold that provides adequate strength as well as stimulates 
and enhances the healing potential, the proposed research aims to engineer the 
mechanical properties (suture retention strength and stiffness) of allograft fascia lata 
ECM in a manner that will allow it to be used as an augmentation device for rotator cuff 
repairs. As described in this dissertation, stitching was developed as a method to engineer 
the mechanical properties of fascia lata ECM (Chapter 2). A rat model was used to 
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investigate the host response and time-dependent changes in mechanical properties of 
reinforced fascia scaffolds after implantation (Chapter 3). Further, simple quasi-static 
spring-network models of human and canine rotator cuff repairs were also developed to 
elucidate the basic biomechanics of scaffold augmented rotator cuff repairs (Chapter 4). 
The human augmented repair model was then parametrically simulated for clinically 
relevant scenarios, namely, changes in tendon quality, altered surgical technique(s) and 
different scaffold designs, to predict the manner in which these scenarios may influence 
the biomechanical performance of the repair construct and the load carrying capacity of 
the scaffold component (Chapter 5).  
 
Specific Aim 1: Engineer the suture retention strength and stiffness of allograft 
fascia lata ECM at time zero using stitching as a method of reinforcement   
Studies presented in this dissertation demonstrate stitching as a technology to 
engineer the suture retention and stiffness of allograft (human derived) fascia lata ECM. 
The results show that  stitching fascia ECM with braided, resorbable, polymer fibers in a 
unique, controlled manner not only increased the suture retention load of reinforced 
fascia scaffolds (≥ 250N) by six fold over non-reinforced fascia, but also exceeded the 
suture retention properties of human rotator cuff tendon (~250N). The suture retention 
load of 6PLLA/2PGA reinforced fascia was significantly greater than 100% PLLA 
reinforced fascia at time zero. However, the stiffness of fascia scaffolds reinforced with 
either braid was not significantly different, particularly at low displacements. Scaffolds 
reinforced with either braid were able to sustain at least 2500 cycles of cyclic loading, but 
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only 6PLLA/2PGA reinforced scaffolds consistently survived 5000 cycles of cyclic 
loading.  
Together, these tests suggest that reinforced fascia scaffolds could be used to 
mechanically augment the rotator cuff repair and modulate retraction of the tendon repair 
during the post-operative period. Further, these studies establish stitching as a novel and 
versatile method for engineering the mechanical properties of fascia lata ECM. Finally, 
the tension-with-side constraint test, which mimics the surgical application of scaffolds 
for rotator cuff repair is being advocated as a tool to assess the mechanical properties of 
scaffolds for such applications.  
Specific Aim 2: Investigate the host response and time-dependent changes in 
mechanical properties of reinforced fascia scaffolds after implantation in a rat 
model  
The host response to all fascia scaffolds after implantation in rat abdominal wall 
defect model was characterized by infiltration of chronic inflammatory cells and non-
inflammatory fibroblasts-like cells, and as hypothesized, reinforced fascia scaffolds had 
an increased presence of foreign body giant cells due to the presence of the polymer 
braid. The mechanical properties of the reinforced fascia scaffolds after implantation in a 
rat dorsal subcutaneous model were compared to the properties at time zero (before 
implantation) (Specific Aim 1). The suture retention load of 100% PLLA reinforced 
fascia scaffolds remained essentially unchanged after in vivo implantation (~300N). In 
contrast, the suture retention load of 6PLLA/2PGA reinforced fascia scaffolds decreased 
by ~40% after implantation, but still remained at ~ 250N. The stiffness of the scaffolds 
reinforced with either braid trended towards a decrease after implantation, with the 
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decrease being more predominant (~35%) in 6PLLA/2PGA reinforced fascia scaffolds 
than 100% PLLA reinforced fascia scaffolds (~15%). Together, these studies support the 
hypothesis that the decrease in the mechanical properties of 6PLLA/2PGA reinforced 
fascia scaffolds will be more predominant than 100% PLLA reinforced scaffolds.  
These studies demonstrate that the suture retention load of reinforced fascia 
scaffolds after in vivo implantation is comparable to the suture retention properties of 
human rotator cuff tendon (~250N). The change in the mechanical properties of the 
reinforced fascia scaffolds after in vivo implantation, amongst other factors, is dependent 
on the type of braid used to engineer fascia lata ECM. These results suggest that fascia 
reinforced with either braid may be able to withstand the mechanical loads on a rotator 
cuff tendon repair.  
Specific Aim 3: Develop and validate a quasi-static spring-network model for 
simplified rotator cuff repairs  
The spring-network model was developed by modeling the individual components 
of the repair constructs as non-linear springs, and the model equations were formulated 
based on the physics of springs in series and parallel (Chapter 4). The developed model 
predicted that the scaffold component (i.e., the scaffold plus its attachments to tendon and 
bone) carries ~20-30% of the total load on the repair. The sensitivity analysis suggested 
that the greatest improvements in the force carrying capacity of a tendon repair may be 
achieved by improving the properties of the bone-suture-tendon interface.  
The parametric simulation study predicted that the biomechanics (yield load and 
stiffness) of a rotator cuff repair can modestly be increased by augmenting the repair with 
a scaffold that has tendon-like properties at the time of surgery. Based on model 
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predictions, in the clinical setting of a weak tendon-to-bone repair, scaffold augmentation 
could significantly off-load the repair and largely mitigate the poor construct properties. 
However, engineering a scaffold with supra-physiologic stiffness is predicted to not 
translate into stiffer or stronger repairs. Further, the mechanical properties of a repair 
construct are most influenced by the properties of the tendon-to-bone repair. Finally, this 
study suggested that future efforts should be directed toward strategies that strengthen the 
tendon-to-bone repair or towards engineering scaffolds with tendon-like mechanical 
properties that may promote rapid or effective biologic healing.  
 
7.2 Future Studies   
The results of these studies set stage for future studies. The future studies described 
herein are being broadly classified in four areas, namely, 1) scaffold development 2) in 
vitro studies, 3) in vivo studies and 4) spring-network model development.  
 7.2.1 Scaffold Development  
Irrespective of the type of test (failure or fatigue), the mode of failure for all 
samples (in vitro and in vivo) occurred by breaking of the braid secondary to slipping of 
the braid through the fascia matrix. Hence, there is a need for strategies that may 
strengthen the fascia matrix/braid interface and minimize the observed slipping through 
the fascia matrix. Potential strategies included are 1) use of tissue adhesives, 2) 
modification of the surface roughness of braids, 3) coating braids with polymer coating(s) 
and 4) use of silk based biomaterials as braids. These potential strategies along with their 
pros and cons are being explained as follows:  
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 Use of Tissue Adhesives  
Tissue adhesives may be applied over the stitching regions after scaffold 
fabrication. The mechanism for using tissue adhesives is believed to be “gluing” of the 
braids to the fascia matrix at t he points of insertion in the fascia matrix, which may 
prevent early slippage of the braids through the fascia matrix and result in an efficient 
load sharing across the interface. Two concerns with the use of this strategy are 1) current 
tissue adhesives options have been be approved by the FDA only for topical use (e.g., 
wound closure), that is to say, they are not intended for deep tissue application and 2) the 
hardening of the tissue adhesive is achieved by exothermic polymerization of 
cyanoacrylate (polymer used to make synthetic adhesives), which may damage both, the 
fascia matrix and braid and may elicit unfavorable response in vivo at these sites.  
 Modification of Surface Roughness of Braids  
Another strategy is to increase the surface roughness of the braids in a manner 
that will increase the frictional resistance at the fascia/braid interface and minimize 
slipping at the interface. The Murthy lab at Rutgers University, NJ attempted to increase 
the surface roughness of 100% PLLA braids using ultra violet (UV) laser ablation 
(removal of material). However, the lack of aromatic groups in PLLA did not allow 
absorption of UV required to achieve ablation. An alternative approach suggested by Dr. 
Murthy was to coat the braid with microspheres of PLLA. The only immediate concern 
with the use of this strategy is the possibility of the microspheres detaching from the 
braid during stitching.  
 
 
  174 
 Coating Braids with a Polymer Coating 
Needle penetration during scaffold fabrication widens the fascia matrix (on the 
order of millimeters) to accommodate for braid (B) during stitch formation as shown in 
Figure 7.1 A. It is hypothesized that filling this so called “gap” may result an efficient 
bonding between the braid and the fascia matrix. One possible approach is to coat the 
polymer braid with a polymer coating that swells and polymerizes (hardens) on hydration 
(blue color in Figure 7.1 B). The advantage of this approach is that the coating may not 
get disrupted during stitching as it will only polymerize (hardens) on hydration, i.e., 
during the pre-requisite soak prior to implantation. However, such a polymer will have to 
be identified and possibly engineered. The University of Akron, Akron, Ohio is one 
possible source that may provide assistance in such an endeavor.  
                                                            
         
Figure 7.1: Pictorial depiction of mechanism of polymer coating for braid (A) “Gap” formation 
during stitching and (B) Filling of “gap” after coating braid with polymer 
 
 
 Silk Based Biomaterials as Braids  
Silk is a natural biomaterial with slow resorption kinetics and a long standing 
history in biomedical applications. More importantly, its mechanical properties (Ultimate 
Tensile Strength: 500-1000 MPa) are superior to any biomaterial including tendon (150-
200 MPa) 2. Hence, its superior mechanical strength may allow development of a braid 
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having braid dimensions < 300µm and tensile strength > 100N. It is hypothesized that a 
smaller diameter braid may minimize the so called “gap” formation during scaffold 
fabrication, achieve a tighter stitch (due to increased needle and bobbin tension), which 
together may minimize slipping of the braid through the fascia matrix. Additionally, a 
high strength braid may allow a stitch configuration (pattern) that will minimize the 
amount of braid in the fascia matrix. Further, such a braid may also increase the 
mechanical properties (suture retention strength and stiffness) of the reinforced fascia 
scaffold. However, eliminating contaminating sericin from silk worm is critical to avoid 
biocompatibility problems in vivo. Although several groups 2, 3, 15, 20, 24, 25 have reported 
use of sericin free silk for different biomedical applications, sericin free silk is currently 
commercially unavailable, which makes it difficult to use it as braid material for scaffold 
development. One possibility is the use of recombinant spider silk 13, 14, but this 
technology is still in the research phase. Nevertheless, silk as a potential braid material 
has excellent potential and must actively be pursued.  
Recommendation for Scaffold Development  
As the development of reinforced fascia scaffold enters the second phase of “re”-
development in our laboratory, it is believed that collaboration with a School of Textiles 
may augment this work by providing their expertise in the area of stitching and braid 
development. In particular, identifying different stitches, braid designs (braiding 
parameters) and high output commercial sewing machine(s) will be helpful. One such 
collaboration that may be pursued is with Dr. Martin W. King, Professor of Biotextiles, 
College of Textiles, North Carolina State University, NC, USA. Dr. King has previously 
collaborated with the Cleveland Clinic in the area of endovascular devices.  
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7.2.2 In Vitro Testing - Pseudo In Vivo Tests  
Caruso et al., 9 have shown accelerated collagen degradation of ACL grafts that 
affect their mechanical properties when cyclically loaded in solutions having proteolytic 
enzyme concentrations similar to the synovial fluid. Development of a similar test for in 
vitro fatigue testing of ECM scaffolds might predict the fatigue behavior of the scaffold 
when cyclically loaded in vivo. Such a test could be used as an in vitro screening tool for 
any collagen based scaffold prior to in vivo animal studies.  The validity of such a test to 
mimic the in vivo environment could be assessed by comparing the post implantation 
failure tests (Chapter 3) to tests conducted in a proteolytic enzyme solution.  
7.2.3. In Vivo Studies  
 Braid Degradation  
In Chapter 3, decrease in the mechanical properties of the reinforced fascia 
scaffolds after in vivo implantation was hypothesized to be due to a possible concomitant 
decrease in mechanical properties as a consequence of polymer degradation. Hence, 
future studies should investigate the change in the surface morphology (using Scanning 
Electron Microscopy), molecular weight (using Gel Permeation Chromatography), 
crystallinity (using Differential Scanning Calorimetry) and mechanical properties of the 
braids after in vivo implantation. Such a study may help characterize the time dependent 
changes in the properties of polymer braids and their possible influence on the 
mechanical properties of the scaffold constructs. Further, these studies may also help 
develop resorbable braids that have slow degradation kinetics and are able to retain their 
mechanical properties after implantation. It should be noted here that similar studies are 
also possible using an in vitro degradation tests (ISO 15814:1999) 26 . While these studies 
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do not truly replicate the in vivo environment, they could be considered for the 
preliminary evaluation of candidate braid materials, particularly polymers. 
Cell Mediated Response Studies  
Immune Response 
Macrophages and lymphocytes are known to modulate the downstream 
remodeling outcome of ECM scaffolds 6, 7, 27. Hence, characterizing the macrophage 
phenotypes (M1 and M2) and T lymphocytes phenotypes (Th1 and Th2) immune 
response to the scaffolds would be of great interest.  
M1 are pro-inflammatory macrophage phenotypes and M2 are pro-remodeling 
phenotypes 4, 7, 12, 16, 18. Th1 lymphocytes produce cytokines (e.g., interleukin (IL)-2, 
interferon (IFN)-γ, and tumor necrosis factor (TNF)-β) that lead to a pathway associated 
with implant rejection 1, 6, 11, 17, 22, 28 and Th2 lymphocytes produce cytokines (IL-4, IL-5, 
IL-6 and IL-10) that lead to a pathway associated with implant acceptance 5, 10, 19.  
Previously, our laboratory has established an immunostaining protocol for CCR7 
(M1 macrophage marker) and CD163 (M2 macrophage marker). However, an 
immunostaining protocol for CD69/CD134 (Th1 lymphocyte marker) and CD30              
(Th2 lymphocyte marker) would need to be established for such a study. Alternatively, 
the cytokine expression of the Th1/Th2 cells can also be determined using reverse 
transcriptase polymerase chain reaction (RT - PCR).  
Host Tissue Response  
For the in vivo study (Chapter 3), twelve weeks was the latest time point 
investigated. It would also be important to investigate the clearance of lymphocyte 
infiltrates and foreign body giant cells, as well as scaffold remodeling (incorporation in 
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host tissue) at later time points. Additionally, longer time points would allow evaluating 
the extent of braid degradation and fascia matrix remodeling on the mechanical properties 
of the scaffolds.  
The host tissue response could also be investigated in athymic mice (laboratory 
mouse lacking a thymus gland). The use of such a model will mount no rejection due to 
the greatly reduced number of T cells and allow investigating the biocompatibility of the 
reinforced fascia scaffolds in a model that may better represent their use as allografts in 
human patients.  
7.2.4 Alternate Model for Time Dependent Variation in Scaffold Mechanical 
Properties  
One of the limitations of the in vivo study (Chapter 3) was that scaffolds were not 
mechanically loaded using the rat subcutaneous model. Mechanical loading may well 
affect the rate and extent of scaffold remodeling and braid degradation. Hence, there 
remains a need to develop in vivo model(s) that will allow dynamic loading of the 
scaffolds and investigate the time dependent variation in the scaffold mechanical 
properties under mechanical loaded conditions. Further, a full understanding of the 
clinical efficacy of these novel materials will require pre-clinical studies using cadaveric 
and animal models for rotator cuff repair.  
7.2.5 Quantification of MMP Activity  
In Chapter 3, it was hypothesized that the secretion of matrix metalloproteinases 
(MMP) -2, -3, -9 and -12  by macrophages and giant cells and degradation of fascia 
matrix possibly due to secretion of matrix metalloproteinases (MMP) -1, -8, -13 and -14 
as  possible mechanisms of decrease in the stiffness of reinforced fascia scaffolds after              
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in vivo implantation. The presence of these enzymes in the explanted fascia scaffolds 
could possibly be verified using an enzyme-linked immunosorbent assay (ELISA) and/or 
Western blotting or Zymography to support the hypothesis.  
7.2.6 Model Development  
One limitation of the spring-network model is that compared to clinical scenario, 
the experimental repairs used to develop the models were greatly simplified and 
idealized. More importantly, the model as validated only allows prediction of trends and 
relative changes as opposed to absolute values for failure loads and stiffness. Future 
studies could develop a clinically relevant model that will allow prediction of the failure 
loads and stiffness for different scaffolds. The mechanical test data for such a model 
could be obtained from a clinically relevant human cadaver model developed in our 
laboratory that measures gap-formation during cycling loading in two dimensions. And, 
also using the data generated from the time zero failure testing of reinforced fascia 
scaffolds presented in Chapter 3. The approach to the development of the model would 
be the same as explained in Chapter 4. While the advantage of the development of such a 
model will be it’s clinically relevance, it applicability as a predictive tool would still be 
restricted to only one type of surgical technique.  
Another limitation of the existing model was that the parameter ‘A’ did not have 
any direct physical corollary. Future studies could include collecting a library (set) of 
parameters for different surgical techniques and scaffold designs. This will allow 
simulation of the model with parameters that have clinically meaningful representations.  
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7.3 Other Applications of Reinforced Fascia Scaffolds  
The concept of stitching may be easily extended to other ECM materials as well. This 
technology could also be translated for the development of large scaffolds much needed 
for the treatment of massive tendon and bone defects commonly seen in trauma 
applications. In particular, these large scaffolds could be developed by stitching two or 
more pieces of similar or different ECM material(s).  However, in such cases in addition 
to the suture retention strength of the scaffold, the seam strength will be of equal 
importance as it will dictate the structural integrity of the scaffold in vivo. Reinforced 
fascia scaffold may also be effective in treatment of repairs other than musculoskeletal 
repairs including gynecology, urology and abdominal wall repairs.  
 
7.4 Conclusion  
The overall goal of this work was to engineer the suture retention strength and 
stiffness of allograft fascia lata in order to develop an extracellular matrix (ECM) derived 
scaffold with robust mechanical properties for general use in musculoskeletal soft tissue 
repair, and more specifically rotator cuff repairs. The precise design criteria of scaffolds 
for such applications are difficult to specify because the mechanical demands in the 
clinical scenario are variable and unknown. As a guidance, however, one might consider 
the suture retention properties of human rotator cuff tendon (~250 N) 21, the maximum 
expected loads on a rotator cuff repair post-operatively (~180 N), the number of duty 
cycles that a rotator cuff repair may be exposed to in the early post-operative period              
(it is estimated that during the first six weeks of post-operative rehabilitation, the human 
rotator cuff repair might experience ~60 cycles/day = 2500 cycles), and the amount of 
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medial tendon retraction that might increase the likelihood of repair failure                     
(5-10 mm) 8, 23as a possible design criteria.  
The studies in this dissertation demonstrate that the suture retention load of fascia 
reinforced with either braid remain ≥ 250  N, even after twelve weeks of implantation. 
Furthermore, the model predicted that the scaffold augmentation component carries           
only ~20-30% of the total load acting on the tendon repair (~50 - 60 N). Although 
reinforced fascia scaffolds in this study were not cycled to 50 N, the data support the 
possibility that at cyclic elongation of reinforced fascia scaffolds at 50 N would remain 
on the order of 5 mm or less, even after 2500 cycles. Together these results suggest that 
fascia scaffolds reinforced with either braid have robust load-deformation properties that 
are possibly sufficient to provide mechanical augmentation to rotator cuff repairs, 
modulating tendon retraction in a manner that reduces the incidence of tendon re-tear.  
The spring-network model provides for the first time, estimates of the load-
sharing ability of augmentation scaffolds used for rotator cuff repair, and offers unique 
insight into how changes to various components of the repair may influence the 
biomechanical performance of the repair construct. The simulation studies suggest that 
future efforts in the field of rotator cuff repair augmentation should be directed toward 
strategies that strengthen the tendon–to-bone repair or toward engineering scaffolds with 
tendon-like mechanical properties that also promote rapid or effective biologic healing. 
The results in this dissertation are expected to have a positive impact because they 
support the further development and translation of polymer reinforced fascia scaffold for 
tendon repair in humans, offering the orthopedic surgeon with a robust allograft scaffolds 
for increasing the likelihood of clinical success of large, debilitating, and chronic rotator 
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cuff tears frequently encountered by the aging population. The spring-network model can 
be used to direct and inform the design of new repair strategies aimed at improving the 
biomechanical performance of rotator cuff repairs and may have broader implications for 
understanding the basic mechanics of scaffold augmentation of other soft tissue repairs as 
well.  
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Conditioning of the Model Equations and Numerical Solution  
 As described in Chapter 4, the mechanical behavior of the cuff repairs was 
modeled using a network of springs connected in series and parallel as shown in Figure 
A.1C and A.1F. The formulation of the model equations for non-augmented and 
augmented canine repairs is presented here, though the equations for human repairs were 
similarly derived. 
Non-Augmented Rotator Cuff Repair 
The model structure has been explained in Chapter 4.  Briefly, the non-augmented 
rotator cuff repairs were modeled as two springs in series, namely, the bone-suture-
tendon interface (spring#1) and the tendon itself (spring#2) (Figure A.1C).  
 
Figure A.1: Schematics of non-augmented (A) human, (B) canine and augmented (D) 
human, (E) canine rotator cuff repairs and their corresponding analogies with the spring 
models (C, F). The dotted lines represent suture markers that were placed on the tendon, 
and the black dot represents the optical marker that was placed on the bone, for optical 
displacement measurements during mechanical testing. 
 
The load-displacement behavior of this arrangement of springs is governed by the 
following equations: 
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F1(x1)- F2(x2) = 0………………………………………(A.1)  
(x1) + (x2) = d…………………………………………(A.2) 
In other words, there are two equations Eqns. (A.1) and (A.2) with two unknowns, where:  
where: 
F1  = Force in the bone-suture-tendon interface (spring#1) 
F2  = Force in the tendon only component (spring#2) 
x1  = Displacement in the bone-suture-tendon interface (spring#1) 
x2  = Displacement in the tendon only component (spring#2) 
d   = Displacement of the non-augmented repair constructs 
The displacement, ‘d’, is known from experimental in vitro mechanical testing of non-
augmented repair constructs.  
 As described in Chapter 4 (Section 4.6), the mechanical behavior of the bone-
suture-tendon interface (spring#1) and the tendon only component (spring#2) for canine 
repairs were modeled using a biphasic and single phase non-linear equation, respectively.   
Hence:  
F1 = F10+ A1x1b11+ B1x1c1    ……………………………………(A.3) 
 F2 = F20+ A2x2b2………………………………………….(A.4) 
Fk0, Ak, b,k Bk, c k are component specific parameters estimated by non-linear-least 
squares analysis of component specific data  (See Chapter 4, Section 4.8 for details) From 
the physics of springs in series, we know that the forces in the two springs will be equal 
to the force in the non-augmented repair model 
F1= F2  = FNon-Aug Repair Model …………………………(A.5) 
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This implies:  
 
F2 
F1
= 1……………………………………………………… (A.6) 
 
Substituting equations (A.3) and (A.4) in (A.6): 
F20+ A2x2
b2
F10+ 
A1x1
b1
1+ B1x1
c1
 = 1……………………………………………(A.7) 
Rearranging (A.7): 
F10 + A1x1b11+ B1x1c1 = F20 + A2x2b2 
F10�1+ B1x1
c1� + A1x1b1 = F20�1+ B1x1c1� + A2x2b2�1+ B1x1c1� 
�F10 - F20��1+ B1x1c1� + A1x1b1 = F20�1+ B1x1c1� + A2x2b2�1+ B1x1c1� 
A1x1
b1+ �F10 - F20��1+ B1x1c1� - A2x2b2�1+ B1x1c1� = 0 
x1
b1  + �F10 - F20�
A1
�1+ B1x1
c1� - 
A2
A1
x2
b2�1+ B1x1
c1� = 0     
  x1
b1   +  F1,20 �1+ B1x1c1� - A1,2x2b2�1+ B1x1c1� = 0…………. (A.8) 
Where: 
 
A1,2= 
A2
A1
, and  
F1,20 = 
F10 - F20
A1
 
Again from the physics of springs in series, we know that the displacement of the two 
springs will be additive 
That implies:  
d = x1+ x2 
    d - x1+ x2 = 0………………………………………. (A.9) 
d = displacement of the non-augmented repair constructs 
 Hence, a single equation [Eqn. (A.8)] was formulated for the non-augmented 
rotator cuff repairs, which was then solved numerically under static equilibrium 
  205 
conditions using a robust (i.e., will always converge to a unique solution) non-linear 
solver for system of non-linear equations available in MATLAB (MathWorks Inc, 
Natick, MA, USA). The advantage of formulating a single equation is that it allows 
finding a solution to the non-augmented repair model (problem) using a combination of 
open methods (faster, but with convergence constraints, which becomes severe for 
systems with exponentials) and closed methods (robust, i.e., will always converge to a 
unique solution).  
Augmented Rotator Cuff Repair 
 The non-augmented rotator cuff repairs were modeled as five springs connected 
in series and parallel. The tendon (spring#2) was split into two half springs, spring#2’ and 
spring#2”. The bone-screw-scaffold-suture component (spring#3) and the medial suture- 
tendon interface (spring#4) were in series with each other and together in parallel with 
the non-augmented repair (spring 1 and 2’). The entire augmented rotator cuff repair 
model was then placed in series with the other half tendon spring#2” to conform the 
model for augmented rotator cuff repairs (Figure A.1F).  
The load-displacement behavior of this arrangement of springs is governed by the 
following equations: 
F1(x1) -   F2'(x2') = 0…………………………………. (A.10) 
F3(x3) -   F4(x4) = 0 ….………………….…………….(A.11) 
F1(x1) - F2'�x2'� +  F3(x3) - F4(x4) - F2"(x2") = 0………(A.12)  
  (x1  +  x2') - (x3  +  x4) = 0………………………….. (A.13) 
 (x1  + x2') + x2" = (x3  + x4) + x2" = d………………....(A.14)  
In other words, there are five equations Eqns. (A.10 - A.14) with five unknowns: 
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Where 𝐹𝑖 represents the force in spring “i” and  𝑥𝑖   the corresponding displacement 
Fi  = Force in the spring ‘i’  
x1  = Displacement of spring ‘i’ 
d   = Displacement of the augmented repair constructs 
The displacement, ‘d’, is known from experimental in vitro mechanical testing of 
augmented repair constructs.  
 As described in Chapter 4 (Section 4.6), the mechanical behavior of the bone-
suture-tendon interface (spring#1) and the medial suture-tendon interface (spring#4) of 
canine repairs were modeled using a biphasic non-linear equation. And, the mechanical 
behavior of the tendon only component (spring#2) and the bone-screw-scaffold-suture 
component (spring#3) using a single phase non-linear equation  
Hence:  
F3 = F30 + A3x3b3………………………………………(A.15) 
 
F4 = F40+ A4x4b41+ B4x4c4  ………………………………….(A.16) 
 
where: 
F3  = Force in the bone-screw-scaffold-suture component (spring#3) 
F4  = Force in the medial suture-tendon interface (spring#4) 
x3  = Displacement in the bone-screw-scaffold-suture component (spring#3) 
x4 = Displacement in the medial suture-tendon interface (spring#4) 
Fk0, Ak, b,k Bk, c k are component specific parameters estimated by non-linear-least 
squares analysis of component specific data  (See Chapter 4, Section 4.8 for details)  
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 The bone-screw-scaffold-suture component (spring#3) and the medial suture-
tendon interface (spring#4) are in series with each other. Hence, from the physics of 
springs in series, we know that the forces in the two springs will be equal. 
  F3 =  F4  …………………………………………………(A.17)  
Previously, a single equation was formulated for the non-augmented repair model     
Using [Eqn. (8)] again,  
x1
b1  + F1,20 �1+ B1x1c1� - A1,2x2b2�1+ B1x1c1� = 0……………. (A.18) 
A similar equation was now formulated for the augmentation component, .i.e., the bone-
screw-scaffold-suture component (spring#3) and the medial suture-tendon interface 
(spring#4), which are in series with each other.  
x4
b4 + F4,30 �1+ B4x4c4� - A4,3x3b3�1+ B4x4c4� = 0 ……………. (A.19) 
where: 
A4,3 = A3A4 
F4,30 = 
F4 0 - F30
A4
 
From the physics of springs in series, we know that the displacement of the springs in 
series will be additive.  
That implies: 
x1,2 =  x1+ x2 
x3,4 =  x3+ x4 
= z…………………………………………………...(A.20) 
The displacement of the augmented rotator cuff repair construct is given by: 
 
 d - (x1 + x2 '+ x2") = 0   d - (x3 + x4 + x2") = 0 
  d - (z + x2") = 0…………………………………. (A.21) 
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where: 
𝑑   = Displacement of the augmented rotator cuff repair construct 
𝑥2′  = Displacement in the tendon half spring component (spring#2’) 
𝑥2" = Displacement in the tendon half spring component (spring#2”) 
 From, the model structure, we know that the entire augmented rotator cuff repair 
model was placed in series with the half tendon spring#2”. The force acting on tendon 
half spring (spring#2”) will be: 
F2" =  FAug Repair Model  
 
 We know that the bone-screw-scaffold-suture component (spring#3) and the 
medial suture- tendon interface (spring#4) were in series with each other and together in 
parallel with the non-augmented repair (spring 1 and 2’). Hence, from the physics of 
springs in series we know that: 
  FAug Repair Model = F2' +  F4 = F1 +  F3 
Therefore: 
F2"= F1+ F3   
F2"= F2'+ F4 
That implies:     F1+ F3 - F2" = 0 
  F2'+ F4- F2" = 0…………………………………….. (A.22) 
 
We now have a set of four equations A.18, A.19, A.21 and A.22 and four unknowns, 
x1,x4,x2",z  
 This set of equations can be solved numerically under static equilibrium 
conditions using a robust (i.e., will always converge to a unique solution) non-linear 
solver for a system of non-linear equations available in MATLAB (Mathworks Inc, MA, 
USA). Unlike, the solution of a single equation formulation that uses both an open and 
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closed method; the solution of a set of non-linear equations only uses an open method 
whose convergence depends on the starting (initial guess).  
 Model equations for human repairs were similarly formulated. The scripts 
employed for the numerical solutions of non-augmented and augmented repairs can be 
found in Appendix B. 
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MATLAB SCRIPTS FOR ROTATOR CUFF REPAIR MODELS  
All Matlab Scripts were developed with the help of Dr. Jorge E. Gatica 
B. 1 Single Equation Formulation for Non-Augmented Repair Model 
 
% function single_equation.m 
%   System of Equations were reduced to a  
%   has been reduced to a single equation with the help from Dr. Gatica  
  
% The springs’ parameters “A” and “b” are  
%     found via independent experiments  
%     and then used to correlate experiments  
%     from the “augmented rotator cuff repair” 
  
%Lower Arm springs:  
% Spring#1: Bone-tendon-suture component  
% Spring#2: Tendon only component  
  
function f = single_equation02(x) 
%   contains equations of the form f(x) = 0 
%   Single equation, can be solved using fzero 
%   [and the more robust open-closed methods combination] 
  
% the experimental displacement is  
%   considered free of error [or negligible compared to F] 
global d Fo A B b c 
  
% display ([Fo A B b c]); 
  
f = 0; 
  
% recover the unknown 
x1 = x; 
  
x1 = min(max(0, x1), d);  
x2 = d - x1; 
  
% As explained in the Model Formulation 
% The Original System of Equations 
% can be reduced to a single equation 
%   system equations 
%   The displacement of the springs  
%   are additive for springs in series 
%   x = x1 + x2 => x2 = x – x1 
  
%   Force definition / correlated independently 
%   Fi = Foi + Ai * xi^bi/(1 + Bi * xi^ci) 
  
  
%   Main hypothesis,  
%       Forces in the two springs will be  
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%       identical for spring in series 
%   F1 = F2 => F2/F1 = 1 
  
A12 = A(2)/A(1); 
F12 = (Fo(1)-Fo(2))/A(1); 
denom1 = 1; 
if B(1) > 0 
    denom1 = 1 + B(1)* (x1^c(1)); 
end 
  
f = (x1^b(1)) + F12 * denom1 - A12 * denom1 * (x2^b(2)); 
  
% display ([x1 x2 f]); 
  
return; 
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B.2 Code for Reading the Data for Non-Augmented Repair Model 
 
% This formulation uses a single equation for the  
NON-AUGMENTED REPAIR (TWO SPRING MODEL) was developed with the help of 
Dr. Gatica  
  
% Program calculates the CI intervals 
% of the model using error propagation analysis  
  
clear;  
  
% the experimental displacement is  
%   considered free of error [or negligible compared to F] 
global d Fo A B b c 
  
  
% Springs Constants: Estimated Parameters 
% define name of data file 
! copy Spring_parameters.dat DataFile.dat 
  
load -ASCII DataFile.dat; 
Fo0 = DataFile(:,2); 
A0  = DataFile(:,3); 
b0  = DataFile(:,4); 
B0  = DataFile(:,5); 
c0  = DataFile(:,6); 
  
% Springs Constants: Standard Errors     
% define name of data file 
! copy Spring_errors.dat DataFile.dat 
  
load -ASCII DataFile.dat; 
FoE = DataFile(:,2); 
AE  = DataFile(:,3); 
bE  = DataFile(:,4); 
BE  = DataFile(:,5); 
cE  = DataFile(:,6); 
  
Fo1 = [Fo0, Fo0-FoE, Fo0+FoE]; 
A1  = [A0 , A0-AE  , A0+AE]; 
b1  = [b0 , b0-bE  , b0+bE]; 
B1  = [B0 , B0  , B0]; 
c1  = [c0 , c0  , c0];       
  
% Read Excel Data: Experimental_Data.xls 
DataRead = xlsread('Experimental_Data'); 
% data = DataRead; 
  
% sort data, according to x 
Data_sorted = sort(DataRead(:,1:2), 1, 'ascend'); 
%  
data = Data_sorted; 
  
% Assign 'data' matrix to 
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%   Total displacement, x = x1 + x2 
x = data(:,1); 
%and 
%   The measured force 
F = data(:,2); 
  
plot( x, F, 'ro'); 
title ('Primary Rotator Cuff Repair (Human)');  
legend ('Experiments'); 
grid; 
xlabel ('Displacement, x, [mm]'); 
ylabel ('Force, F, [N]'); 
pause(2); 
  
% set options 
  
nsig  = 3; 
TolX  = 0.5*10^(1-nsig); 
TolF  = 1.e-05; 
Maxit = 20; 
  
options = optimset('TolX', TolX,'TolFun', TolF, 'MaxIter', Maxit); 
options = optimset('MaxFunEvals', 10*Maxit,'Display', 'off'); 
  
model = 'single_equation02'; 
  
for k = 1 % Since we are only interested in using the first column made 
k = 1 
    Fo = Fo1(:, k); 
    A  = A1(:, k); 
    b  = b1(:, k); 
    B  = B1(:, k); 
    c  = c1(:, k); 
     
% initialize the model force matrix 
F_model = zeros(length(F), 2); 
  
% Initialize matrix for errors of the two springs 
E = zeros(length(F), 2); 
  
% Initialize matrix for writing the CI of the two springs 
Bounds = zeros(length(F), 4); 
  
% the first point has no displacement, skip 
F_model(1, 1) = F(1); 
F_model(1, 2) = F(1); 
  
% added 06/03/09 (JEG) 
Bounds = zeros(size(F_model)); 
  
N = length(x); 
  
x1 = 0.5*x(2); 
for i = 2:N 
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    d = x(i); 
    % initial guess 
    %x0 = [0 x1px2]; 
    x0 = d*0.5; 
    x0 = x1; 
     
    [xx, fval, Exit_Flag, Output] = fzero(model, x0, options); 
     
    x1 = xx; 
    x2 = d - x1; 
     
    fnorm = abs(fval); 
  
    denom1 = 1; 
    if B(1) > 0 
        denom1 = (1 + B(1) * (x1^c(1))); 
    end 
    F_model(i, 1) = Fo(1) + A(1) * (x1^b(1)) / denom1; 
     
    Q = denom1^2; 
    Term1 = abs(x1^b(1)/denom1); 
    Term2 = abs((A(1)*x1^b(1)*log(x1))/denom1); 
    Term3 = abs(A(1)*x1^b(1)*x1^c(1)/Q); 
    Term4 = abs(A(1)*B(1)*x1^b(1)*x1^c(1)*log(x1)/Q); 
     
    %This error term is when using the F = F0 + Ax^b/1 + Bx^c 
(Biphasic) for spring#1 
    E(i,1) = FoE(1) + abs(Term1) * AE(1)  + abs(Term2) * bE(1)  + 
abs(Term3) * BE(1)  + abs(Term4) * cE(1); 
     
    %E(i,1) =  FoE(1) + abs(x1^b(1)) * AE(1)  + 
abs(A(1)*((x1)^b(1))*log(x1)) * bE(1); 
     
    denom2 = 1; 
    if B(2) > 0 
        denom2 = (1 + B(2) * (x2^c(2))); 
    end 
    F_model(i, 2) = Fo(2) + A(2) * (x2^b(2)) / denom2; 
     
     
    % added 06/05/09 (JEG) 
    E(i,2) =  FoE(2) + abs(x2^b(2)) * AE(2)  + 
abs(A(2)*((x2)^b(2))*log(x2)) * bE(2); 
     
%     Bounds(i,1) = abs(E(i,1) + F_model(i,1));% + CI bound for 
SPring#1 
%     Bounds(i,2) = abs(E(i,1) - F_model(i,1));% - CI bound for 
SPring#1 
%     Bounds(i,3) = abs(E(i,2) + F_model(i,2));% + CI bound for 
SPring#2 
%     Bounds(i,4) = abs(E(i,2) - F_model(i,2));% - CI bound for 
SPring#2 
  
% added 06/03/09 (JEG) 
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%   the first point is not calculated, as it is experimental 
    if i > 1 
        Bounds(i,1) = E(i,1); % CI span for Spring #1 
        Bounds(i,2) = E(i,2); % CI span for Spring #2 
    end 
     
    iter = Output.iterations; 
     
    fprintf ('\n \t point no. %3i \t x_1 = %12.3g \t x_2 = %12.3g \t 
||f|| = %12.3g %4i', ... 
        i, x1, x2, fnorm, iter) 
     
    if Exit_Flag < 0 
        fprintf ('\n *** Convergence problems for point # %3i ***',i); 
        fprintf ('\n \t Exit Flag = %3i ', Exit_Flag); 
    end 
       
end 
  
% added 06/03/09 (JEG) 
 display ([x F F_model(:,1) Bounds(:,1) F_model(:,2) Bounds(:,2)]); 
  
% pause; 
  
%plot( x, F, 'ro', x, F_model(:,1), 'b-*', x, F_model(:,2), 'r-
s',x,Bounds(:,1), 'k*',x,Bounds(:,2),'k*', x,Bounds(:,3), 
'c:',x,Bounds(:,4),'c:'); 
  
% added 06/03/09 (JEG) 
N = length(x); 
plot( x, F, 'ro', x, F_model(:,1), 'm-*', x, F_model(:,2), 'm-s',... 
    x(2:N), F_model(2:N,1) + Bounds(2:N,1), 'b.-', x(2:N), 
F_model(2:N,2) + Bounds(2:N,2),'r.-', ... 
    x(2:N), F_model(2:N,1) - Bounds(2:N,1), 'b.-', x(2:N), 
F_model(2:N,2) - Bounds(2:N,2),'r.-'); 
  
  
title ('Non-Augmented Rotator Cuff Repair'); 
legend ('Experiments', 'Model: F_1', 'Model: F_2',... 
    '95% CI (F_1 \pm E_1)','95% CI (F_2 \pm E_2)'); 
grid; 
hold on  
xlabel ('Displacement, x, [mm]'); 
ylabel ('Force, F, [N]'); 
pause(5); 
hold off 
end 
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B.3 Set of Equations for Augmented Repair Model  
 
% function simplified_model.m 
%     
function f = simplified_model01 (x) 
%   contains equations of the form f(x) = 0 
%   Single equation, can be solved using fzero 
%   [and the more robust open-closed methods combination] 
  
% [Experimental] displacement 
%   considered free of error [or negligible compared to F] 
global d Fo A B b c 
  
f = zeros(size(x)); 
  
% 4 equations with 4 unknowns  
% (x1, x4, x5, and z).  
% recover the unknown 
x1 = x(1); 
x4 = x(2); 
x5 = x(3); 
z  = x(4); 
  
x2 = z - x1; 
x3 = z - x4; 
  
%   The displacement of the springs  
%   are additive for springs in series 
%   x = x1 + x2 => x2 = x – x1 
  
%   Force definition / correlated independently 
%   Fi = Foi + Ai * xi^bi/(1 + Bi xi^ci) 
  
%   Main hypothesis,  
%       Forces in the two springs will be  
%       identical for spring in series 
%   F1 = F2 => F2/F1 = 1 
  
% A21 = A(2)/A(1); 
% F21 = (Fo(2)-Fo(1))/A(1); 
%  
% f(1) = x1^b(1) - F21 - A21 * (z-x1)^b(2); 
  
A12 = A(2)/A(1); 
F12 = (Fo(1)-Fo(2))/A(1); 
  
denom1 = 1; 
if B(1) > 0 
    denom1 = 1 + B(1)* (x1^c(1)); 
end 
  
f(1) = (x1^b(1)) + F12 * denom1 - A12 * denom1 * (x2^b(2)); 
  
%F3 = F4 => F3/F4 = 1 
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%A34 = A(3)/A(4); 
%F34 = (Fo(3)-Fo(4))/A(4); 
%  
% f(2) = x4^b(4) - F34 - A34 * (z-x4)^b(3); 
  
A43 = A(3)/A(4); 
F43 = (Fo(4)-Fo(3))/A(4); 
  
denom4 = 1; 
if B(4) > 0 
    denom4 = 1 + B(4)* (x4^c(4)); 
end 
  
f(2) = (x4^b(4)) + F43 * denom4 - A43 * denom4 * (x3^b(3)); 
  
f(3) = d - (z + x5); 
  
x2 = z - x1; 
x3 = z - x4; 
  
% F1 + F3 - F5 = F2 + F4 - F5 = 0 
  
        denom1 = 1; 
        if B(1) > 0 
            denom1 = (1 + B(1)*(x1^c(1))); 
        end 
         
        F1 = Fo(1) + A(1)*(x1^b(1)) / denom1; 
        F3 = Fo(3) + A(3)*(x3^b(3)); 
  
        denom4 = 1; 
        if B(4) > 0 
            denom4 = (1 + B(4)*(x4^c(4))); 
        end 
         
        F2 = Fo(2) + A(2)*(x2^b(2)); 
        F4 = Fo(4) + A(4)*(x4^b(4)) / denom4; 
         
        F5 = Fo(5) + A(5)*(x5^b(5)); 
  
f(4) = F1 + F3 - F5; 
  
return; 
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B.4 Code for Reading the Data for Augmented Repair Model 
 
% Five-Spring - AUGMENTED REPAIR 
% This formulation uses a Simplified Model having 4 Equations with 4 
unknowns 
% The unknowns in this case are the displacements of the individual 
springs 
% from which the individual force of the springs and the force of the 
% repair will be calculated  
%   Springs No.1 & 4 are represented by  
% Fi = Foi + Ai xi^bi/(1 + Bix^ci) - Biphasic equation  
%   Springs No. 2 & 3 are represented by  
% Fi = Foi + Ai xi^bi - Power law with y intercept 
  
clear;  
  
% the experimental displacement is considered free of error [or 
negligible compared to F] 
% d is the system displacement OR measured displacement from 
experiments 
 % assign global to the parameters and the system displacement  
 global d Fo A B b c 
  
% Springs Constants: Estimated Parameters  
% define name of data file 
! copy FiveSpring_parameters01.dat DataFile.dat 
  
load -ASCII DataFile.dat; 
Fo0 = DataFile(:,2); 
A0  = DataFile(:,3); 
b0  = DataFile(:,4); 
B0  = DataFile(:,5); 
c0  = DataFile(:,6); 
  
% Springs Constants: Standard Errors     
% define name of data file 
! copy FiveSpring_errors01.dat DataFile.dat 
  
load -ASCII DataFile.dat; 
FoE = DataFile(:,2); 
AE  = DataFile(:,3); 
bE  = DataFile(:,4); 
BE  = DataFile(:,5); 
cE  = DataFile(:,6); 
  
% Define matrix with the parameters and +/- errors to calculate the 
% approximate Confidence Intervals of the model  
  
Fo1 = [Fo0, Fo0-FoE, Fo0+FoE]; 
A1  = [A0 , A0-AE  , A0+AE]; 
b1  = [b0 , b0-bE  , b0+bE]; 
B1  = [B0 , B0  , B0]; 
c1  = [c0 , c0  , c0];       
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% Read Excel Data: Experimental_Data05.xls 
DataRead = xlsread('Experimental_Data05'); 
  
% sort data, according to x 
Data_sorted = sort(DataRead(:,1:2), 1, 'ascend'); 
  
data = Data_sorted; 
  
% Assign 'data' matrix to  
  
x = data(:,1); 
  
% The measured force 
F = data(:,2); 
  
% initialize the model force matrix 
F_model = zeros(length(F), 2); 
  
% set options 
  
nsig  = 5; 
TolX  = 0.5*10^(1-nsig); 
TolF  = 1.e-07; 
Maxit = 20; 
  
options = optimset('TolX', TolX,'TolFun', TolF, 'MaxIter', Maxit); 
options = optimset('MaxFunEvals', 100*Maxit,'Display', 'off'); 
  
% load function file  
model = 'simplified_model01'; 
  
% for loop for calculating forces using the model generated forces and 
the 
% CI of the model  
  
for k = 1 
  
    % set parameters 
  
    Fo = Fo1(:,k); 
    A  = A1(:,k); 
    b  = b1(:,k); 
    B  = B1(:,k); 
    c  = c1(:,k); 
  
  
    N = length(x); 
  
  
    % the first point has no displacement, skip 
    F_model(1, 1) = F(1); 
    F_model(1, 2) = F(1); 
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    % Initialize matrix for errors of the two springs 
  
    E = zeros(length(F), 4); 
    Bounds = zeros(length(F), 4); 
  
% Assign values to alpha and beta that will be used for calculating the 
% initial values for fsolve 
  
alpha = 0.3; 
beta  = 0.2; 
%for loop  
  
for i = 2:N 
     
    d = x(i); % Assign experimental displacement to d 
     
    % initial guess 4 equations with 4 unknowns (x1, x4, x5, and z) 
    x0 = [alpha*d; beta*d; (1-1.1*(alpha+beta))*d; (alpha+beta)*0.9*d]; 
     
    %[X,FVAL,EXITFLAG,OUTPUT]=FSOLVE(FUN,X0,OPTIONS) 
    [xx, fval, Exit_Flag, Output] = fsolve(model, x0, options); 
     
    x1 = xx(1); 
    x4 = xx(2); 
    x5 = xx(3); 
    z  = xx(4); 
         
    fnorm = norm(fval); 
    iter = Output.iterations; 
     
    %if statement for ignoring points for which there is no 
convergence. 
    %Good programming practuce as suggested by Dr. Gatica  
     
    if Exit_Flag < 0 
        fprintf ('\n *** Convergence problems for point # %3i ***',i); 
        fprintf ('\n \t Exit Flag = %3i ', Exit_Flag); 
        fprintf ('\n \t %12.3g %12.3g %12.3g %12.3g', ... 
        x1, x4, x5, z); 
        fprintf ('\n ** point no. %3i (%7.3f %7.2f) \t ||f|| = %12.3g 
%4i', ... 
        i, x(i), F(i), fnorm, iter); 
        x1 = min(d, max(0,x1)); 
        x4 = min(d, max(0,x4)); 
        x5 = min(d, max(0,x5)); 
        z  = min(d, max(0,z));   
         
        F_model(i, 1) = 0; 
        F_model(i, 2) = 0; 
         
        pause(2); 
    else 
        x2 = z - x1; 
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        x3 = z - x4; 
     
        denom1 = 1; 
        if B(1) > 0 
            denom1 = (1 + B(1)*(x1^c(1))); 
        end 
         
        F1 = Fo(1) + A(1)*(x1^b(1)) / denom1; 
        F3 = Fo(3) + A(3)*(x3^b(3)); 
  
        denom4 = 1; 
        if B(4) > 0 
            denom4 = (1 + B(4)*(x4^c(4))); 
        end 
         
        F2 = Fo(2) + A(2)*(x2^b(2)); 
        F4 = Fo(4) + A(4)*(x4^b(4)) / denom4; 
     
        F_model(i, 1) = F1 + F3; 
        F_model(i, 2) = F2 + F4; 
         
    % Error term for spring#1 for biphasic equation 
    Q = denom1^2; 
    Term1 = x1^b(1)/denom1; 
    Term2 = (A(1)*x1^b(1)*log(x1))/denom1; 
    Term3 = A(1)*x1^b(1)*x1^c(1)/Q; 
    Term4 = A(1)*B(1)*x1^b(1)*x1^c(1)*log(x1)/Q; 
    
    E(i,1) = abs(FoE(1)) + abs(Term1*AE(1)) + abs(Term2*bE(1)) + 
abs(Term3*BE(1)) + abs(Term4*cE(1)); 
    % This is the error term when spring#1 is of the form F = F0 + Ax^b 
     
    %E(i,1) = abs(FoE(1)) + abs((x1^b(1))*AE(1)) + 
abs((A(1)*((x1)^b(1))*log(x1))*bE(1)); 
     
    % Error term for spring#4 
    Term5 = x4^b(4)/denom4; 
    Term6 = (A(4)*x4^b(4)*log(x4))/denom4; 
    Term7 = A(4)*x4^b(4)*x4^c(4)/denom4^2; 
    Term8 = A(4)*B(4)*x4^b(4)*x4^c(4)*log(x4)/denom4^2; 
     
    E(i,4) = abs(FoE(4)) + abs(Term5*AE(4)) + abs(Term6*bE(4)) + 
abs(Term7*BE(4)) + abs(Term8*cE(4)); 
     
    %Error in spring#2 (spring#2 is of the form F = F0 + Ax^b) 
      
    E(i,2) = abs(FoE(2)) + abs((x2^b(2))*AE(2)) + 
abs((A(2)*((x2)^b(2))*log(x2))*bE(2)); 
     
    %Error in spring#3 (spring#3 is of the form F = F0 + Ax^b) 
      
    E(i,3) = abs(FoE(3)) + abs((x3^b(3))*AE(3)) + 
abs((A(3)*((x3)^b(3))*log(x3))*bE(3)); 
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        alpha = x1/d; 
        beta  = x4/d; 
         
    % the first point is not calculated, as it is experimental 
    if i > 1 
        Bounds(i,1) = E(i,1); % CI span for Spring #1 
        Bounds(i,2) = E(i,2); % CI span for Spring #2 
        Bounds(i,3) = E(i,3); % CI span for Spring #3 
        Bounds(i,4) = E(i,4); % CI span for Spring #4 
    end 
  
    end %end statement for the 'if exitflag' 
     
end % end statement for 'for i = 2:N' 
  
N = length(x); 
  
Upper = [F_model(2:N,1) + Bounds(2:N,1),F_model(2:N,1) - 
Bounds(2:N,1)]; 
     
%display ([x F F_model]); 
  
plot( x, F, 'ro', x, F_model(:,1), 'k-*', x, F_model(:,2), 'm-s',... 
    x(2:N), F_model(2:N,1) + Bounds(2:N,1), 'b.-', x(2:N), 
F_model(2:N,2) + Bounds(2:N,2),'r.-', ... 
    x(2:N), F_model(2:N,1) - Bounds(2:N,1), 'b.-', x(2:N), 
F_model(2:N,2) - Bounds(2:N,2),'r.-'); 
  
  
title ('Augmented Rotator Cuff Repair'); 
legend ('Experiments', 'Model: F1+F3', 'Model: F2+F4'); 
grid; 
hold on  
xlabel ('Displacement, x, [mm]'); 
ylabel ('Force, F, [N]'); 
pause(5); 
hold off 
  
end % end statement for 'for k = 1:3' 
 
 
 
